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Abstract 
This thesis details the development of a system of microfabricated devices for 
the adherent culture of stem cells. The multipotency and self renewal of stem 
cells make them a potentially abundant source of valuable human cells, for both 
drug screening and regenerative medicine. However, processing stem cells is 
challenging due to the complexity of whole cell products, the number of process 
parameters, and the typical use of adherent culture. It is hypothesised that a 
microfabricated adherent culture system could facilitate process development 
with  minimal  use  of  resources.  Furthermore,  microfluidic  systems  offer 
advantages  in  spatial  and  temporal  control  over  the  microenvironment  that 
would benefit process development. 
 
An existing prototype culture system is critically evaluated by: assessing the 
design, modelling fluid flow and dissolved oxygen, and successfully co-culturing 
human  embryonic  stem  cells,  on  inactivated  mouse  embryonic  fibroblasts, 
under perfused conditions. The utilisation of reversible seals facilitates the use 
of  standard  tissue-culture  polystyrene  culture  surfaces  and  manual  seeding 
techniques.  The  evaluation  of  the  prototype  system  is  used  to  inform 
improvements to the design, making it easier to use, increasing the robustness, 
allowing monitoring of whole culture chambers by microscopy, and improving 
control over mean pericellular dissolved oxygen. Modelling shows the improved 
culture  system  also  achieves  more  uniform  distribution  of  both  pericellular 
dissolved oxygen and fluid velocity. 
 
The improved culture system shows similar mouse embryonic stem cell seeding 
behaviour  to  tissue  culture  flasks,  but,  with  medium  perfused  at  300  μl.h
-1, 
mouse embryonic stem cells reach full confluency in less than 48 h, compared 
with 72 hours for cells maintained statically in flasks. There is also inconclusive 
data suggesting that the growth rate is limited by pericellular dissolved oxygen 
and is, therefore, increased and made more uniform by the inclusion of a gas 
permeable lid system. The reliability, ease of use, comparability with traditional 
culture systems, and control over process parameters of the improved system 
should make it a useful tool for stem cell process development.   3 
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1.  Introduction 
Stem cells are a promising new area of medical research. Stem cells offer a 
potentially limitless supply of human cells due to their capacity to self-renew and 
their potential to turn into multiple cell types of the human body. Hence, they 
can potentially be utilised to repair and replace tissues treating or curing a wide 
variety of illnesses and injuries (Southwell et al., 2014, Daley, 2012). Stem cells 
also  promise  to  provide  highly  relevant  model  systems  for  drug  screening 
(Egawa et al., 2012, Huh et al., 2010, Thomson, 2007). However, few stem cell 
therapies have thus far made it to the market (FDA, 2015). This is due, in part, 
to the difficulty of developing efficient production processes.  
 
Stem  cell  processing  presents  a  number  of  additional  challenges  when 
compared with the established mammalian cell bioprocessing sector (Kirouac 
and Zandstra, 2008). In stem cell processes, the cell itself is the product rather 
than a protein or small molecule. Whole cells are significantly more complex 
products  to  characterise  and  must  be  kept  viable,  functional,  and  safe 
throughout  processing  (Peterson  and  Loring,  2014,  Taapken  et  al.,  2011, 
Mitalipova et al., 2005). Additionally, the potential of stem cells to differentiate 
introduces a requirement to produce the right cell phenotype (Lee et al., 2013a, 
Serra et al., 2012). However, cell growth and cell fate are influenced by a large 
number  of  physical,  chemical  and  biological  factors,  the  optimum  values  of 
which change over time (Chen et al., 2014, Serra et al., 2012, Wagers, 2012, 
Discher  et  al.,  2009,  Scadden,  2006).  Consequently,  there  is  a  very  large 
experimental space to explore. 
 
Unfortunately, many of the factors required for stem cell culture are extremely 
expensive (Serra et al., 2012). Furthermore, most stem cells do not naturally 
grow in suspension culture (Thomson et al., 1998, Amit et al., 2000, Itskovitz-
Eldor et al., 2000, Kehat et al., 2001, Takahashi and Yamanaka, 2006) and 
adaptation to suspension may impact product quality. While suspension culture 
is well established in the biopharmecuticals industry, adherent culture is less so. 
Adherent cultures are typically performed in culture wells, culture flasks, and 
multilayered flasks (Serra et al., 2012). These are poor analogies to the highly 16 
 
controlled and automated reactors used for suspension culture at bench, pilot, 
and production scale. A potential solution is microfluidics, where volumes are 
reduced to the order of microliters allowing better control and requiring fewer 
resources (El-Ali et al., 2006). Such a culture device would need to be carefully 
designed to control the wide variety of relevant factors while remaining relatable 
to other culture systems.  
 
 
1.1  What are Stem Cells? 
The term ‘stem cell’ encompasses a relatively broad range of cells. Rather than 
having a structural or metabolic role in an organism, the role of a stem cell is to 
produce other cell types for growth, regeneration or repair. They achieve this by 
cell division and differentiation through indistinct intermediary stages to produce 
mature cell types.  Accordingly, the two key properties of stem cells are: the 
ability to turn into another cell type, and the capacity for self-renewal to avoid 
depletion (Thomson et al., 1998, Cai et al., 2004). 
 
1.1.1  Properties of Stem Cells 
Multipotency 
Multipotency is a property attributed to cells that are able to differentiate into 
multiple  types  of  more  committed  cells.  In  the  context  of  stem  cells, 
differentiation is defined as progress, by changes in gene expression, towards 
any  committed  adult  cell  phenotype.  Differentiation  is  typically  discussed  in 
terms  of  discrete  steps,  where  steps  often  represent  branch  points  in  the 
commitment to different cell types. However, it should be recognised that the 
process occurs by continuous dynamic changes in gene expression rather than 
discrete jumps from one pattern of gene expression to the next. 
 17 
 
 
Figure 1.1 - Simplified schematic illustrating how cells progress through different stages of 
potency as they differentiate. 
Adapted from Placzek et al (2009) 
 
The level of potency attributed to cells can differ; as differentiation progresses, 
cells become committed to an increasingly narrow range of cell types. Cells are 
pluripotent if they are able to differentiate into any of the multipotent primary 
germ  layers:  endoderm,  ectoderm  and  mesoderm  (Osorno  and  Chambers, 
2011).  All  adult  cell  types  are  in  turn  differentiated  from  one  of  these  germ 
layers. The progression of differentiation from pluripotency through decreasing 
levels of potency to fully committed adult cells is illustrated in Figure 1.1.  18 
 
 
Figure 1.2 - Self-Renewal of stem cells by symmetric and asymmetric division. 
Adapted from Morisson and Kimble (2006). 
 
Self-Renewal 
The  process  of  self-renewal was  reviewed  in  depth  by  Morrison  and  Kimble 
(2006). Self-renewal is the process through which identical daughter stem cells 
are produced by division of a parent stem cell. Stem cells can undertake either 
symmetric  cell  division,  producing  two  identical  daughter  stem  cells,  or 
asymmetric cell division, producing a single identical daughter stem cell and 
another more differentiated daughter cell (Figure 1.2). Importantly, the identical 
daughter stem cells have the same potency and capacity for continued self-
renewal as the parent cells. Pluripotent stem cells are considered immortal as 
they  have  the  potential to  indefinitely  self-renew  to  expand  or maintain  their 
numbers. Stem cells express very high levels of telomerase activity, particularly 
embryonic stem cells (Hiyama and Hiyama, 2007). Telomerase adds telomere 
ends  to  chromosomes  and  is  associated  with  cell  immortality.  Conversely, 
somatic cells express less telomerase activity and have a very limited lifespan. 
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Figure 1.3 - Early embryonic development illustrating the inner cell mass form which 
embryonic stem cells are derived. 
 
1.1.2  Pluripotent Stem Cells 
Embryonic Stem Cells 
Embryonic stem cells (ESCs) are pluripotent cells derived from the inner cell 
mass of a blastocyst (Figure 1.3) early in embryonic development. In normal 
development these cells go on to form all the tissues of the adult body. When 
undifferentiated  ESCs  are  implanted  into  adult  tissue  they  form  teratomas 
(tumours containing cells from all three germ layers). When mouse ESCs are 
implanted into an immunodeficient blastocyst however, they play a normal role 
in development, producing a chimeric organism, with cells of both native and 
implanted  origin  present  in  every  organ  of  the  adult  organism  (Pease  and 
Williams,  1990,  Bradley  et  al.,  1984).  This  is  also  true  of  teratoma  cells 
implanted  in  a  blastocyst  (Brinster,  1976,  Mintz  and  Illmensee,  1975).  The 
presence of cells of implanted origin throughout chimera organisms illustrates 
the pluripotency of embryonic stem cells. Furthermore, the different outcomes of 
implantation in adult tissue and implantation in a blastocyst demonstrates the 
important influence of the microenvironment on the division and differentiation 
of ESCs (Zipori, 2009, p86-87). 
 
Mouse embryonic stem cells were first derived in 1981 by Evans and Kaufman 
(Evans  and  Kaufman,  1981)  while  human  ESC  lines  were  first  derived  by 
Thompson et al in 1998 (Thomson et al., 1998). Human ESCs are derived from 
unneeded embryos prepared for in vitro fertilisation (IVF) treatment and donated 20 
 
by the parents. Both mouse and human embryonic stem cell lines were first 
derived as adherent cultures. More recently, Steiner et al (2010) achieved the 
first derivation  and expansion  of  human ESCs in  suspension. Two  of fifteen 
inner  cell  masses  and  one  intact  blastocyst  proliferated  in  suspension  to 
produce pluripotent cells with normal karyotypes. 
 
Induced Pluripotent Stem Cells 
A more recent development is the induced pluripotent stem cell (iPSC). Until 
recently, the loss of pluripotency by differentiation was considered irreversible. 
However, in 2006, Takahashi and Yamanaka showed that by introducing four 
genes into fully differentiated adult cells, those cells could be transformed into 
pluripotent stem cells similar to ESCs (Takahashi and Yamanaka, 2006). This 
new class of stem cells were classified induced pluripotent stem cells (iPSCs) 
and are often grouped with ESCs as pluripotent stem cells (PSCs). The original 
genes  introduced  to  transform  cells  were  Oct-4,  Sox-2,  Klf-4,  and  c-Myc  in 
mouse  and  human  fibroblasts  cells  and  Oct-4,  Sox-2,  Nanog,  and  Lin28  in 
human  fibroblasts  (Yu  et  al.,  2007,  Takahashi  et  al.,  2007,  Takahashi  and 
Yamanaka,  2006).  Since  then,  induction  of  a  pluripotent  stem  cell  state  has 
been demonstrated by various methods including introduction of proteins (Zhou 
et al., 2009), mRNA (Warren et al., 2010) and microRNAs (Miyoshi et al., 2011). 
 
iPSCs  are  an  important  breakthrough  for  two  key  reasons.  Firstly,  as  these 
pluripotent  cells  are  not  derived  from  human  embryos  they  do  not  have  the 
same  ethical  issues  as  ESCs.  Secondly,  iPSCs  allow  the  production  of 
pluripotent stem cells (PSCs) from any individual. This second point is important 
as  it  allows  the  production  of  more  diverse  cell  line  libraries  for  screening 
purposes and the production of autologous rather than allogeneic products for 
cell therapies (Both of these applications will be discussed further in section 
1.2).  However,  concerns  have  recently  been  raised  about  genetic  and 
epigenetic variations in iPSCs that may affect their suitability for clinical use 
(Serra et al., 2012, Lee et al., 2013a). 
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Tests for Pluripotent Stem Cells 
ESCs and iPSCs are grouped together as pluripotent stem cells (PSCs). The 
ultimate  test  to  identify  cells  as  pluripotent  stem  cells  is  to  implant  them  in 
immunodeficient  embryos  and  show  that  they  produce  chimeras  that  have 
native and implanted cells present in all tissues of the adult organism (Zhang et 
al., 2013, Buta et al., 2013). This test has been applied to mouse PSCs but is 
not ethically possible with human PSCs and less exacting tests must be used. 
When  implanted  in  immunodefficient  mice, human PSCs will form  teratomas 
containing tissues from all three germ layers (Zhang et al., 2013, Buta et al., 
2013). Similarly, it is possible to direct differentiation of PSCs to all three germ 
layers  in  vitro  or  achieve  all  three  germ  layers  through  spontaneous 
differentiation  in  embryoid  bodies  (roughly  spherical  3D  aggregates  of  cells) 
(Zhang et al., 2013, Buta et al., 2013).  
 
A  more  rapid  if  less  rigorous  assessment  is  to  check  for  the  expression  of 
certain genes, which are expressed together in PSCs but not in more committed 
cells (Zhang et al., 2013, Buta et al., 2013). Among these genes the expression 
of Oct-4, Sox-2 and Nanog are common to both mouse and human PSCs, while 
SSEA-1  is  expressed  only  in  mouse  PSCs  and  SSEA-3/4,  Tra-1-81  and 
Tra-1-60  are  expressed  only  in  human  PSCs  (Zhang  et  al.,  2013).  In  their 
review,  Schnerch  et  al  (2010)  state  that  the  Oct-4  and  Nanog  transcription 
factors are exclusively expressed in pluripotent cells of the developing human 
and mouse embryo, or its in vitro counterparts and are key to self-renewal and 
the maintenance of pluripotency. Sox-2 is also a marker of both mouse  and 
human  ESCs  despite  being  expressed  in  some  differentiated  lineages 
(Schnerch et al., 2010). Human PSCs also express the stage specific surface 
markers SSEA-3, SSEA-4, Tra-1-60, and Tra-1-81, which are down regulated in 
differentiated cells (Draper et al., 2002), while mouse PSCs express SSEA-1 
(Andrews, 1998).  
 
Maintenance of Pluripotent Stem Cells 
The maintenance of pluripotent stem cells requires the use of specific soluble 
growth factors that regulate the pathways involved in self renewal, pluripotency 22 
 
and differentiation, as reviewed by Hyslop et al (2005). Maintenance of mouse 
PSCs requires Leukaemia Inhibitory Factor (LIF) and bone morphogenic protein 
4  (BMP-4).  BMP-4  can  be  supplied  in  serum,  when  serum  is  used  to 
supplement  medium,  or  added  as  a  defined  supplementary  factor.  BMP-4 
induces genes that inhibit differentiation to neuroectoderm. LIF is always added 
as a defined supplementary factor and regulates genes to promote self-renewal 
and inhibit differentiation to mesoderm and endoderm. In contrast, maintenance 
of human PSCs requires Activin A and Transforming Growth Factor β (TGF-β), 
which can be supplemented or provided by co-cultured feeder cells, as well as 
Fibroblast Growth Factor 2 (FGF-2) as a defined supplementary growth factor. 
As  with  mouse  PSCs,  these  factors  regulate  pathways  that  promote  self-
renewal and inhibit differentiation into the various germ lines. 
 
1.1.3  Less Potent Stem Cells 
Outside pluripotent stem cells, other stem cells exist that are more specified in 
the cell types they can produce (Volarevic et al., 2011). Adult stem cells are so 
called because they are found in the various tissues of the adult body (Volarevic 
et al., 2011). Similarly, foetal stem cells are derived from tissues of the foetus 
(Can and Karahuseyinoglu, 2007). The potency of these stem cells varies from 
multipotent  haemopoietic  stem  cell  to  the  unipotency  of  muscle  progenitors. 
Like iPSCs, adult stem cells may be isolated from any individual, which allows 
the  development  of  autologous  treatments.  Reduced  potency  could  be 
considered  a  disadvantage  as  fewer  cell  types  can  be  produced.  However, 
reduced potency also results in easier processing as there is less potential to 
produce unwanted cells (Kirouac and Zandstra, 2008). As with PSCs, each type 
of stem cell expresses a certain combination of genes and requires a specific 
soluble  environment  to  maintain  their  potency,  self-renewal,  and  function 
(Scadden, 2006). 
 
1.2  Why Stem Cells are Useful? 
There are two broad uses for stem cells that take advantage of their unique 
properties. The first is as a source of cells and tissues for screening purposes 23 
 
and the second is in regenerative medicine, either directly as stem cells or as a 
source of adult cells. 
 
1.2.1  Cells and Tissues for Screening 
Stem  cells  provide  a  new  source  of  materials  for  biological  screening.  The 
development of new medicines currently necessitates animal trials followed by 
several phases of human trials. These trials are expensive and present a high 
risk both to the health of trial participants and the finances of the manufacturer. 
The development of a typical drug candidate currently takes approximately 13.5 
years and  costs  $1.8  Billion  USD  (Paul et  al.,  2010). The continuing  risk  of 
failure throughout the development process contributes significantly to this high 
expense of drug development, a cost which is then passed on to the consumer. 
Stem  cells  may  be  able  to  significantly  reduce  the  cost  and  risk  of  drug 
development as they provide a potentially unlimited source of all adult human 
cell types for screening purposes.  
 
As  stem  cells  can  produce  multiple  cell  types,  drug  candidates  could  be 
screened for their effects on both the cell types targeted by the drug candidate 
and  other  high  risk  tissues.  Stem  cells  are  also  responsible  for  replacing 
senescent, damaged and missing cells throughout the body. They are therefore 
a useful tool to study processes such as wound healing and aging and how 
these are affected by different diseases and external factors. Furthermore, there 
is  potential  to  generate  complex  3D  organoids  to  represent  different  organ 
systems in screening applications (Williamson et al., 2013, Huh et al., 2012, 
Huh et al., 2011). Some organoids have already been demonstrated including: 
vascular networks (Jeon et al., 2014, van der Meer et al., 2013), intestinal tissue 
(Kim  and  Ingber,  2013,  Kimura  et  al.,  2008),  liver  (Allen  et  al.,  2005),  lung 
(Douville et al., 2011, Huh et al., 2007), and cerebral organoids (Lancaster et 
al., 2013). iPSCs and adult stem cells are of particular interest for screening 
applications as cells can be derived with disease specific phenotypes and/or 
genotypes allowing patient specific drug screening (Yu et al., 2013, Egawa et 
al., 2012, Itzhaki et al., 2011, Liu et al., 2011). 
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The capacity to produce tissues from a wide range of human cell lines would 
allow extensive, species-specific testing of new medicines in vitro prior to in vivo 
testing. Consequently, it may be possible to eliminate or reduce animal trials 
and perform smaller, safer human trials. In addition to increasing safety for trial 
participants, this would reduce medicine development times and costs. Even if 
the length and cost of clinical trials remains the same, more representative pre-
clinical trials would reduce the risks of clinical trials and, consequently, reduce 
the  high  costs  incurred  by  drugs  failing  during  clinical  trials.  In  fact,  models 
suggest that development costs are most sensitive to the success rate of phase 
II and III clinical trials (Paul et al., 2010).  
 
1.2.2  Regenerative Medicine 
The  application  with  the  potential  for  the  most  significant  impact  to  human 
health  is  regenerative  medicine.  Regenerative  medicine  is  the  practice  of 
replacing or regenerating damaged or missing cells (Mason and Dunnill, 2008). 
While this definition describes all transplants, the term is not generally applied 
to treatments where the donated cells are not required to expand in numbers (in 
vivo or in vitro) or promote proliferation of native cells (e.g. a heart or kidney 
transplant). Consequently, bone marrow transplants are often considered the 
original regenerative medicine; cells in the transplanted bone marrow expand to 
replenish  and  maintain  blood  cells  in  the  recipient.  Regenerative  medicine 
includes the injection of cellular material (cell therapies) and the transplantation 
of grown tissues and organs (tissue engineering) (Mason and Dunnill, 2008). 
 
Pluripotent stem cells have the potential to produce any cell type in the human 
body in large quantities. Hence, it should be possible to replace any damaged 
or missing cells (Hyslop et al., 2005) with cells produced from stem cells in vitro 
or produced in vivo from implanted stem cells. Further, due to their role in the 
natural maintenance and repair of tissues, the presence of certain types of stem 
cell  may  act  to  promote  the  body’s  natural  healing  processes  (Kim  et  al., 
2007b).  
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Cell  therapies  can  be  either  autologous,  where  the  cells  originate  from  the 
patient, or allogeneic, where the cells originate from another donor (Serra et al., 
2012). Autologous therapies are medically preferable for the treatment of non-
genetic conditions as allogeneic therapies risk immune response and rejection. 
However, autologous therapies rely on the ability to derive healthy stem cells of 
the required type from the patient. Autologous therapies also require individual 
product  batches  for  each  patient  (patient  specific  medicine),  which  is  more 
demanding from a processing point of view (Serra et al., 2012). 
 
Despite the promise of stem cells there are currently only 10 cell therapies on 
the market in the USA. 5 of these therapies are based on hematopoietic stem 
cells  (FDA,  2015).  These  multipotent  stem  cells  are  responsible  for  the 
production of all blood cells. Bone marrow transplants, which have already been 
mentioned,  are  an  example  of  a  therapy  based  on  the  transplant  of 
hematopoietic stem cells. However, bone marrow transplants are not classified 
as  a  cell  therapy  by  the  FDA.  While  originally  only  transplanted  as  bone 
marrow, in recent decades haematopoietic cells have been isolated from both 
umbilical cord blood (Broxmeyer et al., 1989) and peripheral blood (Kessinger, 
1991) and expanded in vitro (Brugger, 1993). 
 
Stem  cell  therapies  are  currently  being  investigated  for  a  wide  range  of 
conditions  (Southwell  et  al.,  2014,  Daley,  2012).  Because  cell  therapies  are 
more complicated and expensive to produce than more traditional treatments, 
research  is  largely  focused  on  conditions  which  are  currently  untreatable  or 
difficult  to  manage  with  existing  treatments.  Table  1.1  lists  some  of  the 
conditions  currently  under  investigation  for  potential  treatment  by  stem  cell 
based cell therapies. 
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Table 1.1 - Conditions under investigation for treatment by stem cell based cell therapies. 
Tissue Type  Disease
 
Endocrine  Diabetes 
Blood  Immune Deficiencies 
  Sickle Cell Anaemia 
Liver  Liver Failure 
Renal  Renal Failure 
Neural  Spinal Cord Injuries 
  Parkinson’s Disease 
  Motor Neuron Disease 
  Alzheimer’s Disease 
  Ischemic Stroke 
Musculoskeletal  Muscular Dystrophy 
  Cartilage Injuries  
  Large Bone Defects 
Eye  Retinal Degeneration 
  Corneal Injury 
  Macular Degeneration 
Cardiovascular  Myocardial Infarction 
  Stroke 
  Ischemic Limb Disease 
Dermal  Acute Burns 
  Diabetic Blisters 
A non-exhaustive list conditions under investigation for treatment by stem cell based cell therapies 
categorised by the type of tissue affected (Volarevic et al., 2011, Martínez-Morales et al., 2013, Garbern 
and Lee, 2013, Schwartz et al., 2012, Touboul et al., 2010, Sun and Zweigerdt, 2009, Hernon et al., 2006, 
Cancedda et al., 2003, Koizumi et al., 2001). 
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1.3  The Processing Challenges of Stem Cells? 
1.3.1  Product Attributes 
The  processing  of  stem  cells  presents  a  number  of  challenges  unique  from 
more  traditional  bioprocessing  (Placzek  et  al.,  2009,  Kirouac  and  Zandstra, 
2008). In stem cell processing the cells themselves are the product. Whole cells 
are significantly more difficult to characterise than proteins or small molecules. 
Furthermore,  in  traditional  bioprocesses  cells  are  deliberately  altered  to 
maximise  the  production  of  (a)  target  molecule(s).  However,  the  potential 
applications  of  stem  cells  rely  on  the  production  of  cells  that  are  viable, 
functional, and representative of in vivo cells. As such care must be taken to 
avoid mutational changes to genotype and phenotype that can occur through 
adaptation to in vitro culture conditions (Peterson and Loring, 2014, Taapken et 
al., 2011, Mitalipova et al., 2005).  
 
Karyotypic and other genotypic changes can occur when stem cells are cultured 
in  vitro,  and  increase  in  frequency  with  increasing  passage  number  (culture 
duration). It is important to test for these abnormalities and design processes 
that  minimise  their  occurrence.  Evidence  suggests  in  vitro  culture  creates 
selective  pressure  for  a  variety  of  genotypic  changes  (Peterson  and  Loring, 
2014,  Baker  et  al.,  2007).  Different  culture  conditions  can  create  selective 
pressures for different abnormalities, and the further from in vivo conditions they 
are, the more likely it is that selective pressures will be applied (Baker et al., 
2007). Therefore, it is desirable to keep culture conditions as close to in vivo 
conditions as practical. 
 
Stem cells also introduce an additional product attribute, relative to mature cells, 
through  their  ability  to  differentiate.  Specific  applications  will  require  the 
production of specific cell types and the production of other cell types will not 
only decrease process efficiency but may present safety risks. Unintentionally 
introducing multipotent cells to a treatment site may result in tumour formation 
(Lee et al., 2013a) while introducing mature cells of the wrong type may cause 
other  unforeseen  side  effects.  Ultimately,  trials  and  regulators  will  establish 28 
 
whether certain levels of contaminating cells can be tolerated but the nature and 
quantities of these cells will no doubt require careful control (Serra et al., 2012). 
 
1.3.2  Process Parameters 
Another  major  problem  with  processing  stem  cells  is  the  sheer  breadth  of 
biological, chemical, and physical factors which combine to control stem cell 
growth and differentiation (Chen et al., 2014, Cigognini et al., 2013, Serra et al., 
2012,  Wagers,  2012,  Discher  et  al.,  2009,  Scadden,  2006).  These  factors 
include surface stiffness (Gonzalez-Garcia et al., 2012), hydrodynamic shear 
stress  (Nsiah  et  al.,  2014),  concentrations  of  dissolved  gases  (Fynes  et  al., 
2014, Forristal et al., 2013), nutrients and growth factors, cell density (Gage et 
al., 2013), and the presence of other cell types (Neto et al., 2014). In vivo stem 
cells reside in niches where all these factors are optimal for stem cells to carry 
out their functions. While it is relatively easy to control the initial values of many 
of  these  factors  (e.g.  seeding  density,  initial  medium  composition,  etc), 
controlling them independently over multi-day periods is a major challenge. 
 
Processes  are  increasingly  being  designed  using  quality  by  design  (QBD) 
principles  (Rathore  and  Winkle,  2009).  QBD  involves  exploring  a  range  of 
values for each processing parameter to define a design space that produces 
product  of  acceptable  quality.  A  QBD  approach  allows  some  variation  in 
processing  parameters  (within  the  design  space)  reducing  the  risk  of  failed 
batches (Rathore and Winkle, 2009). QBD also imparts a greater understanding 
of  the  process  which  can  inform  equipment  design  and  scale-up  processes 
(Rathore and Winkle, 2009). For these reasons a QBD approach to process 
development has become increasingly favoured by regulators (Rao et al., 2009, 
Rathore  and  Winkle,  2009).  For  stem  cell  process  development,  a  QBD 
approach will mean exploring ranges of the above variables to investigate how 
they interact to affect product quality. This will obviously require a high quantity 
of  experiments.  It  also  necessitates  the  ability  to  control  each  parameter  to 
precise values, and achieve those values as uniformly as possible across the 
culture  area,  so  that  the  cultured  cells  are  representative  of  the  specific 
parameter set to be investigated. 29 
 
 
The  problematic  variety  of  process  parameters  is  compounded  by  a  limited 
understanding  of  which  factors  a  given  process  is  sensitive  to  and  how  the 
optimal levels of these factors change through differentiation (Mondragon-Teran 
et  al.,  2011,  Brack  et  al.,  2008).  Therefore  a  significant  amount  of  process 
development will be required to design production processes for each stem cell 
product  (van  der  Sanden  et  al.,  2010).  It  will  be  expensive  to  perform  this 
development at typical cell culture scales as the costs of some key materials 
are  substantial  (Serra  et al.,  2012).  The  cost  of Leukaemia Inhibitory  Factor 
(LIF), an essential growth factor for mouse ESC maintenance, is £84 per litre of 
mESC  medium  (ESG1107,  Millipore,  UK,  April  2014).  Similarly,  recombinant 
human  Lamini-511,  a  defined  extra  cellular  matrix  that  helps  maintain 
pluripotency of hESCs, costs $50 USD for sufficient material to coat a T-25 
culture flask (N-892002, Iwai, USA, April 2014). 
 
Culture substrate 
One  critical  factor  in  the  culture  of  stem  cells  is  the  culture  substrate 
(Chowdhury  et  al.,  2010,  Melkoumian  et  al.,  2010,  Smith  et  al.,  2009).  For 
culture on flat surfaces this is typically a solid sheet of material with or without a 
coating  of  extra  cellular  matrix.  In  more  complex  cultures  the  substrate  can 
involve microcarriers (Oh et al., 2009) or multi-component 3D scaffolds (Sung et 
al., 2010, Tibbitt and Anseth, 2009). Since the 1960s the majority of adherent 
culture systems have been made of polystyrene  (Berthier et al., 2012). This 
polystyrene is typically treated with oxygen plasma to become more hydrophilic 
and  is  then  classed  as  tissue  culture  polystyrene  (TC-PS).  Its  role  as  the 
standard culture substrate over the past half century and the resulting wealth of 
trusted  cell  culture  data  mean  polystyrene  remains  the  culture  substrate  of 
choice  for  cell  culture  (Berthier  et  al.,  2012).  Significant  research  would  be 
required to introduce a new material, particularly for clinical applications. 
 
Tissue-culture polystyrene is often coated in an extracellular matrix (ECM) prior 
to  cell  culture.  These  extracellular  matrices  typically  consist  of  hydrogels 
containing biopolymers, proteins and small molecules as reviewed extensively 30 
 
by Tibbitt and Anseth (2009). Like culture medium extracellular matrices can be 
complex or defined and defined matrices can be of synthetic, human or animal 
origin. Common biopolymers in ECMs include gelatine, laminin, dextran, fibrin, 
cellulose,  and  alginate  (Tibbitt  and  Anseth,  2009).  Thicker  3D  constructs  of 
these  same  hydrogels  are  also  used  as  scaffolds  for  3D  culture.  Hydrogel 
scaffolds are also made using synthetic polymers such as poly(ethylene glycol) 
(Tibbitt and Anseth, 2009). Both biopolymers and polystyrene are also used to 
make  Microcarriers  (Martin  et  al.,  2011).  Microcarrier  culture  provides  an 
intermediate  between  adherent  and  suspension  culture.  Cells  are  grown 
adherent to microcarriers that are, in turn, cultured in suspension.  
 
The culture substrate interacts with cells in a variety of ways depending on its 
biological chemical and physical properties (Reilly and Engler, 2010). Culture 
substrates  are  bioactive  where  biopolymers,  proteins  and  naturally  derived 
small  molecules  are  present  (Tibbitt  and  Anseth,  2009).  The  presence  of 
endogenous factors can affect viability, proliferation, and specific differentiation 
pathways. However, when using complex ECMs it is not clear what signalling 
pathways are involved.  An example of a complex ECM is Matrigel, which is 
widely  used  to  help  maintain  pluripotency  in  human  embryonic  stem  cells. 
Extracellular matrices that mimic the stem cell niche are likely to have the most 
positive  bioactive  effect.  For  example  decellularised  heart  tissue  has  been 
shown to be a favourable ECM for aortic smooth muscle cells and coronary 
artery endothelial cells (Singelyn et al., 2009). 
 
The  chemical  composition  of  extra  cellular  matrices  impact  the  transport  of 
soluble factors, including nutrients, waste, and signalling molecules (Tibbitt and 
Anseth, 2009). Furthermore, chemical properties of culture substrate such as 
hydrophobicity and the availability of surface groups affect cell adherence and 
motility (Lee et al., 2013b, Peyton et al., 2011, Reilly and Engler, 2010). These 
factors  in  turn  affect  stem  cell  viability,  proliferation,  and  differentiation. 
Similarly, physical properties of the substrate affect stem cells. Elastic modulus 
has been shown to influence differentiation (Lee et al., 2013b, Gonzalez-Garcia 
et al., 2012, Reilly and Engler, 2010), as have substrate geometry (Zhang and 31 
 
Kilian,  2013,  Kilian  et  al.,  2010)  and  creep  (Cameron  et  al.,  2011).  These 
properties determine the forces a cell can exert on its matrix. 
 
Forces 
As mentioned above, stem cells are sensitive to the elastic modulus and creep 
of  the  culture  substrate  which  determine  the  forces  a  cell  can  exert  on  that 
substrate.  Similarly,  stem  cells  are  sensitive  to  forces  applied  by  both  the 
culture  substrate  and  the  surrounding  medium.  Mechanical  strain  activates 
multiple signalling pathways (Zhou and Niklason, 2012) that can influence cell 
growth and fate. Cyclical uniaxial mechanical strain, applied through the culture 
substrate, affects proliferation, gene expression, and differentiation of stem cells 
(Li et al., 2012, Bayati et al., 2011, Kurpinski et al., 2006).  
 
Another important stress in stem cell culture is due to the hydrodynamic force 
resultant from the flow of culture medium (Stolberg and McCloskey, 2009). At 
extreme levels, hydrodynamic shear can impact cell viability. Historically it was 
assumed  that  a  major  source  of  cell  death  in  stirred  culture  systems  was 
hydrodynamic shear generated by the impeller (up to 100 Pa) (Heath and Kiss, 
2007, Nienow, 2006). Impellers can cause cell death when they generate micro-
eddies smaller in scale than a suspended cell or microcarrier (Croughan et al., 
1989). This requires significant agitation rates (Heath and Kiss, 2007) and can 
be prevented by increasing medium viscosity (e.g. with serum or dextran).  It 
was later established that it is in fact bubble breakup (stresses >10,000 Pa) that 
is responsible for the majority of cell damage in gassed suspension reactors 
(Heath and Kiss, 2007, Kunas et al., 2009, Michaels et al., 1996, Jordan et al., 
1994, Kunas and Papoutsakis, 1990). It was subsequently shown that the use 
of  surfactants  in  culture  medium  can  effectively  eliminate  shear induced  cell 
death due to bubble break up by occupying the gas liquid interface.  
 
Sustained  shear  stress  can  induce  cell  death  at  lower  levels  than  the 
intermittent shear stress occurring in stirred bioreactors (Heath and Kiss, 2007). 
In  laminar flow  systems,  hydrodynamic  shear  induced  cell  death  in  Chinese 
Hamster  Ovary  cells  and  in  Human  Embryonic  Kidney  cells  with  thresholds 32 
 
between  0.59  and  1.19  Pa  and  between  1.19  Pa  and  1.67  Pa  respectively 
(Tanzeglock  et  al.,  2009).  Achieving  these  levels  in  a  laminar  flow  culture 
system is unlikely unless the system utilises narrow capillaries. For example it 
would require a flow rate of ~100 ml.s
-1 between 10 cm wide parallel plates with 
3  mm  of  separation,  or  ~300  µl.s
-1  between  1  cm  wide  parallel  plates  with 
500 µm of separation. Consequently the design limitations of shear induced cell 
death on a potential culture device are minimal. 
 
At lower levels hydrodynamic shear causes washout of adherent cells. Washout 
occurs  when  hydrodynamic  shear  overcomes  the  bonds  attaching  adherent 
cells to a culture surface (or other cells when not grown as a monolayer) (Korin 
et  al.,  2009a,  Korin  et  al.,  2009b)..  Consequently,  the  exact  threshold  for 
washout will depend on the particular cells being cultured as well as the culture 
substrate.  Furthermore,  washout  is  more  likely  when  the  shear  stress  is 
maintained rather than delivered in a brief pulse (Korin et al., 2009a). Among 
measured  washout  thresholds  (Toh  and  Voldman,  2011)  report  washout  of 
mESC  cells  at  sustained  hydrodynamic  shear  of  0.1  Pa.  Alternatively,  CHO 
removal from microcarriers has been reported in stirred tank reactors with a 
maximum shear stress ~1 Pa (Heath and Kiss, 2007). These thresholds are 
more likely to be reached in a potential culture system and call for consideration 
in any system design.  
 
Below the levels required for cell washout hydrodynamic shear can still affect 
cultures  in  a  more  subtle  manner.  As  with  mechanical  strain,  hydrodynamic 
shear can affect gene expression and hence stem cell differentiation.  Among a 
number of studies into these effects (Stolberg and McCloskey, 2009, Yamamoto 
et al., 2005), Nsiah et al. (2014) report shear stresses of 0.5 Pa promote the 
expression of endothelial associated genes in mESCs and Toh and Voldman 
(2011)  report  shear  stresses  as  low  as  1.6×10
-3  Pa  priming  mESC  for 
differentiation. Currently, it has not been established what minimum level, if any, 
prevents any shear effect on stem cell gene expression. Without a clear goal in 
mind, any system for the development of stem cell culture processes should 
aim to allow the lowest possible hydrodynamic shear levels. It is a relatively 
simple matter to increase shear stress by increasing medium flow rates thus, 33 
 
the lower the shear stress achievable at a low flow rate, the broader the range 
of shear levels that can be explored.  
 
Dissolved Gases 
The concentrations of dissolved oxygen and carbon dioxide are important in all 
cell cultures. Dissolved carbon dioxide is widely used in cell culture to maintain 
the pH within a range representative of in vivo conditions. Cells are typically 
cultured  in  equilibrium  with  5%  gaseous  CO2.  Dissolved  oxygen  (DO)  is 
required for cellular respiration and can limit cell growth if not maintained at a 
sufficient concentration. Further to this, dissolved oxygen concentration affects 
the oxidative state of cells and the production of hypoxia inducible transcription 
factors, and, through these mechanisms, stem cell differentiation (Yanes et al., 
2010,  Simon  and  Keith,  2008,  Smith  et  al.,  2000).  The  concentration  of 
dissolved oxygen has different affects at different stages through differentiation 
(Mondragon-Teran et al., 2011) and can even precondition cells towards certain 
fates without actually initiating differentiation (Fynes et al., 2014, Mathieu et al., 
2014, Forristal et al., 2013, Yanes et al., 2010, Smith et al., 2000). 
 
Adherent cell culture has typically been carried out with medium in contact with 
20% gaseous oxygen (1 atm total pressure) (Mondragon-Teran et al., 2011). 
The role of dissolved oxygen in embryogenesis was reviewed by Simon and 
Keith  (2008).  In  contrast  to  typical  laboratory  practice,  typical  physiological 
dissolved oxygen is in equilibrium with 2%-9% oxygen and subtle differences in 
dissolved oxygen levels are involved in the spatially defined development of 
tissues  and  organs  during  embryogenesis.  Furthermore,  early  in  mammalian 
embryogenesis uterine  dissolved  oxygen  is  in  equilibrium  with  approximately 
2.5%  gaseous  oxygen  but  increases  to  8.6%  with  connection  to  maternal 
vasculature.  As  with  spatial  variations  these  different  dissolved  oxygen 
concentrations are associated with the control of embryogenesis. In vitro, low 
oxygen  (3-5%  gaseous)  has  been  shown  to  promote  pluripotency  of  hESCs 
(Ezashi et al., 2005). In contrast, both high (40% gaseous oxygen) and very low 
levels of dissolved oxygen (1% gaseous oxygen) have been shown to decrease 34 
 
growth rate and the expression of pluripotency markers in mESCs (Powers et 
al., 2008). 
 
Other Soluble Factors 
Stem  cells  are  also  influenced  by  a  wide  variety  of  other  soluble  factors 
(Hazeltine et al., 2013). As with all cells sufficient nutrients (glucose, glutamine, 
pyruvate, amino acids) must be supplied for cell survival and growth. Similarly, 
over-accumulation of waste molecules such as lactate can inhibit cell growth 
and survival. In addition, stem cells are sensitive to a wide variety of signalling 
molecules. These molecules can be added to the medium or secreted by cells 
in culture (Hazeltine et al., 2013, Titmarsh et al., 2012, Przybyla and Voldman, 
2012).  Secreted  molecules  can  interact  with  the  secreting  cell  (autocrine 
signalling) or neighbouring cells (paracrine signalling). Furthermore, signalling 
can occur between similar cells or between cells of different phenotypes or even 
different  species  (e.g.  human  embryonic  stem  cells  co  cultured  on  mouse 
embryonic fibroblasts) (Hyslop et al., 2005). 
 
As discussed in section 1.12, molecules can also be added to culture medium 
either individually or as part of a complex ingredient such as serum. Specific 
‘growth  factors'  are  often  added  in  different  stem  cell  culture  protocols  to 
promote  or  repress  various  differentiation  pathways.  For  example  leukaemia 
inhibitor factor (LIF) is used to maintain pluripotency in mouse embryonic stem 
cells while basic fibroblast growth factor (FGF2) is used to the same end with 
human embryonic stem cells. Stem cells are sensitive to the concentration of all 
these  soluble  factors  (autocrine,  paracrine  and  exogenous)  with  relatively 
narrow ranges of concentration having optimal effects (Titmarsh et al., 2012). 
 
Cell Density 
The concentration of secreted factors is partly dependent on the cell density 
making it another key factor in stem cell culture (Gage et al., 2013, Whyte et al., 
2011, Ghosh et al., 2010, Lu et al., 2009, Bitar et al., 2007, Reubinoff et al., 
2000). Cell density affects the rate at which nutrients are consumed and waste 35 
 
and signalling molecules released (Csaszar et al., 2012, Fong et al., 2005). Cell 
density also affects the transport of these molecules with dense multi-cell layers 
preventing  free  exchange  between  inner  cells  and  culture  medium, 
concentrating secreted molecules and depleting those supplied by the medium. 
Finally, cell density also affects the extent of physical interaction between cells; 
adhering to, pulling on, and pushing against each other. Cell density has been 
shown  to  influence  a  variety  of  stem  cell  culture  protocols  such  as:  the 
differentiation of human ESCs to pancreatic endocrine cells (Gage et al., 2013), 
the vascular differentiation of human bone marrow stromal cells (Whyte et al., 
2011),  the  endocrine  potential  of  adipose  derived  stem  cells  (Ghosh  et  al., 
2010),  the  adipogenic  differentiation  of  human  bone  marrow-derived 
mesenchymal stem cells (Lu et al., 2009), and the derivation of human ESCs 
(Reubinoff et al., 2000).  
 
Cell density varies throughout a culture as cells expand, starting at the seeding 
density and continuing to increase until the cells are passaged. This makes the 
passaging method critical. Passaging when cell density reaches a certain upper 
limit  helps  to  limit  the  level  of  cell  signalling  and  waste  accumulation  while 
maintaining minimum levels of nutrients and dissolved oxygen. Likewise, the 
density the cells are re-seeded at determines the initial levels of cell signalling. 
In some cases cells seeded as individuals perform significantly worse than cells 
seeded in clumps (e.g. hESCs in the absence of rock inhibitor) (Watanabe et 
al., 2007, Pyle et al., 2006). Where this is the case physical dissociation may be 
necessary  (e.g.  cutting  colonies  into  small  clumps)  rather  than  enzymatic 
dissociation.  
 
1.3.3  Culture Systems 
The requirements of stem cell culture systems have been reviewed in depth by 
Kirouac  and  Zandstra  (2008)  and  Serra  et  al  (2012)  amongst  others.  The 
challenging product attributes and process parameters of stem cells necessitate 
certain requirements from any potential culture system. In bioprocessing cells 
are grown in free suspension or on microcarriers wherever possible. However, 
suspension culture would require adaptation of most stem cell types (with the 36 
 
notable exception of cells occurring in the blood). Unfortunately, adaptation (as 
previously mentioned) may increase the likelihood of changes in cell phenotype 
and  karyotype  rendering  them  inappropriate  for  some  applications  (Peterson 
and Loring, 2014, Taapken et al., 2011, Mitalipova et al., 2005). Suspension 
culture also results in higher amounts of shear damage (Kehoe et al., 2010, 
Cherry and Kwon, 1990). Culture on microcarriers may require less adaptation 
than suspension culture but results in a less controlled microenvironment, with 
variable cell densities and transport distances in and around the microcarriers. 
Microcarrier  culture  also  makes  cell  recovery  challenging  as  cells  must  be 
detached, freed, and separated from the microcarriers. (Serra et al., 2012). 
 
 
 
Figure 1.4 - Suspension and adherent culture scale-up trains. 
A typical suspension culture scale-up train compared to the available scale-up train for adherent 
culture.  For  suspension  culture  scale,  control  and  monitoring  increase  from  shaken  microwell 
plates through shake flasks, bench-top reactors, and pilot reactors to full scale bioreactors. For 
adherent  culture  it  is  possible  to  scale  up  from  wells  to  multi-layer  systems  but  control  and 
monitoring are similar at all scales. 
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Initially,  pluripotent  stem  cells  could  only  be  isolated,  maintained,  and 
differentiated  in  adherent  culture  (Thomson  et  al.,  1998,  Amit  et  al.,  2000, 
Itskovitz-Eldor  et  al.,  2000,  Kehat  et  al.,  2001,  Takahashi  and  Yamanaka, 
2006). More recently some processes have been demonstrated in suspension 
and on microcarriers (dos Santos et al., 2014, Serra et al., 2012, Fluri et al., 
2012, Sun et al., 2011, Steiner et al., 2010). However, adherent culture remains 
a mainstay of stem cell processing, particularly in the later differentiation stages 
of a process. A variety of systems are available for adherent culture, though 
none reach the same scale as industrial suspension. These systems include 
culture wells and flasks, and multilayer systems (e.g. Cell Factories by Thermo 
Fischer  Scientific,  Millicell  HY  Flasks  by  Millipore,  and  HYPERFlasks, 
CellStacks, and CellCubes by Corning). However, these are poor analogies to 
the  highly  controlled  and  automated  reactors  used  for  suspension  culture  at 
bench, pilot, and production scale (Figure 1.4). 
 
Hollow fibre bioreactors are a notable exception to the above points. Hollow 
fibre bioreactors were first developed in the 1970s for mammalian cell culture 
(Knazek  et  al.,  1972).  Typically  medium  is perfused  through  multiple  narrow 
tubes  made  of  a  semi-permeable  material,  while  cells  grow  in  the  space 
surrounding these fibres. Alternatively, cells can be grown inside the fibres and 
medium  perfused  in  the  external  space  (Roberts  et  al.,  2012).  Soluble 
components, bellow a certain size, are exchanged through the fibre walls. In 
this way nutrients can be supplied and waste molecules removed while the cells 
are shielded from any shear stress. Hollow fibre bioreactors offer significantly 
higher  culture  areas  than  flat  sheet  culture  systems.  However,  hollow  fibre 
bioreactors do not allow continuous non-invasive monitoring of cultured cells by 
microscopy. Cell recovery may also be suboptimal as hollow fibre bioreactors 
were  initially  designed  for  the  production  of  secreted  molecules  rather  than 
whole cells. 
 
A  major  challenge  with  current  adherent  systems  is  control  of  soluble 
microenvironment.  The  majority  of  adherent  culture  systems  do  not  perfuse 
medium. Therefore there is limited control over the concentration of  nutrient, 
waste, and signalling molecules. The concentrations of these soluble factors will 38 
 
rise and fall between medium exchanges at variable rates depending on cell 
density (Csaszar et al., 2012, Fong et al., 2005). In systems where medium is 
perfused, velocity distributions are non-uniform and flow paths are long resulting 
in a highly variable soluble environment (Aunins et al., 2003). Furthermore, as 
adherent systems are not well mixed the concentration of dissolved molecules 
will vary with distance from the cultured cells. This includes dissolved oxygen 
(DO). Even when there is an external source of oxygen it must diffuse from that 
gas supply or head space (Millman et al., 2009, Serra et al., 2010). 
 
A second challenge with adherent systems is monitoring (Jaccard et al., 2014a). 
The  well  established  monitoring  methods  employed  with  suspension  culture 
systems are often unsuitable for adherent culture as they assume a well mixed 
system. Monitoring of the soluble environment typically involves measuring at a 
single point and assuming that point is representative of conditions throughout 
the culture system. As outlined above, adherent systems are not well mixed and 
conditions vary with distance from culture surfaces. Additionally, monitoring of 
cell  density  and  quality  rely  on  measuring  a  representative  cell  suspension 
which is clearly not possible without significant disruption in an adherent system 
(Jaccard et al., 2014a). 
 
1.4  What is Microfluidics? 
One  promising  technology  for  stem  cell  culture  is  microfluidics.  Microfluidics 
makes use of microfabrication techniques to reduce unit operations to the scale 
of  microlitres  or  smaller  (Whitesides,  2006).  Microfluidic  or  microfabricated 
systems have advantages for stem cell culture in terms of both reduced size 
and high levels of control. This makes them well suited for the development of 
stem cell processes. 
 
1.4.1  Microfabrication Techniques and Materials 
The field of microfluidics makes use of a variety of solid materials. One of the 
origins of microfluidics is microelectronics and as such it makes extensive use 
of  silicon  and  silicon  oxide  (Becker  and  Gartner,  2008,  Whitesides,  2006). 39 
 
However, microfabrication techniques have expanded to use glass, metals, and 
thermosetting  and  thermoplastic  polymers  (Becker  and  Gartner,  2008, 
Whitesides,  2006).  The  most  notable  polymer  used  in  microfluidics  is 
poly(dimethylsiloxane)  (PDMS)  (Berthier  et  al.,  2012);  an  elastomeric, 
thermosetting polymer which is ubiquitous in modern microfluidics. PDMS is a 
low-cost, non-toxic polymer that is highly gas permeable, has a low stiffness, 
and is optically transparent to wavelengths greater than 230 nm (Berthier et al., 
2012,  Sia  and  Whitesides,  2003).  These  properties  are  well  suited  to 
microfabrication techniques, gas delivery, and optical and fluorescent analysis. 
However, PDMS has been shown to absorb small hydrophobic molecules and 
leach unlinked oligomers, which can impact on biological applications (Regehr 
et al., 2009). Thermoplastic polymers are also popular in microfluidics due to 
their  low  cost,  ease  of  manufacture  and  optical  transparency  (Becker  and 
Gartner, 2008). 
 
Microfabrication techniques are focused on introducing micro-scale features to 
solid  substrates  and  the  bonding  of  those  substrates.  Microfabrication 
techniques for polymers have been thoroughly reviewed by Becker and Gartner 
(2008).  One  common  technique  to  introduce  features  is  photolithography. 
Photolithography uses a mask to protect part of a surface from electromagnetic 
radiation. The surface hit by the radiation is altered such that it is harder or 
easier to remove, by a method such as a chemical wash, and leaves a structure 
corresponding to the mask. Photolithography can use lenses to shrink  mask 
features and wavelengths including UV light or x-ray radiation depending on the 
substrate material. A similar technique is etching which uses a chemical to strip 
material from some areas while other areas are protected from the chemical by 
a mask. It can be difficult to deliver vertical feature edges, using both these 
techniques,  as  the  etching  chemical  or  light  used  can  spread  under  the 
protective mask. This problem worsens with increasing channel depth. 
 
Other techniques for targeted removal of material are laser ablation (Becker and 
Gartner,  2008),  which  uses  focused  electromagnetic  radiation  to  remove 
material,  and  micro-milling,  which  uses  small  milling  cutters  to  physically 
remove  material.  Micro-milling  can  give  very  high  dimensional  accuracy  and 40 
 
vertical feature boundaries. However it is very time consuming as the rate of 
tool travel is limited by the force that can be applied to the tool and the heat the 
tool  generates.  Micro-milling  also  has  a  minimum  tool  size  limit  of  5  μm  in 
diameter  (PMT,  2014),  limiting  the  minimum  feature  size.  Conversely,  laser 
ablation is rapid and can achieve much smaller feature sizes (Pronko et al., 
1995). However, laser ablation typically uses non-square intensity profiles (e.g. 
Gaussian  for  CO2  lasers)  and  produces  unclean  feature  boundaries  due  to 
alteration of adjacent material. 
 
Alternatively, some techniques introduce material. Techniques such as vapour 
deposition, electroplating, printing, and spin coating can be used to add thin 
layers  of  material.  For  thicker  features,  replication  methods  such  as  casting 
(Whitesides et al., 2001), injection moulding (McCormick et al., 1997) and hot 
embossing  (Martynova  et  al.,  1997)  are  more  suitable  (Becker and  Gartner, 
2008). These three methods all require the use of a negative mould. These 
moulds are typically fabricated by techniques such as photolithography, laser 
ablation  or  micro-milling.  Injection  moulding  and  hot  embossing  are  typically 
used with thermoplastics, which are also compatible with techniques such as 
micro-milling  and  laser  ablation.  However,  a  single  mould  can  be  used 
repeatedly  to  rapidly  produce  multiple  identical  parts.  Casting  is  used  with 
thermosetting  polymers  such  as  PDMS,  which  are  not  compatible  with 
techniques that remove material such as micro-milling. 
  
Fabricated parts can be bonded together into more complex assemblies by a 
variety  of  techniques  (Tsao  and  DeVoe,  2009,  Becker  and  Gartner,  2008). 
These techniques include; adhesive bonding, eutectic bonding, anodic bonding, 
direct silicon-silicon bonding, thermal bonding, and plasma bonding. The choice 
of bonding technique depends on the materials to be bonded. Parts made of the 
same thermoplastic can be thermally bonded by applying pressure and heating 
them  near  or  above  their  glass  transition  temperature.  PDMS,  on  the  other 
hand, can be bonded to some materials (such as PDMS and glass) by exposing 
the surfaces to be bonded to air plasma before contacting them. Both these 
techniques are superior to adhesive bonding as the added adhesive may alter 
feature dimensions and/or leach. 41 
 
 
1.4.2  Advantages of Microfluidics 
General Advantages 
The most obvious advantages of microfluidic systems are reduction in the size 
and, consequently, the capital and spatial requirements of equipment, the use 
of consumables, and the size of samples (Whitesides, 2006). This can have 
benefits  in  terms  of  both  operating  costs  and  safety  (when  dealing  with 
hazardous  mixtures  or  intermediates).  Furthermore,  because  of  the  small 
distances involved, microfluidic systems are well suited to finely controlled heat 
and mass transfer by diffusion (Berthier et al., 2012, Whitesides, 2006). Finally, 
the  less  obvious  advantages  of  microfluidic  systems  are  the  physical 
phenomena that occur at when surface effects are much more significant than 
bulk effects, e.g. laminar flow (Whitesides, 2006). 
 
Advantages for Stem Cell Processes 
Microfluidic culture devices have small culture areas and small culture chamber 
volumes.  Furthermore,  culture  chambers are  typically  fully  enclosed  allowing 
large  culture  area  to  volume  ratios  (Paguirigan  and  Beebe,  2008). 
Consequently,  microfluidic  systems  can  allow  significant  reductions  in  the 
required quantities of both expensive growth factors, and difficult to isolate stem 
cells (Berthier et al., 2012). In addition, the fully enclosed chambers eliminate 
meniscus effects, and reduce evaporation compared to open vessels. In any 
culture  system  evaporation  will  increase  the  concentration  of  soluble  factors 
over  time.  Additionally,  in  static  systems  with  a  medium/gas  interface  (e.g. 
culture  wells  and  flasks)  evaporation  can  reduce  the  height  through  which 
gases must diffuse affecting pericellular concentrations. Menisci similarly create 
non-uniform medium heights as well as interfering with imaging of the cultured 
cells (Paguirigan and Beebe, 2008). 
 
Microfluidic systems also offer advantages in control over a number of factors 
important  to  stem  cell  fate  and  function  (Berthier  et  al.,  2012).  The  short 
characteristic  lengths  in  microfluidic  systems  facilitate  rapid  heat  and  mass 42 
 
transfer  by  diffusion  (Paguirigan  and  Beebe,  2008).  Rapid  heat  and  mass 
transfer  in  turn  allows  fine  control  over  temperature  and  concentration  of 
dissolved  gases.  Similarly,  fine  spatial  and  temporal  control  over  the 
concentration of soluble factors is possible thanks to the laminar flow typical in 
microfluidic systems (Paguirigan and Beebe, 2008). Laminar flow can be used 
to  establish  highly  uniform  fluid  velocity  fields  as  well  as  spatially  precise 
concentration gradients (Dertinger et al., 2001). 
 
1.5  What are the Requirements of a Microfluidic System for 
the Development of Adherent Stem Cell Processes? 
There are two major requirements of a microfluidic system for the development 
of stem cell processes. Firstly, the system must deliver a controlled and uniform 
microenvironment.  As  discussed  previously,  this  is  both  a  key  advantage  of 
microfluidics and a chief requirement of process development. Secondly, the 
system  must  have  comparability  with  large-scale  systems  to  allow  validation 
(Young and Simmons, 2010). Furthermore, a system should be comparable to 
existing culture wells and plates to take advantage of pre-existing research. 
 
1.5.1  A Controlled and Uniform Microenvironment 
To  achieve  a  controlled  microenvironment,  medium  must  be  perfused. 
Perfusion  of  medium  replenishes  consumed  nutrients  while  controlling  the 
accumulation of waste and signalling molecules (Yeo et al., 2013). Further to 
this the medium must be perfused with a uniform fluid velocity field. Assuming 
the  initial  seeding  of  cells  is  uniform,  non-uniform  velocities  will  result  in 
variation  of  the  soluble  microenvironment  across  the  width  of  the  growth 
surface. In addition, perfused medium introduces shear stress, which must also 
be kept uniform by delivering a uniform velocity field. As well as being uniform, 
the  magnitude  of  shear  stress  at  the  culture  plane  should  be  controlled,  as 
shear stress can affect stem cell growth and fate (section 1.3.2). 
 
Another key factor in stem cell growth and fate is the concentration of dissolved 
oxygen  (Fynes  et  al.,  2014,  Mathieu  et  al.,  2014,  Forristal  et  al.,  2013),  as 43 
 
previously  discussed  in  section  1.3.2.  In  culture  wells  and  flasks  oxygen  is 
delivered through the direct gas medium interface above the culture surface. 
This method achieves poor control in these systems due to the large height of 
medium  through  which  oxygen  must  diffuse  (relative  to  the  diffusivity). 
Furthermore,  this  method  of  oxygen  supply  is  not  possible  in  enclosed 
microfluidic  systems. Nevertheless,  dissolved  oxygen  must  be delivered  in  a 
uniform and controlled manner. Likewise, as with all culture systems, methods 
to control pH and temperature are required (Veraitch et al., 2008). These are 
typically controlled by an incubator that heats the culture system and utilises 5% 
gaseous CO2 for pH control. Incubators may be compatible with microfabricated 
culture devices depending on their design and periphery systems. 
 
1.5.2  Compatibility with Other Systems 
To be compatible with other culture systems a microfluidic system must allow 
the use of the same materials and methods. The key material in adherent cell 
culture devices is the growth surface. Growth surfaces for monolayer culture 
have  traditionally  been  tissue  culture  polystyrene  (TC-PS).  However,  this 
material is not common in microfluidics as it is difficult to bond (Berthier et al., 
2012). A microfabricated device for process development should facilitate use 
of TC-PS substrates. Stem cells are also increasingly cultures in 3D scaffolds 
such as hydrogels (Chen et al., 2013, Sung et al., 2010, Tibbitt and Anseth, 
2009). Therefore it would be desirable if both TC-PS and 3D scaffolds could be 
readily integrated. 
 
Beyond the medium exchange regime, stem cell methods include cell seeding, 
inspection, passaging, harvesting and immunostaining. Cell seeding is typically 
conducted  statically,  with  a  cell  suspension  being  introduced  directly  to  the 
culture surface by pipette. Conversely, microfluidic culture systems commonly 
use dynamic seeding due to their fully enclosed culture chambers (Kim et al., 
2007a).  In  dynamic  seeding  a  cell  suspension  is  introduced  to  the  culture 
chamber  through  channels  at  a  defined  flow  rate.  The  flow  is  then  stopped 
allowing cells to settle and attach. Care must be taken to avoid cells settling and 
persisting  outside  the  culture  chamber  as  well  as  ensuring  cells  are  evenly 44 
 
distributed  above  all  of  the  culture  chamber  before  flow  is  stopped.  Static 
seeding typically allows finer control over the density and spatial confinement of 
seeded cells as a uniform suspension can be introduced to only the culture 
chamber (Kim et al., 2007a).  
 
As with static seeding, passaging, harvesting, and immunostaining typically rely 
on  direct  access  to  the  culture  surface.  Immunostaining  and  enzymatic 
dissociation  of  cells  could  be  performed  via  perfused  channels  but  larger 
reagent  volumes  would  be  required  and  higher  cell  loss  may  be  expected. 
Furthermore, enzymatic dissociation requires adaptation and has been shown 
more likely to impact cell karyotype than manual dissociation (Ellerstrom et al., 
2007, Mitalipova et al., 2005). Manual dissociation is also necessary where cells 
cannot be passaged as single cells e.g. hESC passaged as colony fragments 
(Ellerstrom et al., 2007). Consequently, direct access to the culture chamber is 
a key requirement of a microfabricated culture system for process development. 
 
On the other hand visual inspection does not require direct physical access to 
the culture chamber. It does, however, require clear optical access to the cells. 
Many of the materials used in microfluidics are transparent but a system must 
be designed so that the cells are not optically obstructed by opaque materials or 
complex features (Cimetta et al., 2009). Furthermore, while most materials are 
transparent to visible light fewer are transparent to the UV light which may be 
required when immunostaining. To allow in-situ immunostaining all materials in 
the light path should be transparent to wave lengths above 320 nm (for DAPI 
staining). 
 
Finally,  in  addition  to  comparability  with  existing  systems,  it  may  be 
advantageous  if  the  microfluidic  system  could  be  scaled  up  directly.  While 
processes developed on the proposed system could inform processing in other 
existing systems, they may not  be able to achieve desired levels of control. 
Therefore, a microfabricated system which could be scaled up and/or out  to 
production scale may provide a useful future production system.   45 
 
1.6  Existing Microfluidic Adherent Stem Cell Culture 
Systems 
A variety of microfluidic culture devices have been developed either to culture 
cells for drug screening applications, or to study specific aspects of stem cell 
culture.  However,  these  devices  have  not  been  manufactured  as  complete 
process development tools that meet all the above requirements. 
 
Screening devices include those of Tan et al (2013) for high-density hepatocyte 
culture,  Jeon  et  al  (2014)  for  the  generation  of  vascular  networks  from 
mesenchymal stem cells, and Peng et al (2013) for screening the effect of drugs 
on  cells  at  different  dissolved  oxygen  concentrations.  Unfortunately,  most  of 
these devices do not meet the need for comparability. This is due, in part, to 
their inability to incorporate TC-PS and use of static cell seeding and recovery. 
In  addition,  they  are  not  all  designed  to  precisely  and  uniformly  control  key 
parameters of stem cell process such as shear stress, dissolved oxygen, and 
the concentration of soluble molecules. 
 
Other  devices  have  been  developed  to  control  and  investigate  specific 
parameters. For example, Yoshimitsu et al (2014) investigated different defined 
media and extra cellular matrices as well as the effects of different perfusion 
rates. Xu et al (2013) produced a device to screen soluble factor concentrations 
with  no  hydrodynamic  shear.  Titmarsh  et  al  (2012)  investigated  exogenous 
factors  and  paracrine  signalling.  Giulitti  et  al  (2013)  produced  a  device  to 
investigate medium perfusion strategies. However, these devices focus only on 
the  parameter  of  interest  while  other  parameters  are  either  uncontrolled,  or 
controlled at set levels, and often aren’t uniform over the culture area. 
 
 
1.7  Research Objectives 
It is hypothesised that a system of microfabricated devices, for the development 
of processes involving the adherent culture of stem cells, will allow small-scale 
process  development  with  reduced  use  of  resources.  Furthermore, 46 
 
microfabricated systems offer advantages in the spatial and temporal control of 
process parameters, which may be useful in process development. Thus, such 
a  system  may  help  accelerate  the  development  of  processes  culturing  stem 
cells  for  both  drug  screening  and  regenerative  medicine.  An  effective  small-
scale process development tool will require high levels of spatial and temporal 
control  over  a  range  of  process  parameters,  and  comparability  with 
production-scale  culture  systems  so  that  developed  processes  can  be 
translated to these systems.  
 
The  research  in  this  thesis  aims  to  build  on  an  existing  prototype  culture 
system, to develop a system that meets these needs. Central to the system will 
be a number of microfabricated culture devices. In order to be comparable with 
production scale systems, these devices should facilitate the use of traditional 
TC-PS  culture  surfaces  and  have  directly  accessible  culture  chambers  to 
facilitate static seeding and cell recovery. The culture devices should integrate 
medium perfusion, through microfabricated channels, to achieve uniform shear 
stress  and  concentrations  of  soluble  factors  in  the  culture  chambers.  The 
culture device should also minimise the shear stress introduced by this medium 
perfusion.  In  addition  the  devices  should  have  controllable  and  uniform 
concentrations of pericellular dissolved oxygen.  
 
The  system  incorporating  the  culture  devices  should  control  key  processing 
parameters. Control over the medium flow rate will affect both hydrodynamic 
shear  and  the  concentrations  of  soluble  factors  in  the  culture  chamber. 
Similarly, medium composition shuld be controlled to affect the concentration of 
soluble  factors  in  the  culture  chamber.  Finally,  the  culture  system  should 
incorporate monitoring by phase contrast microscopy. The entire system must 
be robust and easy to use with the ultimate goal being a system that could be 
produced  and  distributed  to  stem  cell  researchers  for  application  in  process 
development. 
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2.  Investigation of a Prototype Microfabricated System 
for the Adherent Culture of Embryonic Stem Cells 
The majority of work presented in this chapter has been previously published in 
Reichen & Macown et al (2012). Portions of the text in this chapter appear as 
previously  published  (particularly  materials  and  methods).  Material  in  this 
chapter  not  appearing  in  the  above  publication  includes;  the  modelling  of 
dissolved oxygen (sections 2.2.4 and 2.3.3), the seeding and culture of mouse 
embryonic  stem  cells  (sections  2.2.5,  2.2.8,  2.2.9,  2.3.5,  and  2.3.6),  and 
analysis of the control and automation platform (section 2.3.8).  
 
2.1  The Prototype Microfabricated System for the Adherent 
Culture of Embryonic Stem Cells 
An autoclavable, microfabricated device for the adherent culture of embryonic 
stem cells (ESCs) was previously developed at University College London by 
Marcel  Reichen  (Reichen,  2012,  Reichen  et  al.,  2012).  The  prototype 
microfabricated culture device was designed with a re-sealable culture chamber 
to  allow  traditional  static  seeding  in  an  otherwise  fully  assembled  device. 
Additionally, the prototype device was designed to reversibly seal with a TC-PS 
microscope slide (or any other standard-sized microscope slide), allowing the 
use of standard culture substrates. Furthermore, a multiplexed automation and 
control  platform  was  developed  to  house  three  of  these  prototype  devices 
simultaneously, and control them through perfusion cultures for several days 
(Reichen et al., 2013). 
 
The prototype culture system required evaluation to demonstrate its stem cell 
culture  potential  and  to  elucidate  areas  requiring  improvement.  To  be  an 
effective  tool  the  system  needs  to  be  robust  and  easy  to  operate.  The  key 
design features needed evaluating to ensure they were fit for purpose, including 
the low shear perfusion system, the re-sealable lid and the reversible method of 
sealing. Critically, the ability to culture stem cells in the prototype device needed 
to be demonstrated. This included demonstrating that the prototype device can 
be effectively sterilised and seeded with cells as well as showing the expansion 48 
 
of  stem  cells  and  maintenance  of  pluripotency  when  following  standard 
expansion protocols. 
 
 
2.2  Materials and Methods 
2.2.1  Fabrication of the Culture Device 
All parts and moulds were based on the designs of Marcel Reichen (Reichen, 
2012).  3D  designs  were  reproduced  as  parts  in  SolidWorks  CAD  (computer 
aided design) software (SolidWorks 2010, Dassault Systemes SolidWorks, UK). 
Technical drawings are shown in Appendix 1. Polycarbonate (PC) parts were 
fabricated  from  3  mm  and  5  mm  sheets  with  a  CNC  micro-milling  machine 
(M3400E,  Folken  Industries,  USA)  using  2-flute  standard  length  end  mills 
(Kyocera  Micro  Tools,  USA).  The  G-code  for  the  micro-milling  machine  was 
generated from the CAD files using MasterCam software (MasterCam X2, CNC 
Software, USA).  
 
Structured  poly(dimethylsiloxane)  (PDMS)  (Sylgard  184,  Dow  Corning,  USA) 
parts  were  cast  in  moulds  milled  out  of  5 mm  thick  PC,  and  3  mm  thick 
aluminium.  The  monomer  and  curing  agent  were  mixed  at  a  10:1  ratio  (by 
weight),  degassed  in  a  vacuum  desiccator  to  remove  bubbles,  poured  into 
moulds, and degassed a second time.  The mould was covered with a flat sheet 
of polycarbonate, clamped between aluminium plates, and cured at 90°C for 2 
hours.  Once  cooled,  parts  were  removed  from  the  moulds  and  any  excess 
PDMS trimmed away with a scalpel.  
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Figure 2.1 - Schematic of fabrication process for PDMS chip. 
The fabrication of the PDMS chip involves casting a structured layer in a micro-milled mould, spin 
coating a thin spacer layer on a silicon wafer, and bonding the two together using air plasma. 
 
PDMS ‘spacer layers’ were fabricated by spin-coating PDMS onto silicon wafers 
using a standard spin coater. (P6708D, Specialty Coating Systems, USA). A 
4” silicon  wafer  (Prolog  Semicor,  Ukraine)  was  silanised  by  placing  it  in  a 
vacuum  desiccator with  200  μl of Trichloro(1H,1H,2H,2H-perfluorooctyl)silane 
(448931, Sigma-Aldrich, UK) for 2 hours. 5 ml of degassed PDMS monomer-
curing agent mixture was transferred to the centre of the wafer using a syringe. 50 
 
The wafer was spun at 500 RPM for 50 seconds and then cured at 90ºC for 
1 hour. PDMS chips and spacer layers were bonded using air plasma (90 s, 
30 W, 500 mTorr, PDC-002, Harrick Plasma, USA), and cured in an oven at 
90ºC for 2 hours. Figure 2.1 shows a schematic of the fabrication steps. 
 
2.2.2  Burst Pressure Measurements 
To measure burst pressure a 10 ml plastic syringe (613-3931, VWR, UK) was 
connected  to  one  interconnect  bar  via  tubing  and  a  3-way  valve  (732-8103, 
Bio-Rad Laboratories, UK). Tubing connected to the other interconnect bar was 
blocked with a Luer lock plug. The third port of the 3-way valve was connected 
to a pressure sensor (40PC100G, Honeywell, USA) glued into a fitting (P-207, 
Upchurch Scientific, USA) with epoxy glue. A syringe drive was used to pump 
air into the device at 5 ml.min
-1 and the pressure was logged using LabVIEW 
software (LabVIEW 2011, National Instruments, USA) and a data acquisition 
card  (USB-6229BNC,  National  Instruments,  USA).  The  burst  pressure  was 
taken as  the  highest  pressure  recorded for  a  given  experiment. A  prototype 
device was assembled and disassembled 12 times. Each time the  prototype 
device was assembled the burst pressure was recorded 3 times. Additionally, 
for  the  last  3  assemblies,  single  burst  pressure  measurements  were  made 
following iterations of  lid  removal  and  reinsertion.  Measurements  were  made 
following 1-10,  20  and  30  iterations.  Lid  replacement  burst  pressures  were 
normalised  against  the  initial  burst  pressure  before  applying  analysis  of 
variance  to  investigate  the  relationship  between  burst  pressure  and  lid 
replacement. All device components used for burst pressure experiments had 
previously been autoclaved. 
 
2.2.3  Fluid Dynamic Modelling 
Fluid  flow  through  the  PDMS  chip  and  culture  chamber  was  modelled.  The 
Navier-Stokes equations were solved by using the finite element method (FEM) 
software package COMSOL Multiphysics 4.4 (COMSOL, Cambridge, UK). The 
bulk  fluid  was  water  at  a  temperature  of  310K,  with  the  viscosity  (of  water) 
modified to 7.8×10
-4 Pa.s (Bacabac et al., 2005) to reflect the higher viscosity of 
cell  culture  media.  Fully  developed  steady-state  flow  was  assumed  for  the 51 
 
laminar flow physics, with no-slip conditions at the boundaries. The pressure at 
the  outlet  was  set  to  0  Pa  and  the  flow  at  the  inlet  was  set  to  300  μl.h
-1. 
Tetrahedral elements were employed to mesh the 3-D domains of the culture 
device. The mesh size was between 40 to 100 µm with a scaling factor of 3 in 
the z dimension resulting in 6.3×10
6 elements. The model was solved with a 
built-in GMRES iterative solver.  
 
Hydrodynamic  shear  stress  at  the  culture  surface  was  calculated  from  the 
simulated velocity profile using equation 2.1, where h is the shear stress at a 
height h from the surface,  the dynamic viscosity and γ the average shear rate 
from the FEM model. 
   h   (2.1) 
To verify the calculated shear stress from the model, the analytical solution for 
the wall shear stress between infinite parallel plates was used (equation 2.2). 
w h
Q
6 2 W      (2.2) 
w is the shear stress at the wall, h the height of the culture chamber, w the 
width of the culture chamber,  the dynamic viscosity and Q the volumetric flow 
rate. 
 
2.2.4  Dissolved Oxygen Modelling 
The dissolved oxygen (DO) expected in the culture medium was calculated at 
different  gaseous  oxygen  concentrations  and  cellular  oxygen  uptake  rates 
(OURs) using the parameters shown in Table 2.1 (Macown et al., 2014). 
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Table 2.1 - Parameters used for dissolved oxygen modelling. 
Parameter  Value/Formula  Units
  Source 
Solubility of O2 in Media  9.04×10
-7  mol.cm
-3.atm
-1  (Nishikawa et al., 2008) 
Diffusivity of O2 in Media  2.00×10
-5  cm
2.s
-1  (Nishikawa et al., 2008) 
Maximum O2 
Consumption During 
Growth Phase 
2.80×10
-17  mol.cell
-1s
-1  Mouse ESCs at 20% and 
40% O2, (Powers et al., 
2008) 
Minimum Cell Density  5.00×10
4  cells.cm
-2  Typical Seeding Density 
(mESC) 
Confluent Cell Density  8.00×10
5  cells.cm
-2  Typical Confluent Density 
(mESC) 
 
Fick’s law (equation 2.3) was used to calculate DO concentrations in statically 
cultured flasks and culture wells. It was assumed the rate of change of OUR is 
low enough that DO concentrations could be approximated using steady state 
calculations. At steady state, the flux is equal to the oxygen uptake rate, which 
is the product of oxygen consumption per cell (OC) and cell density (CD). The 
equation  can  then  be  integrated  across  a  layer  of  uniform  material  to  give 
equation 2.4. 
x
C
D J


    (2.3) 
D
x CD OC
C C 1 2
  
     (2.4) 
where J is the flux in mol.cm
-2s
-1, D is the diffusion coefficient in cm
2s
-1, C is the 
concentration in mol.cm
-3 and   is the length of the diffusion path in cm. At the 
interface with atmosphere, C1 is the saturation solubility of O2 in the material. 
 
The distribution of dissolved oxygen in  the prototype device under perfusion 
conditions  was  modelled  using  the  finite  element  method  (FEM)  software 
package COMSOL Multiphysics 4.4 (COMSOL, Cambridge, UK). The PDMS 
chip was previously built as a 3D model in COMSOL for fluid dynamic modelling 
with physics for laminar flow (section 2.2.3). For DO modelling, “transport of 
dilute species” physics were added to the model. The consumption of oxygen 
was  modelled  as  a  constant  flux  out  through  the  culture  surface  with  a 
magnitude equal to the OUR. All other surfaces were specified to have no flux. 53 
 
The inflow of medium at the inlet had a dissolved oxygen concentration of 0.2 
mol.m
-3,  the  saturation  concentration at 37°C and 1.05  atm.  Oxygen  left  the 
system at the outlet dissolved in the waste medium. The model was solved for 
two OURs, 1.40×10
-8 and 2.24×10
-7 mol.m
-2s
-1, representing mESCs at typical 
seeding and fully confluent cell densities respectively. 
 
2.2.5  Sterilisation Study 
Two PDMS chips and two polycarbonate lids were incubated for 17 hours at 
37°C in Terrific Broth containing E. Coli XL10-Gold Kan® (Stratagene, UK). One 
of each type of part was then autoclaved at 121°C for 20 minutes. Following 
autoclave, each of the four parts were placed in separate shake flasks of sterile 
Terrific Broth and incubated on a shaker for 6 hours. A flask containing only 
media  was  also  incubated  as  a  negative  control.  After  6  hours  the  optical 
density of broth samples at 600 nm (OD600) were measured  relative to the 
negative control. Terrific Broth agar plates were seeded with 100 μl of broth 
from each shake flask and incubated for 1 day at 37°C.  
 
2.2.6  Mouse Embryonic Stem Cell Maintenance 
E14Tg2a  mouse  embryonic  stem  cells  (passage  number  <70,  Stem  Cell 
Sciences, Edinburgh, UK) were maintained in T-25 Nunclon® cell culture flasks 
(156367,  Fisher Scientific,  UK)  and  passaged  1:8 every  three  days.  Prior to 
passaging flasks were coated with 0.1% gelatin (G1890, Sigma-Aldrich, UK) for 
15 minutes at room temperature. To passage, medium was aspirated from a 
flask,  the  surface  was  washed  with  Dulbecco’s  phosphate  buffer  solution 
(DPBS)  (D1408,  Sigma-Aldrich,  UK),  and  then  the  cells  incubated  with 
trypsin:EDTA (ethylenediaminetetraacetic acid) solution (T4049, Sigma-Aldrich, 
UK) for 3 minutes. The trypsin was quenched with culture medium and the cell 
suspension was centrifuged at 500 g for 3 minutes. The pellet was resuspended 
in culture medium consisting of Knock-Out Dulbecco’s Modified Eagle Medium 
(10829-018) supplemented with 15% v/v Fetal Bovine Serum (26140-079), 1% 
v/v  100x  Glutamax  (35050-038),  1%  v/v  100x  non-essential  amino-acids 
(11140-035),  0.1mM  β-mercaptoethanol  (31350-010,  Life  Technologies,  UK) 
and 10 ng.ml
-1 Leukaemia Inhibitory Factor (130-095-779, Miltenyi Biotech, UK). 54 
 
One eighth of the cell suspension was used to seed each new flask with a total 
volume of medium per flask of 7 ml. Flasks were incubated at 37°C and 5% 
CO2 with medium exchanged two days after passage. 
 
2.2.7  Ethics Statement 
Primary  mouse  embryonic  fibroblasts  (MEFs)  were  derived  from  mouse 
embryos,  which  were  harvested  at  day  12.5-13.5  of  pregnancy  (E12.5-13.5) 
from  a  naturally  mated  CD-1  female  mouse.  The  pregnant  female  and  the 
embryos  were  humanely  sacrificed  following  Schedule  1  of  the  Animals 
(Scientific Procedures) Act 1986, for which specific ethical approval and licence 
are not required according to UK regulations. 
 
2.2.8  Human Embryonic Stem Cell Maintenance 
Cells of the Shef-3 hESC line (< passage 70), obtained from the UK Stem Cell 
Bank, were cultured on a layer of feeder cells consisting of inactivated MEFs (< 
passage 5). They were passaged every 3 days into T-25 Nunclon® cell culture 
flasks and cultivated in a humidified incubator at 37ºC with 5% CO2.  
MEF’s were maintained in Dulbecco’s Modified Eagle Medium (DMEM) (41965, 
Invitrogen, USA) supplemented with 10% (v/v) heat inactivated foetal bovine 
serum (FBS) (10270, Invitrogen, USA) and 1% (v/v) Non-Essential Amino Acids 
(NEAA)  (11140,  Invitrogen,  USA).  They  were  passaged  every  3  days.  To 
inactivate the MEFs the growth medium was replaced with 5-7 ml of normal 
MEF  growth  medium  supplemented  with  1 mg.ml
-1  of  mitomycin C  (M4287, 
Sigma-Aldrich, UK) and incubated for 2 hours at 37 ºC. After inactivation cells 
were  washed  three  times  with  DPBS,  detached  by  incubating  with  a 
trypsin:EDTA solution (T4049, Sigma-Aldrich, UK) for 3 minutes, quenched with 
normal MEF medium, centrifuged and re-suspended in MEF media. Cells were 
seeded, at a density of 9,200 cells cm
-2, into T-25 Nunclon® cell culture flasks 
that had been pre-coated with a 0.1% (w/v) in DPBS gelatine solution (G1890, 
Sigma-Aldrich, UK) for 10 minutes at room temperature. 
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hESCs  were  cultivated  in  KnockOut  DMEM  (10829,  Invitrogen,  USA) 
supplemented  with  20%  KnockOut  Serum  Replacement  (10828,  Invitrogen, 
USA),  supplemented  with  1 %  100x  NEAA  (11140,  Invitrogen,  USA),  2 mM 
L-Glutamine  (21051,  Invitrogen,  USA),  0.1 mM  β-mercaptoethanol  (M3148, 
Sigma-Aldrich, UK) and 4 ng.ml
-1 FGF2 (fibroblast growth factor 2) (4114-TC, 
R&D Systems, USA). For passaging, medium was aspirated and flasks were 
incubated with 1.5 ml of 0.025 mg.ml
-1 collagenase solution (17104, Invitrogen, 
USA)  for  5 minutes,  before  being  replaced  with  fresh  hESC  medium.  hESC 
colonies were then dissected into medium-sized colony fragments using pasteur 
pipettes and transferred into a new flask containing feeder cells prepared as 
outlined above. 
 
 
Figure 2.2 - Device setup for seeding and perfusion. 
The device in open configuration [a], for coating of the culture surface and cell seeding by pipette, 
and the device in closed configuration setup for perfusion culture [b]. 56 
 
 
2.2.9  Seeding of Mouse Embryonic Stem Cells 
Parts  for  six  prototype  culture  devices  were  autoclaved  and  assembled  with 
sterile Nunclon® TC-PS microscope slides (16004, Fischer Scientific, UK) in a 
class II biological safety cabinet. Lids were not included in the assembly as the 
experiments required only the open configuration (Figure 2.2[a]). The culture 
chambers were filled with 0.1% gelatine solution to ensure complete coverage 
of the culture surface. Similarly, the culture surfaces of six T-25 Nunclon® cell 
culture flasks were each covered with 0.1% gelatine solution. The gelatine was 
left for 15 minutes and removed before seeding. 
 
Cells  were  harvested  from  a  T-25  flask  as  per  a  normal  passage.  The 
concentration  of  resuspended  cells  was  taken  as  the  mean  of  two 
haemocytometer measurements and the concentration of the cell suspension 
was  adjusted  to  between  3.5  10
4  and  11.5  10
4  cells.ml
-1  by  the  addition  of 
medium.  The  concentrations  of  the  adjusted  cell  suspensions  were  checked 
with a haemocytometer. The cell suspensions were then used to seed the six 
T-25 flasks and six prepared prototype culture devices. The total volume of cell 
suspension seeded was 7.5 ml and 156 μl in the T-25 flasks and prototype 
devices respectively.  The culture devices and flasks were then placed in an 
incubator  at  37˚C  with  5%  CO2.  The  prototype  devices  were  incubated  in  a 
large glass petri dish (2175553, Schott, USA) to avoid contamination. The lid of 
the petri dish was propped open by small polycarbonate blocks to allow gas 
exchange with the incubator atmosphere. 
 
Chips and flasks were removed from the incubator at set times. The media was 
aspirated  and  the  culture  surfaces  were  washed  with  DPBS.  Attached  cells 
were  then  detached  with  trypsin-EDTA  and  the  resulting  cell  suspension 
collected.  The  concentration  of  cells  in  the  aspirated  medium  and  aspirated 
trypsin-EDTA  were  measured  using  a  haemocytometer.  Haemocytometer 
measurements were repeated and means taken.  
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2.2.10 Mouse Embryonic Stem Cell Culture 
Parts for one prototype device were autoclaved and then assembled in a sterile 
manner  in  a  class  II  biological  safety  cabinet  using  sterile  Nunclon®  TC-PS 
slides  (16004,  Fisher  Scientific,  UK).  The  culture  surfaces  of  the  prototype 
device and a T-25 culture flask were coated with 0.1% gelatin (G1890, Sigma-
Aldrich, UK) for 15 minutes at room temperature. After removal of the gelatine, 
a suspension of E14 mouse embryonic stem cells (in standard mESC culture 
medium) was added by pipette to give a cell density of 4.9×10
4 cells.cm
-2 and a 
medium height of 3 mm. The device (in the open configuration; Figure 2.2[a]) 
and flask were then incubated at 37°C and 5% CO2 for four days. The prototype 
device was incubated in a large glass petri dish to avoid contamination. The lid 
of the petri dish was propped open by small polycarbonate blocks to allow gas 
exchange with the incubator atmosphere.  
 
Medium was changed in both vessels every day and images were taken on an 
inverted fluorescence microscope (Ti-E, camera Fi-1, Nikon Instruments, UK). 
Images were then analysed with PHANTAST software (Jaccard et al., 2014a) to 
calculate the confluency of stem cells in each image. The settings of ˃=3.5416, 
ʵ=0.0876, and a maximum halo removal ratio of 0.2812 were found using the 
built  in  parameter  optimisation  function.  This  optimisation  maximised  the 
F-value  (an  indicator  of  precision  and  accuracy  where  1  represents  perfect 
classification of pixels) to 0.9579 by testing different parameter sets against a 
set of manually classified pixels (selected from images of the flask and culture 
device over the four days). The remaining settings were, for halo processing, a 
minimum fill area of 25 pixels and removal of small objects setting of 400, and, 
for additional processing, removal of small objects bellow 100 pixels. 
 
2.2.11 Human Embryonic Stem Cell Culture 
Prior to each cell culture experiment, parts for one prototype culture device and 
all  tubing  and  tools  required  for  assembly  were  autoclaved  at  121°C  for  20 
minutes. The culture device was then assembled with a sterile Nunclon® TC-PS 
slide (16004, Fisher Scientific, UK) in a class II biological safety cabinet. For 
substrate  coating  and  cell  seeding,  the  lid  was  removed  (Figure  2.2[a]). 58 
 
Laboratory pipettes with disposable 200 µl pipette tips were employed for all 
steps. The TC-PS culture surfaces of the prototype device and three single-well 
dishes (353653, BD Biosciences, USA; culture area 2.89 cm
2) were coated with 
0.1% (w/v) gelatine in DPBS solution, and left to incubate at room temperature 
for  15 min.  Then,  each  dish  was  seeded  with  ~45,000  inactivated  MEFs 
(seeding density of ~15,600 cells cm
-2) in 1000 µl of MEF medium. The culture 
device  was  seeded  with  ~15,000  inactivated  MEFs  (~  28,800  cells  cm
-2)  in 
200 µl of MEF medium. (A higher cell density was chosen for the culture device 
to ensure a sufficient confluency.) The dishes and prototype culture device were 
transferred to an incubator (37 C, 5% CO2). The culture device was placed in a 
large sterile glass Petri Dish to avoid contamination prior to insertion of the lid. 1 
day  later  the  MEF  media  was  replaced  with  hESC  media,  dissected  hESC 
colonies were seeded in the prototype device and the control dishes, and both 
were incubated (37 C, 5% CO2) for a further day.  
 
After 1 day of static culture, the medium in the culture chamber was aspirated 
and  the  culture  device  closed  with  the  re-sealable  lid  (Figure  2.2[b]).  An 
autoclavable polyphenylsulfone tubing (R1230, Upchurch Scientific, USA), with 
Upchurch  fittings  (P207,  Upchurch  Scientific,  USA)  and  a  gas-permeable 
silastic  tubing  (R3607,  Tygon,  USA)  connected  a  20  ml  syringe  with  the 
prototype culture device. The two types of tubing were attached to each other 
via  Luer  adapters  (F331  and  P659,  Upchurch  Scientific,  USA).  The  gas 
permeable tubing was included to allow gas exchange between an incubator 
atmosphere and the medium, before it enters the culture chamber. The culture 
device was manually primed with culture medium using a syringe after which, 
the syringe was placed on a syringe drive (Model100, KD Scientific, USA) and 
culture medium perfused for 2 days at 300 μl.h
-1.  Everything but the syringe 
pump  was  placed  in  an  incubator  to  maintain  the  culture  temperature  and 
atmospheric  composition  (Figure  2.2[b]).  Medium  in  the  control  dishes  was 
exchanged every day. 
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2.2.12 Cell staining and imaging 
Daily cell culture inspections and end-point assay imaging were performed with 
an  inverted  microscope  (Ti-E,  camera  Fi-1,  Nikon,  UK).  Cell  staining  in  the 
culture device was performed in the open configuration. For apoptosis/necrosis 
staining,  cells  were  washed  once  with  DPBS  then  incubated  for  5  min  with 
Annexin V-FITC and propidium iodide (PI) each diluted 1:100 in binding buffer 
(K101-25, BioVision, USA).  
 
For immunostaining, hESC colonies were fixed with 4% (v/v) paraformaldehyde 
(PFA) in DPBS for 20 minutes then washed three times. All washing was with 
DPBS supplemented with 10% (v/v) FBS to block non-specific binding. Cells to 
be  stained  for  nuclear  marker  Oct-4  were  permeabilised  by  incubating  with 
0.2% Triton X-100 for 15 min at room temperature before washing a further 3 
times.  Cells  were  incubated  with  primary  monoclonal  antibodies  Oct-4  (SC-
5279, Santa Cruz, USA) or SSEA-3 (ab109868, Abcam, UK), at a dilution of 
1:200 in blocking solution, for one hour at room temperature. The cells were 
then  washed  three  times  and  incubated  with  corresponding  secondary 
antibodies  that  had  excitation  wavelengths  of  488 nm  (Oct-4,  A11017, 
Invitrogen, USA and SSEA-3, A21212, Invitrogen, USA) for one hour at room 
temperature.  Cells  stained  for  Oct-4  were  then  washed  three  times  and  co-
stained  for  Tra-1-81  by  repeating  the  primary/secondary  staining  procedure 
above with a Tra-1-81 primary (ab16289, Abcam, UK) and a secondary with an 
excitation wavelength of 555 nm (A21426, Invitrogen, USA). Finally, the cells 
were washed with DPBS and stained with 4',6-diamidino-2-phenylindole (DAPI) 
(D1306,  Invitrogen,  Carlsbad,  CA,  USA).  DAPI  at  a  dilution  of  1:200  was 
incubated with cells at room temperature for 10 minutes.  
 
Stained  cells  were  imaged  with  an  inverted  fluorescent  microscope  (Ti-E, 
camera  Fi-1,  Nikon,  UK)  using  an  LED  excitation  system  (CoolLED  pE-2, 
CoolLED,  UK).  Three  experienced  cell  culture  scientists  (>3  years  culturing 
adherent mammalian cells) counted cells staining positive for DAPI and Oct-4 in 
images  of  individual  and  partial  colonies.  Cells  in  images  of  three  different 
colonies were counted in both the culture device and the control dish. The mean 60 
 
counts across the three users were used to calculate the percentage of positive 
cells in each colony image.  
 
2.3  Results and Discussion 
2.3.1  Prototype Microfabricated Culture Device Design 
The prototype microfabricated culture device (Figure 2.3) consists of a lid (PC), 
two interconnect bars (PC), top and bottom frames (PC), a gasket (PDMS), a 
microfluidic chip (PDMS), and a TC-PS slide (Reichen, 2012). 
 
 
Figure 2.3 - Design of prototype microfabricated culture device. 
Exploded view (a) and profile view (b) of the prototype device.  61 
 
The  top  frame  includes  an  opening  to  accommodate  the  lid  as  well  as  two 
recesses.  The  first  recess  positions  the  PDMS  chip  with  respect  to  the  top 
frame, and the second deeper recess accommodates the gasket. The top plate 
also has two 1 mm diameter bores as fluidic inlet and outlets. Centred on each 
bore is a boss that compresses the PDMS chip to form a seal. The bottom 
frame  has  the  same  outer  dimensions  as  the  top  frame  and  a  recess 
dimensioned to hold the TC-PS slide. An opening in the centre is designed to 
allow close proximity between objectives from an inverted microscope and the 
TC-PS slide for cell culture imaging. The bottom frame is also open at either 
end where it extends beyond the length of the PDMS chip.  
 
The top and bottom frame are clamped together by ten M3 screws with five 
distributed evenly down each side of the frame. The central pair of screws also 
attaches the lid when in use. All the screws are tightened to 2 N.cm to form 
seals between the components by compression of the PDMS chip and gasket. 
While  a  larger  number  of  screws  ensure  a  more  uniform  distribution  of 
compressive  force,  they  also  complicate  assembly.  This  is  particularly 
problematic  when  a  device  must  be  assembled  in  a  sterile  manner.  The 
assembly is further complicated by requiring application of a precise torque to 
the screws. Care in both assembly and manufacture of parts is necessary to 
reliably deliver the correct torque. This reduced ease of use was noted and 
addressed in subsequent design improvements (section 3.3.3). 
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PDMS Chip 
 
Figure 2.4 - Design of the prototype PDMS chip. 
A top view of the PDMS chip [a], showing the flow channel structure, and a magnified view of the 
culture chamber area [b], showing the perfusion barrier layout. The chip is made of two layers (c); a 
structured layer containing the flow channels bonded to a spacer layer to elevate the channels above 
the culture surface. 
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The top layer of the prototype PDMS chip (Figure 2.4) contains the 200  μm 
deep flow channels connecting the inlet and outlet ports to the culture chamber 
(Reichen, 2012). The flow is expanded from a narrow inlet prior to the culture 
chamber and condensed back to a narrow outlet after the chamber by three 
merging channels. To promote flow uniformity across the chip, the top layer also 
includes flow equalisation barriers (or perfusion barriers) on each side of the 
culture  chamber,  each  200 µm  wide  and  1000 µm  long  (Figure  2.4[b]).  The 
apertures  between  the  barriers  have  rectangular  cross-sections  (400 µm  × 
200 µm). The identical flow resistance added by each aperture was intended to 
significantly  outweigh  the  differences  in  the  resistances  of  the  different  flow 
paths to the apertures. Therefore the relative variation in flow rate through the 
apertures would be minimal. The efficacy of perfusion barriers at distributing 
flow  has  been  previously  demonstrated  (Petronis  et  al.,  2006,  Hung  et  al., 
2005). However, these examples use a significantly larger ratio between the 
channel height prior to the apertures and the aperture height (and therefore a 
larger  ratio  between  the  flow  resistances).  The  effectiveness  of  perfusion 
barriers in this design merited further investigation, which was carried out in 
chapter 3 (section 3.3.1).  
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Figure 2.5 - The effect of inlet height on the velocity distribution immediately after 
expansion to the culture chamber. 
Raising the inlet above the culture surface (a), rather than having the inlet adjacent to the culture 
surface (b), results in low fluid velocity and hydrodynamic shear stress at the culture surface. This 
is due to the non-symmetrical velocity profiles that occur as fluid transitions from established flow 
in the inlet to established flow in the culture chamber.  
 
A more uniform distribution of flow results in more uniform concentrations of 
soluble factors perpendicular to the direction of flow. If medium travels across 
cells at the same speed, the same amount of soluble factors should be added 
and removed for each unit of distance travelled. Similarly, a more uniform flow 
distribution  will  result  in  more  uniform  shear  stress,  another  important  factor 
affecting cell growth and differentiation. In addition to striving for uniform shear 
effects, efforts have also been made to minimise them. The second (‘spacer’) 
layer of the chip elevates the first layer above the cell culture area by 120 µm 
(Figure 2.4[c]) to reduce shear stress. The shear experienced at the wall, in 
established flow between parallel plates, depends on only cross sectional area 
and flow rate (equation 2.2). However, immediately adjacent to expansions, the 65 
 
position of the inlet has an effect (Figure 2.5). A greater elevation of the inlet 
above  the  culture  surface  reduces  shear  stress  at  that  surface.  The 
effectiveness of recessed culture chambers has been previously demonstrated 
in straight channels with grooves (Korin et al., 2009b), round wells (Figallo et 
al., 2007), and rectangular chambers (Petronis et al., 2006).  
 
Culture Chamber 
Both  layers  of  the  PDMS  chip  have  a  rectangular  hole  defining  the  culture 
chamber. The chamber is 13 mm wide and 4 mm in the direction of flow, giving 
a culture area of 0.52 cm
2 (between 96-well and 48-well plates). This is large 
enough  to  produce  sufficient  cells  for  immunostaining  or  qPCR  (quantitative 
polymerase  chain  reaction)  and  may  be  sufficient  for  conventional  flow 
cytometry (e.g. 4.2×10
5 cells based on an observed confluent cell density of 
~8×10
5 with mESCs). The fabrication method can achieve a culture area of just 
0.01 cm
2 but analysis of the cells cultured in this volume would be significantly 
more  challenging.  The  design  of  the  device  limits  the  size  of  the  culture 
chamber to  the  size  of  the  PDMS  chip,  less  the  size  of  the  inlet  and  outlet 
channels. The size of the chip is in turn limited to the size of a microscope slide.  
 
The  optimum  culture  area  depends  on  the  intended  application,  requiring 
knowledge of the required number of cells and the expected final cell density. 
Investigation of different culture processes or screening applications requires 
sufficient  cells  for  statistically  relevant  analysis.  As  indicated  previously  the 
chosen culture area provides sufficient cell numbers for immunostaining and 
qPCR at typical cell  densities (0.05-1.00×10
6 cells.cm
-2). The expected dose 
sizes for medical applications range from 5×10
4 to 1×10
9 cells (Simaria et al., 
2014,  Mason  and  Dunnill,  2009).  Hence,  the  slide  limited  system  may  be 
adaptable  to  production  of  very  low  dose  personalised  treatments  if  high 
efficiencies  can  be  achieved.  However,  the  majority  of  treatments  are 
impractical to produce in a single layer system, or require removal of the size 
limitation of this design and/or significant scale-out to multiple parallel devices. 
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In addition to chamber size, the culture chamber length to width ratio must also 
be considered. When investigating the effects of specific process variables it is 
advantageous  that  these  variables  are  uniform  across  the  entire  cell  culture 
area.  However,  in  long,  narrow  perfusion  chambers,  the  consumption  and 
secretion of soluble factors by cells near the inlet alter the conditions for the 
cells downstream (Titmarsh et al., 2012). This effect is exacerbated at lower 
flow rates as upstream cells have more time to alter medium before it reaches 
downstream  cells.  Consequently,  when  designing  the  culture  area  of  the 
prototype  device,  the  length  dimension  of  the  culture  chamber  was  kept 
minimal.  The  resulting  dimensions  are  distinctly  different  from  other 
microfabricated devices for hESC culture (Yoshimitsu et al., 2014, Kamei et al., 
2009, Korin et al., 2009a, Titmarsh et al., 2011, Villa-Diaz et al., 2009). 
 
Re-sealable Lid 
Previously Tkachenko et al (2009) presented a re-sealable system that requires 
seeding  before  assembly.  In  contrast,  the  prototype  device  includes  a  re-
sealable lid enabling operation of the device in an ‘open’ configuration for cell 
seeding  and  recovery,  and  a  ‘closed’  configuration  for  medium  perfusion 
(Figure 2.2[a]). A similar system by Figallo et al (2007)  limits the height of the 
culture chamber to the total thickness of the device. However in the prototype 
device, the lid is T-shaped with the upper ‘horizontal’ bar acting as a bed stop 
when the lid is pushed into the opening of the top frame. This defines the height 
of  the  culture  chamber  at  450 µm.  The  lid  forms  a  press-fit  with  the  PDMS 
gasket to seal the chamber. The dimensions of the inserted portion of the lid 
match the footprint of the culture chamber of the microfluidic PDMS chip. 
 
In the closed configuration, the height of the culture chamber is defined by the 
re-sealable lid and the hard material of the lid does not deform during medium 
perfusion. In the open configuration, the culture chamber is directly accessible 
with  laboratory  pipettes,  facilitating  the  pipette-based  methods  typically 
employed in laboratory-scale stem cell maintenance. These methods include 
static seeding, static cell recovery and immunostaining. A further advantage of 
the  device  is  that,  in  open  configuration,  the  depth  of  media  in  the  culture 67 
 
chamber is not limited to the height of the closed chamber. Thus, larger liquid 
volumes can be used during cell seeding, staining and recovery.  
 
TC-PS Incorporation 
Tissue-culture polystyrene TC-PS is the most widely employed culture surface 
in adherent stem cell biology (Berthier et al., 2012). TC-PS is used in tissue 
culture flasks, culture wells and larger systems such as Cell Factory™ systems 
(Thermo Scientific). Thus, use of TC-PS as a culture surface makes translation 
of results to other production scales more straightforward. However, integration 
of TC-PS with microfluidic devices is difficult, as TC-PS is not compatible with 
conventional  air  plasma  or  thermal  bonding.  Consequently,  microfabricated 
devices for adherent cell culture make ubiquitous use of glass or PDMS culture 
surfaces (Young and Beebe, 2010), neither of which are commonly employed in 
regenerative  medicine  (Berthier  et  al.,  2012).  Introduction  of  novel  growth 
surfaces  to  processing  for  medical  applications,  or  accurate  comparison  of 
results  with  experiments  using  standard  materials,  would  require  extensive 
testing and validation.  
 
In  the  prototype  device,  TC-PS  is  successfully  integrated  through  use  of 
compression  seals  between  the  PDMS  components  and  smooth  surfaces. 
Furthermore, the modular design of the device allows materials other than TC-
PS  to  be  integrated  as  long  as  they  have  a  smooth,  flat  surface  and  the 
dimensions  of  a  microscope  slide;  a  common  standard  in  microfluidics  (van 
Heeren, 2012). This sealing system makes a number of materials immediately 
available for investigation. As a result, the prototype device could be employed 
to  test  growth  surface  candidates  from  microarray  screening  (Flaim  et  al., 
2005),  under the  defined  culture  conditions  obtainable  in  the  device.  This is 
analogous to the scale-up train in traditional biotechnology, where ‘hits’ from 
high-throughput screening plates are first investigated in shake flask cultures or 
small-scale bioreactors. 
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Interconnect bars 
To facilitate rapid set-up of cell culture experiments and achieve leak-free long-
term  operation,  an  easy  and  robust  interconnection  with  the  macro-world  is 
required (Fredrickson and Fan, 2004). The interconnect bars of the prototype 
device (Figure 2.3) are threaded to accept M6 Upchurch fittings and therefore 
permit simple connection with tubing for the provision and removal of media. 
The interconnect bars are interchangeable allowing the use of different fluidic 
connectors as required (e.g. ¼-28 threaded connectors). The interconnect bars 
are  simple  but  attaching  them  (by  two  screws  each)  adds  another  step  to 
assembly which is an inconvenience that could be avoided in future designs (as 
discussed in chapter 5). Further, it would be convenient to extensively reuse the 
interconnect bars but the threads tend to fail after just a few uses. This was 
addressed by different material choice in chapter 3. 
 
Burst Pressure 
The burst pressure of the prototype device was investigated to determine the 
robustness  of  the  system  and  the  multiple  compression  seals.  The  burst 
pressure is the maximum pressure that can be achieved before a rapid loss of 
pressure due to the failure of a component or seal. A positive burst pressure 
does not confirm that a system is leak free as any pathway for gradual fluid loss 
(such  as  extremely  small  channels  or  permeable  material)  that  is  available 
regardless  of  pressure  will  not  necessarily  be  detected.  The  mean  burst 
pressure of the prototype device is 59 kPa with a standard deviation of 18 kPa 
(n=36) and the lowest recorded burst pressure was 35 kPa. The mean standard 
deviation in burst pressure for the same assembly is 5% (standard deviation 
n=3, mean across 12 assemblies). Repeatedly achieving similar burst pressures 
without reassembly indicates the method of failure is reversible i.e. it is failure of 
a compression seal. 
 
In comparison to the burst pressure, the pressure drop across the device at a 
flow rate of 500 ml.h
-1 is 20 kPa. This flow rate is three orders of magnitude 
higher than the intended maximum rate of medium perfusion. Therefore, the 
significant  variation  in  the  burst  pressure  may  be  acceptable  as  it  remains 69 
 
greater  than  the  operating  pressure.  However,  high  variation  between 
assemblies indicates that the compression based seals are highly sensitive to 
variations  in  manufacturing  and/or  assembly.  Furthermore,  variation  in 
compression seal strength is most likely caused by similar variation in the level 
of compression which will also impact fluid flow. Based on this evidence, further 
investigation and design improvements were made to increase burst pressure 
reduce this variability (chapter 3). 
 
Analysis of variance shows no statistically significant relationship between burst 
pressure  and the number of times the lid is removed and reinserted for up to 30 
repetitions (α=0.05, p=0.99, n=3). For a single assembly the variation in burst 
pressure  is  significantly  lower  than  that  between  assemblies.  The  mean 
standard deviation between lid removals for a single assembly is 7% (n=12) 
relative  to 31% between assemblies  (n=12). Together,  these  results  indicate 
that the re-sealable lid can be reliably used for repeated access to the culture 
chamber  without  significant  impact  on  the  performance  of  the  device  during 
perfusion.  These  results  also  indicate  that  the  seal  around  the  lid  and  the 
manner in which the lid is attached are not responsible for the high variation in 
burst pressure. 
 
2.3.2  Modelling Velocity Fields and Hydrodynamic Shear 
To  evaluate  the  design  of  the  prototype  PDMS  chip,  the  velocity  fields  and 
shear stress produced at a flow rate of 300 μl.h
-1 were calculated numerically 
and  by  finite  element  modelling.  A  flow  rate  of  300  μl.h
-1  corresponds  to 
replacing 13.8 ml of media per day for each square centimetre of culture area, a 
rate 50 times higher than typical in hESC culture. It is therefore unlikely cells 
would ever be subjected to a higher shear stress during perfusion culture in the 
prototype device. The uniformity of the velocity field in the culture device was 
investigated at various heights above the culture surface (i.e. above the TC-PS 
slide).  
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Figure 2.6 – Distribution of fluid velocity in the prototype PDMS chip. 
The results of finite element modelling of media flow through the prototype PDMS chip at 300 μl.h
-1. 
The fluid velocity is shown at half the height of the flow channels (a), 220 μm above the culture surface 
(the same plane as half channel height) (b), and 10 μm above the culture surface (c). 
 
Non-uniform growth patterns could be caused by spatial differences in shear 
stress or spatial differences in the exchange of soluble factors. The PDMS chip 
design produces a relatively even velocity field across the majority of the culture 
chamber (Figure 2.6). Consequently there should be minimal non-uniform cell 
growth patterns which can arise from variations in velocity fields (Aunins et al., 
2003).  
 
Previous reports indicate that shear stress is a critical parameter that can lead 
to cell dislodgement during perfusion of medium (Korin et al., 2006, Korin et al., 
2009b).  In  the  prototype  device,  finite  element  modelling  predicts  a  mean 
hydrodynamic shear stress, 10 μm above the culture surface, of 1.33×10
-4 Pa ± 
0.37×10
-4 Pa (standard deviation, based on a uniform grid of 4.7×10
4 calculated 
points) at a flow rate of 300 μl.h
-1. The analytical solution for shear stress at the 71 
 
culture  surface  is  1.48×10
-4  Pa  (assuming  infinite  parallel  plates),  which 
supports  the  result  obtained  through  finite  element  modelling.  The 
hydrodynamic shear stress of 1.33×10
-4 Pa is three orders of magnitude below 
1×10
-1 Pa, the critical value previously reported for mESCs by Toh et al. (2011). 
Cell  washout  is  therefore  unlikely.  Effects  on  gene  expression  have  been 
reported at shear rates as low as 1.6×10
-3 Pa (Toh and Voldman, 2011) and 
cannot  be  ruled  out  in  the  prototype  device.  However  the  very  low  shear 
stresses achievable in the prototype devices are expected to minimise induced 
changes in gene expression. 
 
As previously discussed (section 2.3.1), low shear stress in the prototype device 
is primarily achieved through the large cross section of the culture chamber. 
The spacer layer of the PDMS chip also contributes by elevating the inlet and 
outlet  channels  120 µm  above  the  culture  surface.  This  reduces  the  shear 
stress  at  the  culture  surface  relative  to  an  identical  chamber  height  with  no 
spacer  layer.  The  effectiveness  of  recessed  culture  chambers  has  been 
previously demonstrated (Korin et al., 2009b, Figallo et al., 2007, Petronis et al., 
2006). Since the thickness of the spacer layer is determined by spin-coating 
parameters, the elevation can easily be changed. This capacity to vary how far 
the culture surface is recessed could be utilised to investigate different shear 
stress levels at a fixed medium flow rate, or different flow rates with a fixed 
shear stress.  
 
Higher velocity and culture plane shear stress are observed at the boundaries 
of  the  culture  chamber  (Figure  2.6).  The  large  gap  between  the  outermost 
perfusion barrier and the edge of the chamber has a lower resistance than the 
gaps between perfusion barriers resulting in a higher fluid velocity. This effect is 
deliberate and was included to remove air bubbles entrapped during closing or 
filling of the culture chamber. An alternative solution that does not affect flow 
uniformity  was  implemented  in  the  next  design  (chapter  3)  as  uniformity  of 
conditions is a key advantage of the microfabricated system.  
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The remaining heterogeneity in the culture plane velocity field stems from; low 
velocity areas adjacent to the perfusion barriers, low velocity caused by wall 
shear on either side of the chamber, and low velocities immediately adjacent to 
the  expansion/contraction  in  fluid  height.  Wall  shear  is  unavoidable  and  the 
fraction of the culture area affected is already reduced by the wide and short 
aspect ratio of the culture chamber. Furthermore, it is desirable to retain the 
difference in height between the channels and culture chamber as removing it 
would  significantly  increase  either,  cell  shear  stress,  or  medium  hold  up. 
Conversely, it is not clear from these results whether the perfusion barriers have 
a  net  positive  effect  on  flow  uniformity.  Consequently,  this  was  a  target  of 
further investigation (section 3.3.1). 
 
2.3.3  Modelling of Dissolved Oxygen 
Typically,  in  culture  flasks  and  culture  wells  with  direct  medium/atmosphere 
interfaces, dissolved oxygen (DO) is not controlled, only the partial pressure of 
oxygen in the local atmosphere is kept constant. Under these conditions, the 
consumption of oxygen by cells creates a DO gradient, through the depth of 
medium,  which  drives  oxygen  transport  by  diffusion.  Consequently,  the  DO 
experienced by cells (pericellular DO) will be lower than the saturation value 
and will reduce as the oxygen uptake rate (OUR) increases. Figure 2.7 shows 
how the pericellular DO varies through the duration of an open, static culture. 
Pericellular DO is shown for both a typical medium depth (3 mm), and with a 
medium  depth  equivalent  to  that  found  in  the  device  in  closed  configuration 
(0.45 mm). The figure also shows pericellular DO for local atmospheres with 
both  21%  gaseous  oxygen  (normoxic)  and  2%  gaseous  oxygen  (hypoxic) 
(1 atm pressure).  
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Figure 2.7 - Changes in pericellular dissolved oxygen through the duration of open, static 
culture. 
The pericellular dissolved oxygen concentrations expected through the duration of open, static culture 
(calculated using Fick's law). Dissolved oxygen is shown as percentage of saturation with air (21% 
gaseous 02, 1 atm total pressure). The figure shows pericellular dissolved oxygen for a starting culture 
density of 5×10
4 cells.cm
-2 with a constant oxygen consumption of 2.8×10
-17 mol.s
-1cell
-1. Pericellular 
dissolved oxygen is shown for 2% and 21% concentrations of gaseous oxygen (total pressure of 1 atm) 
and 3 mm and 0.45 mm heights of medium overlay. 
 
It is clear that, in a typical culture flask or well under normoxic conditions, there 
are  significant  changes  in  pericellular  DO  as  the  culture  progresses  from 
seeding to full confluency. The pericellular DO is expected to approach zero 
before  the  cells  reach  full  confluency.  Similarly,  with  hypoxic  conditions, 
pericellular  DO  is  expected  to  approach  zero  immediately  after  seeding.  As 
pericellular  DO  approaches  zero  the  OUR  becomes  limited  by  diffusion  to 
1.27×10
-7 mol.m
-2.s
-1. Consequently, the oxygen consumption per cell will be 
increasingly  limited  as  cell  density  increases.  Figure  2.7  also  shows  the 
significant  effect  the  height  of  medium  has  on  pericellular  DO.  This  is  one 
reason why it is important to control the height of medium when culturing cells in 
open vessels. 
 
The  prototype  culture  device,  in  closed  configuration,  has  no  gas-medium 
interface. Once medium has entered the device the only source of additional 
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oxygen  that  could  enter  the  medium  is  the  PDMS  parts.  PDMS  is  oxygen 
permeable  and  oxygen’s  solubility  in  PDMS  is  over  8  times  higher  than  the 
solubility in water (Sadrzadeh et al., 2010). However, the surface area of PDMS 
in  contact  with  medium  in  the  culture  chamber  (where  dissolved  oxygen  is 
depleted)  is  low  and  confined  to  the  edges  of  the  culture  area.  Thus,  the 
dissolved oxygen available to the cells is essentially limited to what is supplied 
by  incoming  medium.  The  medium  is  oxygenated  by  exposure  to  gaseous 
oxygen before entering the culture device. Thus, the rate of oxygen supplied 
can be controlled by adjusting medium flow rate and/or the partial pressure of 
gaseous oxygen the medium is exposed to. 
 
Figure 2.8 - Finite element modelling of dissolved oxygen in the prototype device  during 
perfusion culture. 
This  figure  shows  the  concentration  of  dissolved  oxygen  at  the  culture  surface  (a,  b)  and  at  a 
vertical slice through the centre of the chamber (c, d) during culture with medium perfused at 300 
μl.h-1.  The  concentration  is  shown  at  two  different  oxygen  uptake  rates;  0.14×10-7  mol.m-2s-1 
corresponding to a typical seeding cell density (a, c) and 2.240×10-7 mol.m-2s-1 corresponding to a 
typical  confluent  cell  density  (b,  d).  Dissolved  oxygen  is  shown  as  percentage  of  saturation  at 
1.05 atm (21% gaseous 02). Cross sections are shown at the same scale. 75 
 
 
To  investigate  the  pericellular  DO  expected  in  the  closed  and  perfused 
prototype culture device, the transport of dissolved oxygen was added to the 
finite  element  model  of  fluid  flow  (section  2.3.2).  Figure  2.8  shows  the 
distribution of DO in the culture device at two different OURs that correspond to 
a  typical  seeding  cell  density  and  a  typical  confluent  cell  density.  DO 
concentration is shown as a percentage of saturation with air at a pressure of 
1.05  atm  (0.20  mMol).  At  a  typical  seeding  cell  density  (OUR  =  0.14×10
-7 
mol.m
-2s
-1) the mean pericellular DO is 97% and the mean DO at the outlet is 
96%. At high confluency (OUR = 2.240×10
-7 mol.m
-2s
-1) the mean pericellular 
DO and outlet DO are 53% and 30% respectively. 
 
At both high and low OURs the DO experienced by the cells is significantly 
higher than in a typical static flask (89% and 0% respectively, Figure 2.7). This 
shows that, with a flow rate of 300 μl.h
-1, oxygen is supplied more rapidly than is 
normally achieved by diffusion from a gas/medium interface. However, the rate 
at which oxygen is supplied is directly proportional to the flow rate. Therefore, 
changes in flow rate during or between experiments will significantly affect the 
pericellular  DO.  It  would  be  advantageous  to  decouple  oxygen  supply  from 
medium flow rate to allow independent control of this key parameter. This was 
achieved by the introduction of a gas permeable lid system in the next design 
(section 3.3.6). 
 
It is clear from Figure 2.8 that, as the OUR increases, significant DO gradients 
develop  across  the  culture  chamber.  At  the  OUR  corresponding  to  high 
confluency, pericellular DO varies from 90% to 15% across the culture surface. 
With  lower  medium  flow  rates  variation  would  be  greater  still.  Such  highly 
non-uniform  concentrations  prevent  the  investigation  of  specific  parameter 
values to find optimum conditions. They may also result in spatial variations in 
growth rate and cell fate. As the device is designed to create a highly controlled 
culture environment this variability needed to be addressed and this, also, was 
achieved  by  the  introduction  of  a  gas  permeable  lid  system  (section  3.3.6). 
Further,  the  DO  distribution  demonstrates  the  importance  of  the  culture 76 
 
chamber dimensions. Concentration gradients across the length of the chamber 
will  also  occur  with  other  (consumed  or  excreted)  soluble  factors  such  as 
glucose  and  signalling  molecules.  Therefore,  the  wide  short  chamber  is 
necessary  to  minimise  variation  in  concentrations  while  retaining  low  fluid 
velocity/shear stress. 
 
2.3.4  Sterilisation by Autoclave 
As the prototype device is designed for cell culture, it is essential that it can be 
sterilised. Autoclave is a simple and widely available sterilisation method which 
would allow the preparation of device parts in most cell culture laboratories. To 
investigate the effectiveness of sterilisation of prototype devices by autoclave, 
components were deliberately contaminated by incubating in E. coli broth prior 
to autoclave. The most complex PDMS component (chip) was used to ensure 
autoclaving could sterilise objects with small and complex geometries, as well 
as polycarbonate (PC) lids to investigate both materials (PC and PDMS) used in 
the device. Autoclaving effectively cleared all contamination from both parts as 
shown by subsequent incubation in sterile broth and plating of these broths after 
a day of incubation (Figure 2.9). The optical densities (OD600) of the broths 
relative to the negative control were 0.00 for the two autoclaved parts, and 1.16 
and  1.55  for  the  PC  and  PDMS  positive  controls  respectively.  Effective 
sterilisation  by  autoclave  was  further  supported  by  infection  free  multi-day 
cultures of mESCs and hESC colonies (sections 2.2.6 and 2.2.7). The reuse of 
parts  sterilised  by  autoclave  in  these  culture  experiments  also  demonstrates 
that autoclaving does not detrimentally affect their function.  
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Figure 2.9 - Results of autoclave sterilisation of parts contaminated with E.Coli. 
PDMS  and  polycarbonate  parts  deliberately  contaminated  with  E.Coli  were  autoclaved  to  ensure 
autoclaving  achieved  sterilisation.  Pane  a)  shows  broth  solutions  after  1  day  of  incubation  with 
autoclaved parts. From left to right the tubes are; autoclaved PDMS chip, autoclaved polycarbonate lid, 
positive control lid, positive control chip, negative control broth. Broth incubated with autoclaved parts 
remains clear, as does the negative control. The overlaid numbers indicate the measured optical density 
at 600 nm relative to the negative control. The two positive controls are cloudy with bacteria. Pane’s b) 
and c) show agar plates made with the first two tubes after a further day of incubation. No colonies are 
visible on either plate unlike the positive controls which showed significant growth (not shown) 
 
2.3.5  Seeding of Mouse Embryonic Stem Cells 
Seeding  cell  density  is  a  critical  variable  to  both  the  expansion  and 
differentiation of stem cell populations (Gage et al., 2013, Lu et al., 2009, Bitar 
et  al.,  2007).  It  is  possible  to  dynamically  seed  systems  by  introducing  cell 
suspension through channels. However, with dynamic seeding it is more difficult 
to control the number of cells and area in which they are seeded as cells are 
prone  to  settle  in  inlet  and  outlet  channels.  Additionally,  dynamic  seeding 
exposes  the  cells  to  shear  stress  which  may  influence  cell  fate  or  cause 78 
 
damage.  Dynamic  seeding  is  particularly  problematic  for  seeding  clumps  of 
cells, as is common practice with hESCs, as the clumps can be broken apart. 
Finally,  weakly  adhering  cells  like  hESC  colonies  typically  require  long 
incubation times to achieve secure attachment  (Oh et al., 2005). During this 
period,  the  static  culture  medium  overlay  provides  the  oxygen  and  nutrient 
demands of the cells. While this height is typically 2-3 mm in wells and flasks, 
the height of medium in closed microfluidic systems is typically very low and 
may be unable to support cells for the required period. 
 
To  overcome  these  issues, and  allow  more  valid  comparison  with  traditional 
well and flask systems, the culture device facilitates static seeding by pipette via 
the  re-sealable  culture  chamber  lid.  Cells  can  be  directly  pipetted  onto  the 
culture surface using standard seeding protocols and, with the lid removed, up 
to a 3 mm height of medium can be used to sustain the cells during attachment. 
Cells  should  thus  experience  the  same  conditions  during  attachment  as  in 
standard flask  culture.  To  investigate  the  seeding  process  and  comparability 
with flask culture, measurements of attached and suspended cells were made 
at different time points after initial seeding. Mouse embryonic stem cells were 
used for this engineering study as they are more easily cultured reproducibly 
than human embryonic stem cells, particularly when seeding as a suspension of 
single cells. Seeding a suspension of single cells allows easier quantification of 
the cells deeded and the attached and unattached cells post-seeding. Mouse 
embryonic  stem  cells  are  from  a  similar  in  vivo  environment  to  human 
embryonic  stem  cells  and  are  therefore  expected  to  be  sufficiently 
representative of human embryonic stem cell behaviour for initial studies. 
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Figure 2.10 – Fraction of seeded cells attached to the culture surface over time. 
Figure showing the fraction of seeded cells that were recovered from flasks and prototype devices, at 
various time points after seeding, using Trypsin. Points at 1, 2, and 4 hours are individual measurements 
while, at  3 and 6 hours, points are  means of 10  measurements and error bars  show  the standard 
deviation between those 10 measurements.  
 
Problems were encountered when trying to measure the number of attached 
cells by enzymatic detachment and subsequent counting. The number of cells 
collected in the aspirated trypsin showed high levels of variation (Figure 2.10). 
Visual inspection by inverted microscope showed some cells remaining on the 
surface after aspiration of trypsin. Subsequent experiments showed that up to 
20% of cells left after aspiration of the initial medium could be removed when 
washing  with  DPBS  in  both  flasks  and  culture  devices.  Further,  in  culture 
devices, a second trypsin treatment could remove up to 35% more cells than a 
single  6  minute  incubation.  Poor  recovery  is  particularly  problematic  in  the 
microfabricated  culture  devices  due  to  the  low  cell  density  (so  early  after 
seeding) and small culture area.  
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Figure 2.11 – Fraction of seeded cells that remain unattached over time. 
Figure showing the fraction of seeded cells that were recovered in medium aspirated from flasks and 
prototype  devices  at  various  time  points  after  seeding.  Points  at  1,  2,  and  4  hours  are  individual 
measurements while, at 3 and 6 hours, points are means of 10 measurements and error bars show 
standard deviation. 
 
Investigation  of  cells  remaining  unattached  suggest  that  >80%  of  mESCs 
settled  and  attached  within  6  hours  (Figure  2.11).  The  unattached  cells  are 
those collected in the aspirated medium. The fraction of the originally seeded 
cells that remain unattached follow trends in the flasks and culture devices that 
are  statistically  indistinguishable.  This  suggests  a  similar  seeding  process 
occurs in both systems, as is expected. The experiments also show a high level 
of repeatability in the process. The standard deviations in the fraction of cells 
unattached after 6 hours were 3% and 7% in the flasks and prototype devices 
respectively (n=10, n=9). These results indicate that a standardised incubation 
period of 6 hours will result in consistent cell attachment. Consequently, this 
incubation period was adopted for subsequent experiments. 
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Figure 2.12 - Mouse ESCs cultured statically for 4 days. 
Phase contrast images of E14 mESCs cultured statically for 4 days with daily medium exchange. Cells were grown in a prototype culture device and a T-25 culture flask. Images 
were taken with a 10× objective. Images were not taken in the same location at each time point. Scale bar represents 200 μm. 
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Figure 2.13 - Confluency over time of mESCs cultured statically. 
The mean confluency of mESCs as calculated using PHANTAST image processing software (Jaccard 
et al., 2014a). A flask and prototype culture device were both seeded from the same cell suspension 
and cultured for 4 days with daily medium exchange and imaging. Error bars show the standard 
deviation between images (n≥9). 
 
 
2.3.6  Culture of Mouse Embryonic Stem Cells 
mESCs were cultured in the prototype culture device without perfusion as an 
initial investigation of its suitability as a culture system. Cells were also cultured 
in a T-25 culture flask to allow comparison of growth rates. Mouse embryonic 
stem cells were used for this engineering study as they are more easily cultured 
reproducibly  than  human  embryonic  stem  cells  and  can  be  seeded  as  a 
suspension of single cells without a layer of feeder cells. As the purpose of 
these  experiments  is  engineering  characterisation  of  the  device,  the  relative 
ease of reproducible culture is worth the lesser relevance of the mouse cell line. 
Mouse embryonic stem cells are from a similar in vivo environment to human 
embryonic  stem  cells  and  are  therefore  expected  to  be  sufficiently 
representative of human embryonic stem cell behaviour for initial studies. Figure 
2.12 shows images of cells in both systems at various time points during the 
culture. PHANTAST image analysis software was used to generate confluency 
values for each image. Confluency is indicative of cell number though it cannot 
be directly related due to small variations in  the area occupied by individual 
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cells over the duration of a culture. Figure 2.13 plots the mean confluency of the 
two culture systems over time. 
 
Results of the culture experiment support the suitability of culture device for the 
culture of stem cells as mESCs survived and proliferated for 4 days. The results 
also suggest that cells proliferate in the prototype device at similar rates to in 
flask  culture  when  the  only  difference  between  the  systems  is  the  culture 
vessel. The number of images taken to represent the two systems was low so 
uncertainties were large. Further experimentation would be required to establish 
comparability between the systems but this was not performed as the culture 
device is only a prototype and was later developed further. It should be noted 
that  the  proliferation  rate  may  change  when  medium  is  perfused  as  this 
changes the conditions experienced by the cells. 
 
2.3.7  Co-culture of Human Embryonic Stem Cell Colonies 
The potential of the prototype culture device to culture stem cells with perfused 
medium was evaluated by culturing feeder-attached hESC colonies. hESC were 
chosen for this study to be consistent with a preliminary experiment performed 
by  Marcel  Reichen.  hESCs  are  more  difficult  to  culture  than  other  common 
model systems  such as  mouse  embryonic stem  cells  and mouse  embryonic 
fibroblasts.  Additionally,  co-culture  techniques,  which  are  inherently  more 
complicated than monoculture, are common in stem cell research. Thus feeder-
attached  hESC  culture  is  a  more  rigorous  test  than  many  other  culture 
processes and successful feeder-attached hESC culture in the prototype device 
would  indicate  likely  suitability  for  most  other  adherent  cell  cultures. 
Furthermore, hESCs are a clinically relevant cell type. 
 
To test the suitability of the  prototype device for hESC culture, open culture 
devices were seeded with inactivated MEF by pipette (Figure 2.2[a]). Single-
well dishes were seeded in parallel to the culture devices to ensure the seeded 
cells proliferated and expressed pluripotency markers when following standard 
culture protocols. The following day hESC colonies were seeded onto the MEF 
layer and the device was incubated in open configuration for a further day. A 84 
 
day  after  hESC  seeding,  the  culture  devices  were  closed  and  media  was 
continuously  perfused  at  300 μl.h
-1,  resulting  in  a  residence  time  of 
approximately 5 min. The media was replaced once a day in the control dishes, 
in  line  with  standard  manual  cell  culture  practice.  During  perfusion,  medium 
equilibrated with the incubator gas partial pressures as it passed through gas 
permeable  inlet  tubing.  This  allowed  dissolved  gases  to  be  supplied  to  the 
culture chamber via the incoming medium. 
 
The above experiment was attempted 44 times (up to 4 attempts at a time in 
parallel). On 13 occasions (30% of attempts) the device clearly leaked. On a 
further  14  occasions  (32%  of  attempts)  the  experiment  failed  due  to  the 
appearance and persistence of bubbles in the culture chamber. Where bubbles 
formed  it  is  not  clear  whether  this  was  a  result  of  slow  leaks,  evaporation 
through PDMS components, outgassing of dissolved gases from the medium, or 
the wash through of bubbles present in tubing or inlet channels at the start of 
perfusion. However, the random occurance makes evaporation and outgassing 
less  likely  causes.  The  combined  62%  failure  rate  indicates  that  the  culture 
system is not robust. This clearly needed to be addressed before the device 
could be a useful culture system for research or production of cells. The cause 
was investigated further and a solution developed as presented in chapter 3. 
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Figure 2.14 - hESC colonies in a prototype device and culture well imaged at intervals during a perfusion culture experiment. 
Phase contrast microscope images of hESC colonies co-cultured on inactivated MEF feeder cells in a prototype culture device [a-c] and a 
single well culture dish [d-f]. For each system, the same colony is shown at each time point. Images were taken after 1 day of static culture 
(from hESC seeding) [a, d], 1 subsequent day of perfusion culture [b, e], and a further day of perfusion culture [c, f]. Images were taken 
with a 4× objective and the scale bars are 500 μm. (Reichen et al., 2012) 86 
 
 
Figure 2.15 - Culture surface of a prototype device at the beginning and end of medium perfusion during the culture of hESC. 
Stitched phase contrast microscopy images showing the majority of the culture surface of a device with hESC colonies co-cultured on inactivated MEF 
feeder cells. The cells are shown after 1 day of static culture (from hESC seeding) and after 2 subsequent days of culture with perfused medium.    87 
 
In experiments where leaks and bubbles did not occur, the inactivated MEFs 
started to attach within 2 hours in both the prototype culture devices and in the 
control dishes. Within one day, the majority of cells had attached and spread in 
both systems. The majority of hESC colonies seeded onto the MEF layer also 
attached within one day. hESC colonies in the prototype devices maintained an 
undifferentiated morphology comparable to the colonies in the control dishes 
(Figure 2.14[a,d]). The successful seeding of both inactivated MEFs and hESC 
colonies  utilising  standard  static  seeding  protocols  demonstrate  how  the  re-
sealable lid facilitates static cell seeding. 
 
After 1 day of perfusion culture, the cells within the colonies were small and 
tightly packed together; a characteristic morphology of undifferentiated hESCs 
(Figure  2.14[b,e]).  After  2  days  of  continuous  perfusion,  hESC  colonies 
maintained an undifferentiated morphology in both the prototype culture device 
and in the control dishes (Figure 2.14[c,f]). Figure 2.15 shows the most of the 
area  of  a  culture  chamber  from  the  beginning  to  the  end  of  perfusion.  The 
majority of colonies expand over the 2 day period. Washout of hESC colonies 
was not observed, consistent with the results of shear stress modelling (section 
2.2.2).  Continued  adherence  and  growth  of  the  cells  in  these  conditions  is 
supported  by  both  the  low  shear  chip  design  and  the  use  of  traditional 
substrate. 
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Figure 2.16 - hESC cells cultured in the prototype device with perfused medium then immunostained for pluripotency markers. 
Images of human embryonic stem cells in the prototype device following 1 day of culture with static medium and 2 days of 
culture  with  perfused  medium.  DAPI  staining  shows  the  nucleus  of  all  cells.  Cells  are  positively  stained  for  nuclear 
pluripotency marker Oct-4 [c], and surface pluripotency markers Tra-1-81 [d] and SSEA-3 [g]. Images were taken with a 20× 
objective. (Reichen et al., 2012) 
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Immunostaining  was  carried  out  to  test  for  the  expression  of  pluripotency 
markers Oct-4, Tra-1-81, and SSEA-3. The sequences of antibody incubation 
and washing were performed with the device in the open configuration (i.e. after 
removing the lid), further demonstrating the value of the re-sealable lid. The 
hESC colonies from one culture device were co-stained for Oct-4 and Tra-1-81, 
and the cells from a second device were stained for SSEA-3 (both devices were 
also co-stained with DAPI). As can be seen in Figure 2.16, the hESC colonies 
stained positively for Oct-4 [c], Tra-1-81 [d] and SSEA-3 [g] with the correct 
localisation (nuclear, surface and surface respectively). These antigens are all 
expressed  in  pluripotent  hESCs but  not  after  early  stage  differentiation.  The 
percentage of cells staining positive for Oct-4, in images of individual colonies, 
was 91% in  the  culture  device  and  94%  in  the  control  well  with  standard 
deviations of 2% and 5% respectively (n = 3 colonies, ~1,500 cells total).  
 
 
Figure 2.17 - Viability staining of hESCs after culture in a prototype device with perfused 
medium. 
Images of hESC cells in a prototype device stained for viability after 1 day of static culture and 2 days of 
culture  with  perfused  medium.  The  cells  visible  in  the  phase  contrast  image  [a]  are  negative  for 
apoptosis marker Annexin V (green) [b] and necrosis marker PI (red) [c]. Images were taken with a 20x 
objective. Scale bar is 200 μm. 
 
In a repeat experiment, a culture device and a control dish were stained with 
Annexin  V  and  propidium  iodide  to  detect  apoptotic  and  necrotic  cells.  The 
numbers of cells staining positive were very low (Figure 2.17). These positive 
staining  results  for  viability  and  pluripotency,  in  combination  with  the 
morphology  observations,  are  evidence  supporting  the  expansion  of  viable, 
undifferentiated hESC colonies through one day of static culture and two days 
of  continuous medium  perfusion. These  results  cannot  be  directly  compared 
with the control wells due to multiple differences between the systems including 90 
 
feeder cell density, medium exchange rate, and availability of oxygen. However, 
they  demonstrate  the  suitability  of  the  microfabricated  device  as  a  culture 
system for hESCs.  
 
2.3.8  Control and Automation Platform 
A prototype control and automation platform was previously developed to house 
three  prototype  culture  devices  and  to  control  them  during  perfusion  culture 
experiments (Reichen, 2012). The platform consists of two modules; a medium 
handling module and a microscope module to house the devices (Figure 2.17). 
The platform is controlled by custom LabVIEW software (National Instruments, 
UK)  via  a  data  acquisition  card  (DAQ).  The  platform  is  designed  to  control 
medium  flow  rate,  medium  source,  and  medium  temperature.  It  also  allows 
acquisition of images with a microscope mounted camera. In this section the 
platform  was  assessed  for  strengths  to  be  retained  and  weaknesses  to  be 
addressed in the improved platform presented in chapter 3. 
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Figure 2.18 – Prototype control and automation platform. 
Photographs of the prototype control and automation platform reproduced with permission (Reichen, 
2012). The platform consists of two modules; a microscope module to house the devices [a] and a 
medium handling module [b]. 
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Medium Perfusion 
The  medium  supply  module  houses  two  custom  made  medium  reservoirs 
(Figure 2.18[b]). Medium is pumped from these reservoirs by displacement with 
a  pressurised  gas  mixture.  The  flow  rate  of  the  medium  is  controlled  by  an 
electronic pressure regulator via the LabVIEW software. When the pressure is 
reduced an exhaust port on the lid of the reservoir allows rapid reduction in 
reservoir pressure. Three way  valves allow  the user to choose between two 
medium reservoirs. Both medium reservoirs are situated in a cooled water bath 
to reduce thermal degradation of components. 
 
The pressure driven pumping system was demonstrated to deliver more rapid 
changes in flow rate than syringe driven flow (Reichen et al., 2013) (Reichen, 
2012).  Sparging  pressurised  gas  into  the  medium  reservoirs  also  introduces 
dissolved  oxygen  and  carbon  dioxide  to  the  medium.  However,  high 
downstream flow resistance will cause back flow of medium when pressure is 
reduced. Also, larger volumes of gas in the reservoirs may reduce the speed at 
which flow rate can be increased (depending on the maximum flow rate of gas). 
Furthermore, the system could make use of a variety of cheap and standardised 
commercially available reservoirs such as Schott bottles.  
 
The pumping system assumes a constant pressure resistance is generated by 
the tubing and culture devices. However, as the collected volumes in the waste 
reservoirs increase over the duration of an experiment, the back pressure will 
also  increase.  Furthermore,  the  burst  pressure  results  indicate  that  the  flow 
resistance of the devices are also likely to be variable. In addition to affecting 
the overall flow rate, this will also affect the distribution of flow between the 
devices. The flow is split between the three devices by a four port junction and it 
is assumed they will have equal flow resistances and hence equal flow rates. 
But results show some variation in the flow rate through three parallel devices 
(Reichen et al., 2013) (Reichen, 2012). Moreover, the flow meter used to make 
these measurements introduces an additional resistance to that flow path which 
may have reduced the flow through that path while the measurement was being 93 
 
made.  These  issues  were  all  considered  in  designing  the  fluidics  for  the 
improved platform (section 3.3.7). 
 
Temperature Control 
The medium reservoirs are situated in a waterbath cooled by a peltier element. 
The device housing “microscope module” contains a preheat unit which uses a 
thin  film  resistor  to  heat  medium  before  it  enters  the  culture  devices. 
Immediately after the preheat is a bubble trap to capture gases evolved as a 
result of the temperature rise. The culture chamber is maintained at 37°C by 
heating the microscope slide. To achieve this, a glass microscope slide coated 
with  a  thin  layer  of  indium  tin  oxide  is  used.  Passing  a  current  through  the 
resistive coating generates heat which is conducted through the slide. These 
systems  were  demonstrated  to  maintain  medium  at  the  desired  temperature 
(Reichen et al., 2013) (Reichen, 2012). 
 
The  major  limitation  of  the  heating  system  is  the  requirement  for  a  glass 
microscope slide. A  unique selling point of the culture device is its ability to 
incorporate multiple substrates including TC-PS. This is also the driving factor 
for use of pressure based seals. Removal of this unique selling point reduces 
the value of the whole design. An alternative solution was developed in chapter 
4  (section  4.3.3).  In  addition,  the  bubble  trap  has  a  fixed  capacity  which  is 
relatively  low  and  can  only  be  refreshed  by  manually  opening  a  valve  and 
allowing  medium  to  force  out  the  trapped  gas.  A  solution  with  a  higher  or 
automatically  refreshed  capacity  would  be  beneficial  and  the  latter  was 
introduced in the next design (section 3.3.7). 
 
Microscopy 
The module housing the devices (Figure 2.18[a]) is designed to sit on the stage 
of a microscope to allow the capture of phase contrast images throughout a 
culture experiment. Phase contrast images provide useful information on cell 
morphology  and  confluency  (Matsuoka  et  al.,  2014).  Therefore,  the  regular 
capture of such images would greatly increase the information output of any 94 
 
culture  experiment.  However,  automated  image  acquisition  can  only  be 
performed at a single position. Any changes to the image position or settings 
(such as magnification) must be performed manually. Further, the window in the 
microscope stage does not cover the culture area of all three chambers. Hence, 
the entire module must be moved if all three chambers are to be imaged. With 
such manual manipulation it is not possible to return to an identical imaging 
position.  If  phase  contrast  imaging  is  to  be  a  key  monitoring  system  of  the 
platform it should be fully automated. This was achieved in the improved design 
by use of a motorised microscope (section 3.3.7). 
 
Software and Connectivity 
The  platform  draws  power  from  eight  separate  DC  power  supplies.  These 
power supplies deliver different voltages ranging from 5 V to 24 V.  Similarly 
eight  separate  4-pin  connectors  are  required  to  connect  to  the  DAQ  for 
communication  with  a  computer.  The  large  number  of  external  connections 
complicates setup of the platform and occupies a lot of physical space. Further 
the requirement for multiple power supplies adds unnecessary expense. The 
connectivity of the improved platform was simplified and a single power supply 
used (section 3.3.7). 
 
The platform is controlled by a computer using a virtual instrument created with 
LabVIEW software. This virtual instrument was developed in parallel with the 
control  and  automation  platform  and  became  unwieldy  and  cluttered  with 
redundant  functions.  While  functional  when  setup  correctly  this  code  is 
complicated to use. There is also redundant code including code for the control 
of  alternative  pumping  solutions  and  code  for  measurement  of  DO,  by 
fluorescent lifetime measurements, using equipment that was never integrated 
with the prototype device. The software was streamlined and the user interface 
simplified  in  the  new  design  to  allow  use  by  researchers  not  proficient  in 
LabVIEW  coding.  The  software  incorporates  a  control  file  which  allows  the 
automated time dependent adjustment of set points for the temperature control 
loops, valve positions, and regulator pressure. There is also facility to override 
pre-programmed set points if required.   95 
 
2.4  Conclusions 
As demonstrated in this chapter, the prototype microfabricated culture device, 
developed by Marcel Reichen, shows considerable promise as a system for the 
perfusion  culture  of  adherent  stem  cells.  The  short  wide  culture  chamber 
reduces variation in the soluble environment caused by cellular consumption 
and  excretion.  In  addition,  the  design  of  the  PDMS  chip  delivers  relatively 
uniform  fluid  velocities  across  the  width  of  the  chip  and  a  low  level  of 
hydrodynamic shear. Hence, the culture device delivers a highly uniform soluble 
environment allowing precise control of conditions. 
 
The device’s resealable lid allows direct access to the culture chamber at any 
point during the culture process. Furthermore, the removal and insertion of the 
lid does not significantly affect the burst pressure of the device. Direct access 
facilitates static seeding, manual cell recovery, and immunostaining as typically 
practised  in  culture  wells  and  flasks.  Similarly,  the  device  facilitates  multiple 
culture surfaces including the TC-PS typically employed in culture flasks, wells, 
and  larger  scale  systems.  These  features  are  advantageous  as  they  allow 
translation  of  processes  and  results  between  the  device  and  other  culture 
systems. 
 
The device is readily sterilised by autoclave, a process commonly available to 
cell culture laboratories. The majority of mESC cells seeded in the device attach 
within 6 hours allowing the prompt initiation of medium perfusion. Furthermore, 
the rate of attachment is the same in the culture device as in a culture flask. 
Likewise, in open configuration, and under static conditions, the device delivers 
a  similar  mESC  growth  rate  to  a  culture  flask.  These  results  indicate  the 
suitability of the device for conventional static cell culture. They also support the 
ability to translate processes and results between the two systems. 
 
The device was used to co-culture hESC colonies on inactivated MEF feeder 
cells  with  continuously  perfused  medium.  The  hESC  colonies  attach  and 
expand  over  the  course  of  perfusion  culture.  Furthermore,  the  cells  remain 
viable and continue to express pluripotency markers. These results show the 96 
 
suitability  of  the  device  for  perfusion  culture  of  stem  cells.  They  also 
demonstrate  the  low  shear  environment,  the  integration  of  a  TC-PS  culture 
surface, the facility to statically seed cells (including cell aggregates), and the 
ability to assemble and operate the device in a sterile manner.   
 
Finally, a prototype control and automation platform has also been developed to 
capitalise on the added control and functionality of the microfabricated device. 
The  platform  houses  three  culture  devices  on  an  inverted  microscope.  The 
platform delivers control over medium temperature at different points, as well as 
medium flow rate. It also allows switching between two medium reservoirs and 
image acquisition for a single field of view.  
 
However, while promising, the prototype device and platform required further 
investigation and improvement before they could be widely applied to stem cell 
processes. The prototype device, platform, and control software needed to be 
made simpler and easier to use (Sackmann et al., 2014). The prototype device, 
while functional, is difficult to assemble due to the large number of parts and the 
sensitivity to screw torque. Similarly, the platform required fewer connections for 
data and power. Finally, the software needed to be streamlined and a better 
user  interface  developed.  These  changes  are  important  to  allow  use  of  the 
system by the widest possible audience. 
 
The device also needed to be made more robust. If it cannot be used reliably it 
will not be adopted by the stem cell sector. The interconnect bars needed to be 
made more reusable by better material choice. However, more pressing is the 
high  occurrence  of  leaks  and  bubbles  in  culture  experiments.  These  issues 
were likely linked to the large variation observed in the burst pressure. Evidence 
suggested this variation stems from a lack of consistency in the pressure based 
seals formed with the PDMS chip. The cause of this inconsistency needed to be 
found and addressed.  
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Modelling results presented in this chapter suggested the uniformity of both fluid 
velocity and dissolved oxygen could be increased. The fluid velocity is made 
less  uniform  across  the  culture  chamber  by  dead  zones  behind  perfusion 
barriers  and  high  velocities  between  them. The  necessity  of  these  perfusion 
barriers  required  investigation  along  with  alternative  methods  of  flow 
distribution. The variation in fluid velocity across the chip also causes variation 
in DO. In addition, DO varies in the direction of flow as oxygen is depleted from 
medium when it passes over cells. The device needed a more uniform delivery 
of oxygen that is independent of medium flow rate.  
 
Finally,  the  control  and  automation  platform  required  a  number  of  key 
improvements. Most importantly, a new solution to heat the culture chamber 
was required. The solution used in the prototype platform requires the use of a 
glass slide, which removes one of the key advantages of the culture device. 
Another major improvement needed is the automation of microscopy, allowing 
regular  and  repeated  imaging  of  multiple  fields  of  view.  Finally,  medium 
handling needed to be improved to ensure equal flow through multiple devices 
and  minimise  the  occurrence  of  backflow.  All  these  areas  for  further 
investigation and improvement were addressed and the results are presented in 
the following chapters. 
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3.  Design Improvements to the Microfabricated Culture 
System 
The majority of work presented in this chapter has been previously published in 
Macown et al (2014). Portions of the text in this chapter appear as previously 
published (particularly materials and methods). Some of the improvements to 
the monitoring and fluid control do not appear in the above publiction. 
 
3.1  Summary  of  the  Prototype  Microfabricated  Culture 
System and Required Improvements 
Investigation  showed  the  prototype  adherent  stem  cell  culture  system 
developed  by  Marcel  Reichen  (Reichen,  2012,  Reichen  et  al.,  2012)  had 
multiple  beneficial  design  features  making  it  a  promising  tool  for  stem  cell 
process  development  (section  2.3.1).  The  design  of  the  prototype  chip  and 
culture  chamber  achieved  a  higher  degree  of  uniformity  in  the  soluble 
microenvironment  than  typical  in  other  microfluidic  culture  devices.  It  also 
minimised hydrodynamic shear stress at the culture plane. The resealable lid 
allowed static seeding and cell recovery and an interchangeable culture surface 
allowed the use of TC-PS (tissue culture polystyrene). These features enable 
translation of processes from traditional flask and dish culture. 
 
The seeding and maintenance of mouse embryonic stem cells (mESCs) in the 
culture device was demonstrated under static culture conditions (sections 2.3.5-
6). Furthermore, the maintenance of human embryonic stem cells (hESCs) co-
cultured  on  inactivated  mouse  embryonic  fibroblast  feeders  (MEFs)  was 
demonstrated with continuous perfusion of medium by a syringe drive (section 
2.3.7). These results supported the devices suitability for the culture of adherent 
stem cells. They also provided evidence of some relation between device and 
flask  culture.  Finally,  a  system  was  established  to  house  multiple  culture 
devices,  control  medium  flow  and  temperature,  and  facilitate  monitoring  by 
phase contrast microscopy (section 2.3.8). 
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Yet  the  prototype  culture  system  required  further  improvement  in  three  key 
areas.  Firstly,  both  the  fluid  velocity  and  dissolved  oxygen  in  the  culture 
chamber could be made more uniform. The fluid velocity in the prototype device 
was higher at the edges due to larger gaps in the perfusion barriers (section 
2.3.2). The necessity and effectiveness of the perfusion barriers also merited 
further  investigation  as  there  was  evidence  they  decreased  rather  than 
increased  flow  uniformity.  Modelling  also  indicated  dissolved  oxygen  would 
become highly heterogeneous at high cell confluency (section 2.3.2). Therefore 
an improved method of oxygen delivery is required. 
 
Secondly, the device and surrounding system needed to be made more robust 
and  simpler  to  use.  A  highly  variable  burst  pressure  indicated  the  prototype 
device design was not robust (section 2.3.1). Furthermore, the mode of failure 
and low variability resulting from lid removal imply that the issue is with the seal 
between the PDMS (poly(dimethylsiloxane)) chip and the microscope slide. The 
interconnect bars could also be made more robust by a material change. In 
addition, the prototype device is complicated to assemble in a sterile manner 
and  would  benefit  from  simplification.  Similarly  the  control  and  automation 
platform merits simplification. 
 
Finally,  improvements  to  the  prototype  control  and  automation  system  are 
required. The system facilitates monitoring by phase contrast microscopy but is 
limited as it requires manual adjustment to the field of view. The fluid control 
system  should  be  upgraded  to  ensure  equal  flows  through  parallel  devices, 
prevent  bubble  formation,  prevent  backflow,  and  allow  more  rapid  medium 
switching.  Last  of  all,  an  alternative  on  chip  heating  solution  is  needed  that 
allows  continued  use  of  TC-PS  culture  surfaces.  This  chapter  will  address 
improvements to the uniformity of the culture environment (sections 3.3.1 and 
3.3.6),  the  robustness  and  ease  of  use  of  the  system  (sections  3.3.2-5), 
monitoring (section 3.3.7), and the fluidic control systems (section 3.3.7). An 
alternative heating solution will be addressed in chapter 4 (section 4.3.3). 
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3.2  Materials and Methods 
3.2.1  Fabrication of Parts 
Polycarbonate and PDMS parts were fabricated as previously (section 2.2.1). 
Briefly,  polycarbonate  parts  were  machined  directly  using  a  micro-milling 
machine,  structured  PDMS  parts  were  cast  in  moulds  fabricated  by  micro-
milling,  and  the  spacer  layer  of  the  PDMS  chip  was  made  by  spin  coating 
PDMS on a silicon wafer before being bonded to the cast element of the chip 
using air plasma. The aluminium interconnect bars were fabricated from 6 mm 
aluminium sheet (grade 6082) by micro-milling. The top plate, bottom plate, and 
brackets of the new device holder were manufactured by Finetech Engineering 
Limited  (Hatfield,  UK).  The  parts  were  fabricated  from  anodised  aluminium 
following technical drawings produced in SolidWorks (Dassault Systemes, UK). 
The clamps and bottom frames, used as an interim solution with the prototype 
design (section 3.3.3), were manufactured from 6082 grade aluminium by Proto 
Labs  Ltd  (Halesfield,  UK).  SolidWorks  drawings  of  all  parts  are  shown  in 
Appendix 2. 
 
3.2.2  Fluid Dynamic Modelling 
As  in  section  2.2.3,  the  flow  of  medium  through  different  chip  designs  was 
analyzed  by  finite  element  analysis using  COMSOL  Multiphysics.  The fluidic 
networks  were  built  as  3D  models  using  SolidWorks  and  imported  as  the 
geometry for the COMSOL models. The fluid material was defined as water with 
the dynamic viscosity adjusted to 7.8×10
−4 Pa.s. A fully developed steady-state 
flow with no slip condition at the boundaries was assumed. The inlet boundary 
conditions were set to an average velocity calculated from the flow rate (300 
μl.h
−1), and at the outlet boundary conditions were set as zero pressure. The 
geometry was divided into a free tetrahedral mesh with maximum and minimum 
element  sizes  of  40.6  μm  and  0.05  μm  respectively  resulting  in  1.4×10
7 
elements  for  the  most  complex  chip  design  investigated.  The  models  were 
solved using COMSOL’s GMRES iterative solver. Hydrodynamic shear stress at 
the  culture  surface  was  calculated  from  the  simulated  velocity  profile  using 
equation 2.1. 101 
 
 
 
 
 
Figure 3.1 - Planes and axes for bending analysis. 
To simplify bending analysis it is assumed there is no bending in the xy and yz planes. 
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3.2.3  Bending Analysis 
A number of assumptions were made in order to approximate the bending of 
rigid device components. Firstly, the problem was treated as a bending beam 
problem rather than a bending plate problem. This simplification was made to 
allow  simpler  and  more  rapid  investigation  of  potential  bending  effects. 
Secondly, the bending was simplified to a 2D problem by assuming no bending 
in the xy and yz planes; the y axis being parallel to a line from the inlet to the 
outlet and the z axis normal to the culture surface (see Figure 3.1). In Marcel 
Reichen’s prototype design, the screw forces are distributed evenly along the 
length of the chip so bending in the yz plane is likely to be negligible. With the 
new  design  the  clamping  points  of  the  aluminium  holder  are  fewer  and 
distributed non-symmetrically relative to the PDMS chip. However, bending in 
the yz plane is still likely to be negligible as the relevant second moments of 
inertia of the aluminium parts are high relative to those relevant to bending in 
the xz plane. As there are no forces applied in the x and y directions bending in 
the xy plane would not be expected. 
 
 Finally,  when  calculating  second  moments  of  inertia,  cross  sections  were 
simplified to be symmetrical and some smaller features were ignored (Appendix 
3).  This  simplification  to  symmetry  was  necessary  as  symmetry  is  a  key 
assumption of the calculation method used. For the prototype design the cross 
sections were already symmetrical but for the new design the recesses were 
shifted off centre. Because height of cross section is much more significant than 
breadth the effects of the simplification should be low. The smaller features that 
were ignored are small holes whose cross section would have little impact on 
the second moment of inertia. 
 
The second moments of inertia for each cross section were calculated using the 
formula for a rectangle (Equation 3.1) and parallel axis theorem (Equation 3.2). 
The second moment of inertia of a rectangle about its centre is given be the 
equation 
12
B H
I
3
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where H is the height (z dimension) and B is the breadth (y dimension). The 
second moment of inertia of the same rectangle about an off centre axis n can 
be calculated using parallel axis theorem; 
2
centroid n centroid n d A I I       (3.2) 
Where A is the cross sectional area and d is the distance between the centre 
and the neutral axis. The second moment of inertia of complex cross sections 
can  be  calculated  as  the  sum  of  the  moments  of  their  components.  See 
Appendix 3 for the calculated second moments of inertia for each cross section. 
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Figure 3.2 - Beam approximations of device components for bending calculations. 
To approximate the bending of device components they were treated as beams. For the prototype 
device the components are approximated as beams bent about pivots at the edge of the slide by 
axial screw force and the PDMS chip’s resistance to compression [a]. For the new device design the 
components  are  approximated  as  beams  fixed  at  both  ends  but  deformed  by  the  PDMS  chip’s 
resistance to compression [b]. The resistance to compression reduces towards the centre of the 
beam where bending reduces the compressive strain. 
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The  Conjugate  Beam  Method  was  applied  to  calculate  the  angle  and 
displacement  of  the  components  above  and  below  the  PDMS  chip. 
Displacement was calculated at 50 μm intervals across the width of the device 
using Microsoft Excel. The prototype device was modelled as beams supported 
by two pivots at the edges of the slide (Figure 3.2[a]). Screw torques as low as 
0.4 N.cm provide enough force that the top frame contacts and pivots about the 
slide edges. One section of the new design was modelled as beams fixed at 
both  ends  (Figure  3.2[b]).  The  elastic  moduli  used  for  Aluminium, 
Polycarbonate, TC-PS, and PDMS were 7×10
10 Pa, 2.3×10
9 Pa, 3.0×10
9 Pa, 
and 1.82×10
6 Pa (Schneider et al., 2008) respectively. The resultant force from 
compression of the PDMS chip was integrated numerically using the rectangle 
rule with a step distance of 50 μm. The axial force delivered by a screw was 
calculated using equation 3.3; 
d p
2
F
 

 
   (3.3) 
where F is the axial force,  is the torque, p is the thread pitch (5×10
-4 m), μ is 
the friction factor (assumed 0.5), and d is the pitch diameter (2.675×10
-3 m). 
 
3.2.4  Burst Pressure Measurements 
Burst pressure of the new device was measured in the same manner as for the 
prototype device in section 2.2.2. Briefly, a 10 ml glass syringe (81660, Essex 
Scientific Laboratory Supplies, Benfleet, UK) connected to a syringe pump was 
used  to  pump  air  into  a  device  at  7  ml.min
-1.  The  outlet  to  the  device  was 
blocked ¼-28 plug fitting. The pressure was measured by a sensor connected 
to a three way junction on the inlet tubing. The highest recorded pressure was 
taken as the burst pressure. The burst pressure was recorded three times for 
each  of  three  unique  sets  of  parts  assembled  in  the  three  slots  of  the  new 
device holder (total of 9 measurements). All device components used in the 
measurements had been previously autoclaved. 
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3.2.5  Dissolved Oxygen 
The distribution of dissolved oxygen (DO) was modelled in COMSOL by adding 
a transport of dilute species model to an existing fluid flow model. The new chip 
design with a tree-like structure of channels and perfusion barriers was used 
(Figure 3.3[d]). Cellular oxygen consumption was modelled as a constant flux 
through  the  culture  surface.  All  other  boundaries  were  set  to  zero  flux.  The 
parameters used for DO modelling are shown in Table 3.1. The diffusivity of 
oxygen in medium was set to 2×10
-9 m
2s
-1. The incoming media had an oxygen 
concentration of 0.2 mol.m
-2, the air saturation concentration at 37°C and 1.05 
atm.  
 
Table 3.1 - Parameters used in dissolved oxygen modelling with gas permeable lid. 
Parameter  Value/Formula  Units
  Source 
Solubility of O2 in 
Media 
9.04×10
-7  mol.cm
-3.atm
-1  (Nishikawa et al., 2008) 
Diffusivity of O2 in 
Media 
2.00×10
-5  cm
2.s
-1  (Nishikawa et al., 2008) 
Solubility of O2 in 
PDMS 
7.92×10
-6  mol.cm
-3.atm
-1  (Merkel et al., 2000) 
Diffusivity of O2 in 
PDMS 
3.40×10
-5  cm
2.s
-1  (Merkel et al., 2000) 
Maximum O2 
Consumption During 
Growth Phase 
2.80×10
-17  mol.cell
-1  Mouse ESCs at 20% and 40% 
O2, (Powers et al., 2008) 
Minimum Cell Density  5.00×10
4  cells.cm
-2  Typical Seeding Density 
(mESC) 
Confluent Cell Density  8.00×10
5  cells.cm
-2  Typical Confluent Density 
(mESC) 
 
The  distribution  of  dissolved  oxygen  was  modelled  for  the  prototype  (all 
polycarbonate) lid design as well as for the new gas-permeable lid system with 
both open and closed polycarbonate elements (Figure 3.13). To model the gas-
permeable lid system a 4.12 mm layer of PDMS was added above the culture 
chamber with a swept mesh. As there is no facility in the software to allow for 
the  different  solubility  of  oxygen  in  PDMS  the  concentration  and  diffusivity 
values were adjusted. The diffusivity of oxygen in PDMS was set to 3.02×10
-8 
m
2s
-1;  the  diffusivity  in  PDMS  adjusted  by  the  ratio  of  solubility  in  PDMS  to 
solubility in medium (Table 3.1). When modelling the gas-permeable lid system 
with a closed PC element, no flux was allowed through the upper surface of the 107 
 
PDMS.  When  modelling  the  gas-permeable  lid  system  with  an  open  PC 
element, the upper surface of the PDMS layer was given a constant defined DO 
of 0.2 mol.m
-2; the solubility in medium in equilibrium with air at 1.05 atm and 
37°C.  
 
The model was solved with a segregated solver with both segregations using 
COMSOL’s  GMRES  iterative  solver.  The  model  was  solved  for  two  oxygen 
uptake rates; 1.40×10
-8 and 2.24×10
-7 mol.m
-2s
-1. These rates reflect a low and 
high confluency of mouse ESCs respectively. As an additional model, the low 
oxygen uptake rate was modelled with the concentration at the top surface of 
the PDMS set to 0.19 mol.m
-2; the air saturation concentration of medium at 
atmospheric pressure. Mean DO at the culture surface was calculated from a 
uniform grid of points with a step size of 10 μm. 
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3.3  Results and Discussion 
3.3.1  PDMS Chip Design and Flow Modelling 
As  discussed  in  sections  2.3.1  and  2.3.2,  the  final  prototype  chip  of  Marcel 
Reichen (2012) was designed with the inlet and outlet channels expanding to 
three channels to distribute the flow (Figure 3.3[a]). Immediately either side of 
the culture chamber are perfusion barriers intended to deliver a highly uniform 
fluid  velocity  across  the  culture  chamber.  This  concept  relies  on  the  fluid 
resistance of the channels between the barriers being significantly higher than 
the fluid resistance in the larger channels. However, where this concept has 
been previously employed the channels between the barriers are substantially 
less deep than the main channels (Petronis et al., 2006, Hung et al., 2005). 
Furthermore,  fluid  dynamic  modelling  of  the  prototype  chip  suggests  the 
perfusion barriers may decrease flow uniformity (Section 2.3.2).  
 
Figure 3.3 - Four chip designs investigated for flow distribution. 
Four different designs of PDMS chip were investigated using COMSOL modelling; the design from 
Marcel Reichen’s prototype device [a], Marcel Reichen’s penultimate design [b], and a new design 
with a tree-like network of channels with [c] and without [d] perfusion barriers. 
 
To  investigate  the  effectiveness  of  the  perfusion  barriers  and  alternative 
methods  of  flow  distribution,  fluid  flow  was  modelled  in  three  further  chip 
designs. The first was the penultimate design of Marcel Reichen (2012). This 110 
 
design  does  not  use  multiple  channels  to  distribute  flow  but  does  employ 
perfusion barriers (Figure 3.3[b]). The other two designs were new and based 
on a tetrahedral tree-like structure of channels (Figure 3.3[c,d]) (Saias et al., 
2011). The tree-like structure expands from a single channel to eight evenly 
spaced  channels.  The  path  from  the  inlet  to  the  end  of  each  of  the  eight 
channels is equal in length and should thus have equal flow resistance. The 
difference between the two designs is the inclusion or exclusion of perfusion 
barriers. Where  the  barriers  are  included  a  larger gap  is no  longer included 
between the chamber wall and outermost barrier. The barriers remain 200 μm 
across but the gap between them increases from 400 μm to 900 μm. 
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Figure -3.4 – Finite element modelling of fluid velocity for four designs of PDMS chip. 
The results of COMSOL modelling showing fluid velocity for a flow rate of 300 μl.h-1. Four designs 
were modelled; Marcel Reichen’s prototype design [a] and penultimate design [b], and new designs 
with tree-like networks of channels with [d] and without [c] perfusion barriers. For each design the 
velocity profile of the whole ship is shown 220 μm above the culture surface (ACS). Also shown is 
the region prior to the chamber with a narrower colour scale, the culture chamber with a narrower 
colour scale, and the culture chamber 10 μm ACS. 
 
Figure 3.4 shows the velocity distribution in the four different chip designs. It is 
clear from Figure 3.4[b] that, where the flow is not expanded by channels, the 112 
 
perfusion barriers are ineffective at eliminating non uniform flow. Evidently the 
resistance of the channels between the gaps is not sufficiently greater than the 
resistance in the main channel. This could be addressed by reducing the width 
and  height  of  the  channels  between  the  barriers.  However,  this  would 
significantly increase the flow resistance of the device. A high flow resistance is 
not desirable as it necessitates a higher burst pressure. Also, if the chip has a 
higher flow resistance it is harder to ensure equal flow between parallel devices 
(see section 3.3.7). Therefore it is desirable to achieve uniform flow through the 
method of expansion so that the intended effect of the perfusion barriers is not 
needed. 
 
Figure  3.4[c]  and  3.4[d]  show  that  with  a  tree-like  structure  of  channels 
perfusion barriers are unnecessary and, in-fact, reduce the uniformity of flow. 
High velocities in the centre of the gaps and dead zones behind the barriers 
result  in  less  uniform  fluid  velocities  at  the  edges  of  the  culture  chamber. 
Comparing the regions prior to the culture chamber, it is also evident that the 
tree-like channel structure is more effective at distributing flow than Reichen’s 
designs. This demonstrates the effectiveness of the tree-like structure’s multiple 
paths with equal path length. The mean shear stresses 10 μm above the culture 
plane are within 2.4% of each other, being 0.131 mPa, 0.131 mPa, 0.128 mPa, 
and 0.128 mPa for the four designs respectively. 
 
In  theory,  the  tree-like  chip design  without  perfusion  barriers  gives  the most 
uniform flow distribution. However, in practice PDMS chips without perfusion 
barriers are less effective. Without the support of perfusion barriers the thin, 
elastomeric spacer layer and, to a lesser extent, the channel containing layer 
deform towards each other. This results in the majority of flow being directed 
along the edges of the culture chamber. Hence, the perfusion barriers play a 
vital  structural  role  in  PDMS  chips.  Accordingly,  the  tree-like  structure  with 
perfusion barriers was adopted as the new chip design. The inlet and outlet 
were also moved further apart to allow more space between the interconnect 
bars. The thickness of the top layer of the chip was increased from 0.95 mm, to 
1 mm to increase compressive force relative to channel deformation, and the 
overall chip length was kept the same. 113 
 
 
3.3.2  Bending Analysis of Prototype Device 
Burst  pressure  analysis  of  the  prototype  stem  cell  culture  device  showed 
significant  variation  between  different  assemblies  of  the  same  parts  (section 
2.3.2).  There  was  also  a  high failure  rate  in  the  attempted  perfusion  culture 
experiments due to leaking (section 2.3.7). Clearly, this needs to be addressed 
before the culture device can be considered a useful tool for stem cell process 
design. Low variation between multiple measurements of the same assembly 
indicates  that  the  variability  originates  from  a  reversible  compression  seal. 
Furthermore,  similar  measurements  of  burst  pressure  after  lid  removal  and 
reinsertion show that the seal in question is unlikely to be between the PDMS 
gasket  and  polycarbonate  lid.  Variation  of  a  compression  seal  is  likely 
correlated  with  variation  in  the  extent  of  compression.  If  the  PDMS  chip 
undergoes variable compression this is likely to translate into variations in flow 
distribution and flow resistance. 
 
 
Figure 3.5 - Displacement of top and bottom frames of prototype device through bending. 
Axial screw force causes the top and bottom frames of the prototype device to bend about two 
pivots at the edges of the TC-PS slide. Here the displacement is approximated by the conjugate 
beam method for an applied screw torque of 2 N.cm. The displacement of the two components is 
relative to zero at the two points where the top frame contacts the edge of the slide. 
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Figures 3.6 - Thickness of PDMS chip compressed by prototype frames at different screw 
torques. 
Axial screw force causes the top and bottom frames of the prototype device to bend. The resulting 
displacement affects the compression of the PDMS chip. This figure approximates the thickness of 
the  PDMS  chip  for  different  applied  screw  torques  (and  hence  axial  screw  force).  The  model 
assumes compressive force is directly proportional to vertical strain. 
 
A  simplified  model  was  used  to  investigate  the  bending  and  compression 
achieved in the prototype culture device. The approximate bending of the rigid 
slide and frames were calculated using the Conjugate Beam Method. In order to 
investigate  sensitivity  to  axial  screw  force,  the  bending  of  the  frames  was 
calculated at  three  different  screw  torques. The model assumes an arbitrary 
coefficient  of  friction  for  the  screws  of  0.5  though  this  varies  depending  on 
thread materials, cleanliness, and quality. The model also assumes the device 
is in the closed configuration i.e. the screws attaching the lid have been inserted 
and tightened. Figure 3.5 shows the bending profiles across the width of the top 
and bottom fames with 2 N.cm of screw torque. Figure 3.6 shows the profile of 
the compressed PDMS chip at all three torques investigated.  
 
It is evident that there is a trade off between the compressive force at the edges 
and the middle of the chip. There will therefore be an optimum where the best 
profile  of  compressive  force  is  achieved.  However,  small  increases  in  axial 
screw  force  bend  the  frame  to  the  extent  that  there  is  a  gap  rather  than 
compression along the centreline of the chip (see Torque = 2 N.cm, Figure 3.6). 
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This gap will result in leaking. At higher forces the frames will bend to the extent 
that the PDMS chip is not compressed at all (see Torque = 3.93 N.cm, Figure 
3.6). Conversely, lower axial forces will result in the minimum bending of the 
frames and the most uniform compression of the chip. The price of this uniform 
compression is that the compressive force will be very low. This may also result 
in leaking. In addition, it is difficult to deliver very low axial screw force and small 
thread or material imperfections will have a very significant impact in relative to 
such low forces. 
 
Between these two extremes of axial force the varying compression profile will 
result  in  varying  burst  pressure  as  encountered  in  the  investigations  in  the 
previous chapter (section 2.3.2). The uneven compression profile will also result 
in a non-uniform profile through the culture chamber contra to the efforts made 
designing the PDMS chip. Attempts are made to always deliver the same axial 
screw  force  by  using  a  high  precision  torque  screw-driver.  However,  as 
mentioned  above,  axial  force  does  not  only  depend  on  torque  but  is  also 
sensitive to the thread materials, quality and cleanliness. Small imperfections or 
contaminating  material  can  significantly  impact  the  axial  force  delivered. 
Furthermore,  the  total  axial  force  depends  on  whether  the  device  is  in  the 
closed configuration (10 screws) or open configuration (8 screws). 
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Figure 3.7 - Interim strengthening of prototype frame. 
As an interim solution to strengthen the prototype frame, 3 mm aluminium clamps [a] were added 
above  the  top  frame  and  surrounding  the  interconnect  bars  [b,  c].  The  bottom  fame  was  also 
changed from 5 mm polycarbonate to 3 mm aluminium [c]. 
 
A  clamping  solution  should  be  sought  that  delivers  a  reliable  profile  of 
compressive force impartial to small variations in screw torque, thread quality 
and thread sensitivity. The profile of compressive force should also be uniform 
in  order  to  maintain  a  uniform  flow  profile.  This  was  addressed  in  the  next 
section  (section  3.3.3).  As  an  interim  solution  a  device  was  trialled  with 
reinforced frames. The bottom frame was changed from 5 mm polycarbonate to 
3  mm  aluminium.  The  top  frame  was  supported  by  two  rectangular  clamps 
made  from  3  mm  aluminium  (Figure  3.7).  Observations  suggested  this 
reinforced device was less prone to leaking. This supports the hypothesis that 
frame bending is responsible for the high failure rate of the prototype device.  
 
3.3.3  Improved Design of Culture Device 
As discussed above, to achieve robust compressive seals, a clamping solution 
is required that delivers a reliable and uniform profile of compressive force to 
the PDMS chip. The solution should not be sensitive to small variations in screw 
torque, thread quality and thread sensitivity. In addition, the device needs to be 117 
 
made  easier  to  assemble  and  use  in  a  sterile  environment.  Moreover,  the 
reusable components of the device, including the interconnect bars, should be 
made  more  robust.  Finally,  to  improve  the  monitoring  capabilities  of  the 
prototype system we integrated it with a motorised microscope stage. To this 
end, it should be possible to position the culture chambers of the maximum 
number of devices within the area of a motorised stage that can be imaged. 
 
Figure 3.8 - Improved culture device design. 
An exploded view [a] of the new culture device design showing the components of the holder and 
individual culture devices (screws are not included). Also shown is an assembled view [b] with the 
lid and interconnects included only for the left most culture device.  A front view of the central 
compartment [c] shows the top frame, flat against the top plate of the holder, and the slide, flat 
against the bottom plate of the holder, with the PDMS chip compressed between them. 118 
 
 
An  improved  culture  device  was  designed  and  fabricated  to  address  all  the 
above concerns (Figure 3.8). Up to three individual culture devices are housed 
in a holder comprised of a top plate, a bottom plate and two brackets. The top 
and  bottom  plates  are  connected  by  four  rows  of  three  screws.  Individual 
bottom frames have been eliminated and microscope slides are now recessed 
into the top frames which have been thickened to 5 mm. An assembly of top 
frame, gasket, chip and slide is inserted into each of the three slots in the holder 
with the screws loosened. The screws are then tightened to a high torque (as 
high as possible by hand) using a standard hex screwdriver.  
 
Compression of the PDMS chips is delivered by the top and bottom plates of 
the holder. As the screws are tightened to a high torque the height of the slots is 
defined as the depth to which they were milled. The top and bottom plates are 
made  from  anodised  aluminium  with  the  intention  that  they  not  bend 
significantly in response to the compressive force. This is investigated in the 
following  section  (section  3.3.4).  The  strength  and  corrosion  resistance  of 
anodised aluminium also make the parts more robust than if they were made 
from  polycarbonate.  Similarly,  the  holder brackets  and  interconnect  bars are 
robust due to the choice of materials (anodised aluminium and 6 mm grade 
6082 aluminium respectively). The thickness of aluminium below each device 
was  originally  0.7  mm  to  allow  close  proximity  of  microscope  objectives. 
However, the aluminium distorted during tooling and the finished piece was too 
flexible.  The  use  of  extra  long  working  distance  objectives  permitted  the 
thickness of the component to be increased to 2.45 mm. 
 
The holder and devices were designed so that six culture chambers (2 holders 
each with 3 devices) could be imaged on a Nikon Ti-E motorised microscope. 
The dimensions of a holder bottom frame are 144 mm by 78 mm such that two 
can  fit  in  the  opening  of  the  motorised  stage  (115  mm  by  157  mm).  The 
brackets suspend the holders from a 5 mm PC sheet laid on top of the stage. 
Positioning  the  devices  below  the  top  of  the  stage  moves  them  into  the 
focusable range of the microscope as specimens are typically positioned slightly 119 
 
inset  to  the  stage  rather  than  elevated  (by  the  holder  bottom)  above  it.  To 
conform to the holder dimensions the top frame was shortened to be the same 
length as the slide (77 mm). The top frame was also widened to 40 mm for 
easier handling as it is not possible to narrow them enough to fit four devices 
side by side within the area that can be imaged. Finally, the chip and gasket 
recesses and hole for lid insertion were offset from the centre of the top frame 
so that the culture chambers would be within the area that can be imaged by 
the microscope. 
 
 
Figure 3.9 - Top frame showing the recess around the lid hole. 
An image showing the 0.5 mm deep recess around the hole into which the resealable lid is inserted. The 
recess is included to contain medium displaced by insertion of the lid. 
 
The culture device is now significantly easier to assemble and use: The number 
of screws that must be done up to seal three devices has been reduced from 24 
to 12. Furthermore, these screws can be left in position, and must merely be 
tightened  and  loosened.  Also  the  screws  do  not  need  to  be  tightened  to  a 
precise and low torque but can simply be tightened as much as possible using a 
standard  hex-head  torque  screwdriver.  Furthermore,  the  elimination  of  the 
bottom frame reduces the number of parts per device. A shallow recess has 
been added to the top of the top frame surrounding the lid hole (Figure 3.9). 
This recess is designed to contain media overflowing from the culture chamber 
limiting the area that it can contact and making it easier to aspirate. Finally, 
there is a recess around the viewing windows in the bottom plate of the holder. 120 
 
These  windows  were  included  to  give  the option  of  inserting a cover slip  to 
improve the thermal insulation of the culture chambers. 
 
 
 
 
Figure 3.10 - Displacement of components due to bending in the new device design 
compared to the prototype design. 
In the new device design, compressive force causes the upper (top plate and top frame) and lower 
(bottom plate and slide) components of the prototype device to bend apart between fixed points. 
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These fixed points occur where the top and bottom plates of the holder are screwed together. Here 
the displacement of these components across one slot in the new device is approximated by the 
conjugate beam method [a]. The displacement is set to zero at the fixed points on either side. For 
comparison the displacement of the prototype device is shown [b] for an applied screw torque of 2 
N.cm, as calculated in reported in section 3.3.2. 
 
Figure 3.11 - Compression across the width of the PDMS chip for the new device design and 
the prototype design. 
In the new and prototype culture devices the PDMS chip is compressed between the top frame and 
slide. The bending of components due to vertical forces affects the compression of the PDMS chip. 
This figure approximates the thickness of the PDMS chip in the new device [a] and in the prototype 
device for different applied screw torques [b]. 
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3.3.4  Bending Analysis of New Devices 
The bending of top and bottom plates of the new chip holder were modelled in 
the same manner as for the prototype design (section 3.3.2) and the results 
compared. Figure 3.10 compares the bending of the components on either side 
of the PDMS chip. It is evident that significantly less bending occurs with the 
new holder system than with the prototype design. Figure 3.11 compares the 
compression profiles of the PDMS chips. The maximum combined displacement 
of the upper and lower components in the new device design is 8.2 μm. This 
compares with 130 μm for the prototype device design with an applied torque of 
2  N.cm.  As  a  result  of  the  lower  deformation  and  thicker  PDMS  chip,  the 
minimum  compressive  strain  is  9.98%  (112  μm  of  compression)  in  the  new 
device.  There  was  no  compression  predicted  at  the  centre  of  the  prototype 
design but instead 13.4 μm of additional space. 
 
The  compression  profile  delivered  by  the  new  device  holder  is  also  highly 
uniform. Compressive strain ranges from 9.98% (112 μm of compression) to 
10.27%  (115  μm  of  compression)  rather  than  the  0%  to  4.9%  (52  μm  of 
compression) achieved in the prototype device. The level of compression can 
also be specified by the thickness of the parts i.e. reducing the recess depths in 
the top frame will increase compression. Furthermore, the model indicates the 
minimum  screw  torque  required  to  achieve  this  compression  is  1.48  N.cm 
(assuming a coefficient of friction of 0.5), while a manual screwdriver can easily 
achieve  hundreds  of  N.cm.  Therefore,  the  new  design  delivers  the  required 
reliable  and  uniform  compression  with  low  sensitivity  to  minor  variations  in 
screw torque or friction factor. 
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Figure 3.12 - Figure showing 'window filler' and the recess into which it sits. 
Top [a], side [b], and 3D [c] views of the polycarbonate window filler which is inserted into the 
viewing window and surrounding recess [d]. 
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3.3.5  Burst Pressure Measurements of New Devices 
The new device design was tested with pumped water to verify that the rigidity 
of the new holder has a positive effect on sealing. Initial investigations found 
that the new device regularly leaked from between the top frame and TC-PS 
slide. It was hypothesised that the portion of slide above the viewing window 
was bending resulting in leaking around the culture chamber. To reinforce this 
area a piece of polycarbonate was inserted in the viewing window, suspended 
from the recess surrounding it (Figure 3.12). The polycarbonate is 2 mm thick 
and protrudes 125 μm above the top surface of the bottom plate to increase 
compression  around  the  culture  chamber.  With  this  addition  leaking  was  no 
longer observed. Polycarbonate was used as it is transparent to visible light, 
tolerant  of  autoclave,  and  easy  to  mill.  However,  polycarbonate  is  not 
transparent to the UV light used with some fluorescent stains so glass may be a 
more appropriate choice in future work. 
 
With  the  polycarbonate  piece  in  place,  burst  pressure  measurements  were 
carried out as for the prototype device (section 2.3.1). The mean burst pressure 
of  the  new  device  is  370  ±  120  kPa  (standard  deviation  n=9),  a  significant 
increase compared with the 59 ± 18 kPa of Marcel Reichen’s prototype design. 
The  standard  deviation  has  also  increased  significantly  though  it  remains  a 
similar  fraction  of  the  mean.  Two  standard  deviations  below  the  mean 
(370-2×120 = 130 kPa), the burst pressure still remains well in excess of the 
previous mean. Furthermore, the lowest burst pressure recorded with the new 
design  was  250  kPa.  These  results  confirm  that  the  manner  in  which 
compression  is  delivered  by  the  new  design  has  significantly  improved  the 
robustness  of  the  culture  devices.  The  increased  burst  pressure  permits  the 
application of higher back pressures with reduced risk of leaks occurring. This is 
important for the redesigning of the external fluidics (see section 3.3.7). 
 
When the burst pressure is exceeded, loss of pressure occurs by reversible 
failure of a compression seal rather than permanent damage to a component. 
This is evidenced by repeatability of the burst pressure with the same parts. The 
mean standard deviation with the same assembly of parts is 10 kPa (standard 125 
 
deviation of 3 measurements, mean for 3 assemblies). Consequently, it is not 
possible to damage reusable parts by exceeding the burst pressure. The high 
variation in the burst pressure measurements remains linked to variation in one 
or more of the reversible seals; between chip and slide, chip and top frame, top 
frame and fluidic connector, chip and gasket, and/or gasket and lid. In turn, this 
variation  could  stem  from  variation  in  assembly  technique  or  variation  in 
manufactured  parts.  The  new  design  should  prevent  assembly  technique 
affecting  seals  involving  the  PDMS  chip.  However,  there  is  still  potential for 
variation in the force applied when attaching the lid and fluidic connectors. Parts 
will remain subject to significant manufacturing variation as long as they are 
manufactured individually and can only be minimized by the care and precision 
of the manufacturer. Upon achieving fine manufacturing tolerances this design 
is  likely  to  achieve  very  well  defined  burst  pressures  with  small  standard 
deviations. 
 
3.3.6  A Gas Permeable Lid System 
Design of Lid System 
Modelling  of  dissolved  oxygen  (DO)  in  the  prototype  device  under  perfusion 
conditions  showed  that  significant  gradients  in  pericellular  DO  would  be 
expected at oxygen uptake rates (OURs) corresponding to high cell confluency 
(Figure  2.7).  In  a  static  device  with  the  medium  volume  of  a  closed  culture 
chamber but without the gas impermeable polycarbonate lid, pericellular DO is 
uniform and much higher than in typical flask or well culture (Figure 2.6). This is 
due to the shorter distance that oxygen must diffuse through medium from the 
gas medium interface. However, when the lid is inserted oxygen can only be 
supplied  with  the  incoming  medium. In addition  to  causing  gradients  at  high 
confluency, this limitation also makes dissolved oxygen highly dependent on 
medium  flow  rate.  DO  gradients  and  a  dependence  on  flow  rate  are  both 
detrimental to the control offered by the culture device. 
 
Dissolved oxygen is key to cell growth as well as being a determining factor in 
stem cell fate. For a process development tool to test a single set of conditions, 
gradients in pericellular DO must be kept to a minimum. It is also important to 126 
 
be able to control pericellular dissolved oxygen over time. With oxygen only 
supplied  via  incoming  medium,  control  can  only  be  achieved  through 
adjustment of flow rate or the partial pressure of oxygen the incoming medium 
is exposed to. The extent to which the partial pressure of oxygen at the inlet can 
be adjusted is limited. If incoming medium is equilibrated with the atmosphere in 
an incubator (as in section 2.2.11) the total pressure is limited to atmospheric. 
Alternatively, if medium is equilibrated with gas in the inlet bottle (see section 
3.3.7) the total pressure will impact the medium flow rate. Using medium flow 
rate to control pericellular DO is not ideal as flow rate also affects shear stress 
and the concentration of other soluble factors. 
 
 
 
Figure 3.13 - Components of gas permeable resealable lid system. 
The new gas permeable resealable lid system consists of two components. The first component is a 
PDMS piece inserted into the lid well [a]. This component is gas permeable and defines the height of 
the culture chamber. The second polycarbonate component secures the PDMS component in place 
and has three variations. The first is open to atmosphere for gas exchange [b], the second has a 
cavity above the culture chamber and ports to connect an external gas supply [c], and the third is 
solid polycarbonate to prevent gas exchange [d]. 
 
New gas permeable lids were designed to address these issues (Figure 3.13). 
A permeable PDMS component inserts through the gasket to seal the chamber 
(Figure 3.13[a]). As with the previous lid design, the PDMS component is T-
shaped and defines the height of the culture chamber. The PDMS component is 127 
 
held in place by a polycarbonate (PC) component. The PC component has a 
cavity with the same footprint as the culture chamber. The cavity can either go 
all the way through the part (Figure 3.13[b]), so that oxygen is supplied from the 
external  atmosphere,  or  can  be  connected  to  a  gas  inlet  and  outlet  (Figure 
3.13[c]). There is also the option to retain a gas impermeable lid by removing 
the cavity all together (Figure 3.13[d]).  
 
Gas permeable lids add a second route of oxygen supply. If this is the major 
source of dissolved oxygen then gradients will be greatly reduced as oxygen is 
supplied evenly across the culture area. Introducing oxygen through the lid also 
takes  advantage  of  the  short  diffusion  distance  through  medium  in  the 
microfabricated  culture  device.  The  PDMS  lid  adds  a  second  diffusive 
resistance to oxygen transfer but PDMS has a much higher permeability than 
medium due to a similar diffusivity and much larger solubility (Table 3.1). 
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Figure 3.14 - Dissolved oxygen distribution at different oxygen uptake rates and with 
different lid systems. 
Dissolved oxygen distribution is shown for two different oxygen uptake rates; 1.4×10-8 mol.m-2s-1 
corresponding  to  cells  at  seeding  [a-c],  and  2.24×10-7  mol.m-2s-1  corresponding  to  cells  at  high 
confluency [d-f]. Three different lid systems are shown; [a, d] the entirely polycarbonate lid of 
Marcel  Reichen’s  prototype  device,  and  the  new  gas  permeable  lid system  with  [b,  e]  a  closed 
polycarbonate  component  and  [c,  f]  an  open  polycarbonate  component.  Shown  for  each 
combination  are  a  vertical  slice  through  the  centreline  of  the  culture  chamber  (top)  and  a 
horizontal  slice  at  the  culture  surface  (bottom).  Dissolved  oxygen  is  shown  as  percentage  of 
saturation  at  1.05  atm  (21%  02).                                                                      . 129 
 
 
Figure 3.15 - Centreline dissolved oxygen at culture surface for different oxygen uptake rates and lid systems. 
The dissolved oxygen concentration along a centreline of the culture chamber at the culture surface. Dissolved oxygen distribution is shown for two different 
oxygen uptake rates (OURs); 1.4×10-8 mol.m-2s-1 corresponding to cells at seeding, and 2.24×10-7 mol.m-2s-1 corresponding to cells at high confluency. Three 
different lid systems are shown; the impermeable entirely PC lid of Marcel Reichen’s prototype device, and the new gas permeable lid system with a closed 
polycarbonate component and an open polycarbonate component. Dissolved oxygen is shown as percentage of saturation at 1.05 atm (21% 02). 
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Modelling of Dissolved Oxygen with Gas Permeable Lid 
Modelling was used to investigate dissolved oxygen in microfabricated culture 
devices under different conditions. Devices were modelled with an entirely PC 
lid, as in Marcel Reichen’s prototype design, and with the new gas permeable 
lid  system  using  closed  (Figure  3.13[d])  and  open  (Figure  3.13[b,c])  PC 
components. As in section 2.3.3 oxygen uptake rates (OURs) were chosen to 
represent the upper and lower limits of what would be expected during mESC 
culture;  1.40×10
-8  mol.m
-2s
-1  to  represent  immediately  after  seeding  and 
2.24×10
-7 mol.m
-2s
-1 to represent a highly confluent culture. The inlet DO was 
set to 0.20 mM, the saturation concentration at 1.05 atm (21% O2 37°C), as 
positive pressure is required to pump the medium. The concentration at the top 
of the permeable lid was set also set to 0.2 mM at both OURs, as well as 0.19 
mM at the higher OUR to investigate the effect lower pressure (1 atm) above 
the PDMS lid. The resulting distributions of DO are shown in Figures 3.14 and 
3.15. Dissolved oxygen is shown as percentage of saturation at 1.05 atm (21% 
02). 
 
At both OURs the mean concentration and the uniformity of DO at the culture 
surface are lowest with an entirely PC lid (Figure 3.14 [a,d] & Figure 3.15) and 
highest with the gas permeable lid system using an open (Figure 3.13 [b or c]) 
PC component (Figure 3.14 [c,f] & Figure 3.15). The mean culture surface DOs 
at low and high OURs are 97% ± 1% and 53% ± 20% (± 1 standard deviation) 
respectively,  for  an  entirely  PC  lid,  and  98.1%  ±  0.4%  and  69%  ±  6% 
respectively, for the gas permeable lid system with an open PC component. The 
mean DO is higher in the gas permeable lid system, as oxygen passes through 
the highly permeable PDMS to replace oxygen consumed from the medium by 
the cells. A gradient must exist as the driving force for this mass transfer. This 
gradient is higher at higher OURs resulting in lower mean DO concentrations in 
the medium.  
 
With an entirely PC lid the only source of oxygen is the medium which, arriving 
from one side of the culture surface, causes a gradient across the length of the 
culture  surface  (Figure  3.15);  the  cells  closest  to  the  inlet  experience  a 131 
 
pericellular  DO  near  the  concentration  of  the  incoming  medium  but  the 
pericellular  DO  then  reduces  along  the  length  of  the  chamber  as  oxygen  is 
consumed  by  the  cells.  The  gas  permeable  lid  system  with  an  open  PC 
component  introduces  oxygen  from  above  the  culture  surface,  reducing  the 
gradient by replacing some of the consumed oxygen. Using the gas permeable 
lid system with an open PC component, pericellular DO reduces from near the 
inlet DO towards the pericellular DO achieved in static conditions (which can be 
calculated from Ficks Law; see below).  
 
The gradient across the length of the chamber will be reduced further if the DO 
concentration in the incoming medium is reduced. The gradient will most rapidly 
reach the equilibrium that exists under static conditions if the DO concentration 
at  the  inlet  is  equal  to  the  mean  DO  in  the  culture  chamber  under  static 
conditions.  Gradients  will  also  reduce  further  as  the  medium  flow  rate  is 
reduced and the lid becomes responsible for a greater portion of the supplied 
oxygen. At a flow rate of zero no gradient should exist across the length of the 
chamber and the DO across the whole culture surface can be calculated using 
Fick’s law, as in chapter 2 (sections 2.2.4 and 2.3.3).   
 
In a static system, at the same pressure used in the finite element models, a 
gas permeable lid system with an open PC component delivers culture surface 
DOs  of  97%  and  59%  at  the  low  and  high  OURs  respectively.  These 
correspond to the asymptotes on Figure 3.15. Due to its high permeability the 
PDMS is responsible for just 38% of the difference between the pericellular DO 
concentration and 100% DO concentration despite creating 90% of the diffusion 
distance.  For  the  same  reason,  reductions  in  PDMS  thickness  have  a  less 
significant impact on culture surface DO than reductions in the medium height. 
For example, halving the thickness of the PDMS lid component only increases 
pericellular DO by 13% at the highest OUR. 
 
When using the gas permeable lid system with a closed PC component (Figure 
3.14[b,e] & Figure 3.15) the DO at the culture surface is more uniform and the 
mean value (96% ± 1% at low OUR and 34% ± 18% at high OUR) is lower than 132 
 
the DO with an entirely PC lid (Figure 3.14[a,d] & Figure 3.15). While no oxygen 
is supplied through the PDMS lid, its high permeability facilitates more rapid 
transfer of oxygen along the length of the chip than the combination of medium 
flow and diffusion through the medium. At the inlet to the chamber the high DO 
of incoming medium drives oxygen into the PDMS reducing culture surface DO 
in  that  area  relative  to  an  entirely  PC  lid.  The  oxygen  is  then  transported 
through the PDMS towards the chamber outlet where it is driven back into the 
now  depleted  medium.  The  oxygen  returned  to  the  medium  near  the  outlet 
reduces  the  decrease  in  culture  surface  DO  along  the  length  of  the  chip. 
Consequently, the culture surface DO is lower on average than with an entirely 
PC lid, but more uniform. 
 
When using the gas permeable lid system with an open PC component, and the 
oxygen  pressure  above  the  gas  permeable  lid  is lower than  the  pressure  in 
equilibrium  with  incoming  medium,  oxygen  is  rapidly  transferred  from  the 
incoming medium to the PDMS lid. The asymptote that the pericellular dissolved 
oxygen approaches is also reduced. This results in a steeper gradient in culture 
pericellular DO and a lower average value. Where the inlet pressure is 1.05 atm 
(21% O2) and the pressure above the lid is 1.00 atm (21% O2), the mean culture 
surface DO is reduced to 66% ± 7% for the higher OUR (compared to 69% ± 
6%). Therefore, it may be advantageous to use a polycarbonate lid component 
connected to a controlled gas supply (Figure 3.13[c]) (the inlet gas supply or a 
secondary  gas  supply)  to  achieve  higher  and  more  uniform  pericellualar 
dissolved oygen 
 
The  gas  permeable  lid  system  with  open  PC  components  can  clearly  be 
employed  to  deliver  higher  and  more  uniform  pericellular  DO.  However, 
achieving  a  specific  target  and  maximising  uniformity  requires  careful 
manipulation of the partial pressure of oxygen both at the inlet and in the head 
space  of  the  PC  lid  component.  The  inlet  pressure  strongly  affects  the 
pericellular DO concentration experienced by cells nearest the inlet. It is best 
manipulated  to  have  a  inlet  DO  concentration  slightly  above  the  target 
pericellular  concentration.  The  partial  pressure  in  the  lid  head  space  should 
then  be  manipulated  to  achieve  the  desired  pericellular  DO  across  the 133 
 
remainder of the culture surface. Such manipulations could be based either on 
model predictions or feedback from an oxygen sensor (Super, 2014). 
 
3.3.7  Improvements to Monitoring and Fluid Control  
Microscopy 
The  design  of  both the  prototype  culture  device  and  the  new  culture  device 
facilitate the monitoring of cell culture by phase contrast microscopy. Moreover, 
acquisition of phase contrast images was automated by the prototype control 
and automation platform. However, automated acquisition was only possible for 
a  single  field  of  view  and  microscope  objective.  To  expand  the  automated 
imaging  capabilities  the  new  culture  device  design  is  compatible  with  a 
motorised  microscope  stage  (MEC56110,  Nikon  Instruments,  UK).  This 
motorised microscope stage delivers accurate and precise x and y positioning 
allowing  the  automated  time-lapse  imaging  of  multiple  xy  co-ordinates. 
Furthermore the motorised stage was purchased as part of a fully motorised 
microscope (Nikon Ti-E, Nikon Instruments, UK). This microscope included a 
motorised  z-drive,  an  digital  microscope  camera  (Fi-1),  and  an  LED  based 
fluorescent excitation system (CoolLED pE-2, CoolLED, UK). 
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Figure 3.16 - Microscope control screen of LabVIEW VI. 
The screen of the LabVIEW VI used to control the microscope. On the top left are controls to adjust 
lighting, nose piece position and fluorescent filter. On the bottom left are controls to adjust the 
motorised xy stage. On the bottom right is a list to which image positions and setting can be added. 
On the top right is the feed from the microscope camera which is displayed in all control screens. 
 
The motorised microscope system is connected to a computer by USB. The 
digital microscope camera and fluorescent excitation system are connected by 
separate USB cables. Control of the microscope and camera were integrated 
into the LabVIEW (National Instruments, UK) VI used for the prototype control 
and  automation  system.  This  programming  was  done  in  conjunction  with 
Nicolas  Jaccard.  The  microscope  control  screen  of  the  LabVIEW  VI  (Figure 
3.16) allows control of the lamp, the nose piece position, the filter turret position, 
and  the  motorised  xy  stage.  The  xy  stage  can  be  stepped  relatively  by  a 
specified increment or moved to an absolute position. Once a set of imaging 
parameters  are  optimised  they  can  be  stored  in  a  list  to  be  cycled  through 
automatically.  
 
The  vision  screen  of  the  LabVIEW  VI  displays  a  live  feed  from  the  digital 
microscope camera that could be switched on and off at will. There are also 135 
 
buttons to perform an auto-white operation to adjust the colour balance and to 
immediately commence imaging each parameter set in the list recorded on the 
microscope  control  screen.  Camera  settings  including  exposure  mode  and 
image size can be set at the start of an experiment in the settings screen as can 
a  frequency  for  automated  image  acquisition.  The  VI  programming  of  the 
microscope  and  camera  allow  the  regular, automated,  time-lapse  imaging  of 
multiple  fields  of  view  (up  to  the  entire  culture  area)  with  the  option  to  use 
multiple  microscope  objectives.  This  greatly  expands  the  quantity  of  phase 
contrast microscopy data that can be captured from each culture experiment 
with the microfabricated culture device. 
 
While the motorised microscope provides a powerful monitoring solution for the 
microfabricated culture device it presents a number of draw backs.  In order to 
carry out the automated time-lapse imaging facilitated by the microscope the 
culture  device  must  either  be  left  in  position  on  the  stage  or  removed  and 
replaced with extreme positional accuracy for each imaging time point. The later 
is impractical but maintaining the device in position on the stage throughout the 
culture is possible. This does however require an on-microscope method for 
temperature and atmospheric control. Atmospheric control should be possible 
through the gas permeable lid designs discussed in this chapter. The prototype 
control and automation platform delivers temperature control by directly heating 
the slide but this is only compatible with glass microscope slides. An alternate 
heating solution is proposed in chapter 4 but an interim solution is the use of a 
cage incubator (Okolab, Italy). With or without a cage incubator, the size and 
expense of the microscope system relative to the 1-6 devices it can support 
means it is not a practical solution for wide scale use. 
 
Fluidics 
The fluidics of the prototype control and automation platform were modified for a 
new design of control and automation platform. The custom medium reservoirs 
were replaced with pressure resistant, amber SCHOTT bottles coupled with 2-
port  lids  (SCOT1094367  &  554-3000,  VWR,  UK).  SCHOTT  bottles  are 
commercially  available  allowing  users  to  more  easily  replace  and  customise 136 
 
reservoirs.  The  amber  glass  also  provides  additional  light  protection,  high 
resistance to autoclave, and a reduced risk of contamination with leachables 
relative  to  plastic.  A  length  of  0.8  mm  ID  PEEK  tubing  with  a  male  Luer 
connector on the end is inserted through each port to the bottom of the bottle. 
One length of tubing introduces pressurised gas mixture which bubbles through 
the medium to the head space and forces medium to flow out of the other length 
of tubing. 
 
 
 
Figure 3.17 - Media storage and cooling unit of new control and automation platform. 
The unit of the new control and automation platform that houses the medium bottles. Up to four 
medium bottles are housed in a water bath. The water bath is elevated to leave room for a peltier 
cooling system. On top of the unit are valves and regulators for gas control. On the back are the 
circuit boards for valve switching and temperature control. Two leads connect the unit to a data 
acquisition card and one lead connects to a unit housing the culture devices and medium switching 
valves. 
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A unit constructed from polycarbonate houses up to four medium bottles in a 
water bath that can be used to maintain medium at a low temperature to reduce 
the thermal degradation of medium components. The base of the water bath is 
polycarbonate with a hole in the centre covered by a 1.2 mm aluminium sheet to 
allow cooling through attachment of a peltier cooling system (designed for CP-
061, TE Technology, USA). Alternately, the water bath can be kept cool by the 
addition of ice. The base and walls of the water bath are insulated with 4 mm of 
calcium-magnesium  silicate  sheeting  (724-8906,  RS  components,  UK)  to 
reduce  the  required  cooling  load.  The  unit  containing  the  water  bath  also 
includes  all  the  circuit  boards  (Appendix  4)  required  for  fluidic  and  thermal 
control as well as the valves and regulators used to control gas flow (Figure 
3.17). These components were kept off the microscope stage to avoid clutter 
and respect the load limits of motorised stages. 
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Figure 3.18 - Design of fluidics for new control and automation platform. 
A schematic design of the fluidics for a new control and automation platform. Either or both of two gas sources can drive medium from any combination of four medium 
bottles. Which bottle supplied each set of three devices is dictated by six 3-way valves. Medium passes through a preheat and bubble trap which includes a purge outlet. 
Heated medium is split to the three parallel devices then flows through equal lengths of high resistance tubing before merging to a single waste stream. 139 
 
The  new  control  and  automation  platform  is  designed  for  two  sets  of  three 
culture devices run in parallel, with a choice of four medium supplies and two 
gas  supplies  (Figure  3.18).  To  test  the  design,  sufficient  components  were 
installed to control one set of three culture devices run in parallel, with a choice 
of two medium supplies and single gas supply. Each gas supply is connected to 
an electronic pressure regulator (ITV0011-2BL, Pneu-Store, UK) that controls 
the  pressure  between  0  and  1  bar  using  a  0-5  V  signal.  The  output  of  the 
regulator is split into four lines each going to an on/off valve (LVM10R3Y-6A1-1-
Q, Pneu-Store, UK) which is, in turn, connected to each of the four medium 
bottles. The on/off valves are used to control which gas (where there are two 
available) is delivered to which bottle. The same gas can be delivered to up to 
four bottles or different bottles can be pressurised by different gas mixtures. 
(The gas leaving the regulator could be connected to gas permeable lids before 
returning to be split to the four on off valves.) Immediately prior to each bottle 
are a 0.22 μm filter for sterility and a check valve to prevent media flowing in 
reverse when gas pressure is reduced. 
 
Medium  flows  from  the  bottles  to  a  small  second  unit  mounted  on  the 
microscope stage. For each set of three parallel devices a combination of three 
3-way valves (LFRA1230110H, The Lee Company, UK) are used to select the 
source  of  medium.  The  selected  medium  then  passes  through  a  combined 
preheat  and  bubble  trap  unit  (technical  drawings  in  Appendix  2).  Up  to  the 
preheat/bubble trap unit all tubing is 0.03” ID PEEK. The preheat and bubble 
trap unit consists of three layers of PDMS clamped between aluminium plates. 
Medium passes through a 50 mm long channel (0.5×0.2 mm) to the bottom of a 
circular  chamber  (2  mm  D,  3  mm  h)  and  then  on  from  the  bottom  of  the 
chamber to the outlet.  
 
Heat  is  introduced  by  a  flexible  heating  circuit  (HK5160R157L12B,  Minco, 
France) in response to readings from a thermistor (B57863S103F40, Farnell, 
UK) positioned near the outlet. The heating circuit is positioned between the 
bottom two PDMS layers (0.12 mm below the below channel). Any bubbles in 
the medium at the end of the channel will rise to the top of the circular chamber. 
The top of the circular chamber is connected to an on/off valve that can be used 140 
 
to regularly purge trapped gas. This valve can also be used to purge the fluidics 
up  to  this  point.  This  capability  facilitates  more  rapid  switching  of  medium 
source. As the purge is very near the culture devices dead volume is minimised. 
 
After the preheat and bubble trap unit the ID is reduced to 0.01” to reduce dead 
volume. The medium is split into three streams connected to the three parallel 
culture devices. A single 10 cm length of tubing is split into three 6 cm lengths 
giving  a  dead  volume  of  approximately  5  μl  per  device.  The  outlet  of  each 
device is connected to a 50 cm length of 0.004” ID PEEK tubing. These lengths 
of tubing are included to add an equal and high resistance to each of the three 
flow paths to achieve equal flow regardless of small variations in the resistance 
of the culture devices. The resistances of each of the three lengths of tubing are 
156,  155,  and  157  TPa.s.m
-3  respectively  (recorded  pumping  medium  at  6 
ml.h
-1). In comparison the resistances of three different culture devices were 
1.58, 1.67, and 1.14 TPa.s.m
-3 (recorded pumping medium at 60 ml.h
-1). The 
difference between the upper and lower resistances of the chips is 37% of the 
mean but when coupled to the high resistance tubing the variation is reduced to 
≤1%. 
 
 
Figure 3.19 - Waste bottle with regulated back pressure. 
Waste medium flows into the bottom of a 15 ml Falcon tube suspended in a SCHOTT bottle. Medium 
overflows from the Falcon tube though holes at the top and into the SCHOTT bottle. This maintains 
a constant height of medium at the tubing outlet. 
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Finally, the three outlets are connected to a single length of 0.03” ID tubing 
connected to a waste reservoir. The waste reservoir was designed to maintain a 
constant back pressure. A small back pressure means that even under low or 
no flow conditions a pressure is maintained on the culture chamber driving out 
gas bubbles and replacing evaporating medium. The waste reservoir consists of 
a 15 ml Falcon tube suspended in the lid of a SCHOTT bottle (Figure 3.19). 
Tubing enters the falcon tube via a small hole in the lid. Four 3 mm holes in the 
tube  just below  the  lid  allow  liquid  to  overflow  into  the  SCHOTT bottle. The 
Falcon tube is initially filled with sterile water which is then displaced by the 
waste medium resulting in a constant height of liquid at the tubing outlet. This 
arrangement maintains a back pressure of approximately 1 kPa. 
 
Software and Connectivity 
An issue with the prototype control and automation platform was the complexity 
of both the software and the connectivity. The prototype platform required 16 
cables to be connected; 8 power supplies and 8 signal cables.  For the new 
platform the number of connections was reduced to a single power connection, 
one  connection  between  the  main  unit  and  the  stage-top  unit,  and  two 
connections  between the  main  unit  and  the  data  acquisition  card  (DAQ)  (NI 
USB-6221,  National  Instruments,  UK).  All  valves,  regulators,  heaters  and 
thermistors were powered by a single  112W 12V DC power supply (L52BR, 
Maplin,  UK)  connected  to  the  main  platform  unit  by  a  simple  cylindrical 
connector.  A  DB-25  serial  cable  transmits  power  and  signals  between  the 
stage-top unit and the main unit. A DB-25 serial cable and a PS/2 cable transmit 
signals and power between the main unit and DAQ. There are not only fewer 
cables to connect in the new platform but the connections are faster to make 
(push  fit).  Because  there  is  only  one  power  supply  less  physical  space  is 
occupied  and  there  is  less  opportunity  to  make  a  wrong  connection.  To 
compensate  for  the  reduced  number  of  power  supplies  the  DC  voltage  is 
stepped up or down for certain components via the circuit boards on the main 
unit. 
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The LabVIEW VI for the prototype platform had a number of redundant sections 
of code. Code for measurement of DO by fluorescent lifetime measurements 
and code for the control of different pumping solutions were removed for the 
new platform. In its place, code was added to control the motorised microscope 
and microscope camera as discussed above. Code was also added to allow 
use of a PreSens dissolved oxygen probe (PreSens, Germany) with the fibre 
mounted to the microscope nosepiece. This was done to support the research 
of Alexandre Super (Super, 2014) to measure pericellular dissolved oxygen in a 
culture device. Efforts were made to reduce the settings that need adjusting for 
each experiment. Typically, a user must select the camera settings (exposure 
mode,  exposure,  gain,  image  resolution)  and  automated  image  acquisition 
settings  (off/on,  period,  save  location).  The  DAQ  input  and  output  lines  no 
longer require adjustment. These software changes increase functionality of the 
software while simplifying operation. 
 
 
3.4  Conclusions 
New  designs  of  microfabricated  culture  device  and  control  and  automation 
platform have been developed based on Marcel Reichen’s prototype designs. 
The new designs build on key features of the prototype designs that  deliver 
well-controlled, uniform culture conditions and processes that can be translated 
to/from traditional culture systems:  
  The use of reversible compression seals to facilitate the use of various 
culture substrates and the inclusion of a resealable lid for direct access 
to the culture chamber.  
  The short wide culture chamber design with raised inlet and outlets that 
delivers low shear perfusion with more uniform concentrations of soluble 
factors.  
  A  proven  capacity  to  culture  embryonic  stem  cells  and  evidence  of 
comparability with traditional culture systems. 
  Gas driven perfusion with automated medium switching. 
  Monitoring by phase contrast microscopy. 143 
 
The  new  design  strengthens  the  culture  device  concept  in  a  number of  key 
areas. 
 
Firstly, a new design of PDMS chip with tree-like channel structures achieves 
more  uniform  expansion  of  perfused  medium  than  the  prototype  design. 
Uniform expansion of medium is vital as modelling shows that the perfusion 
barriers  are  ineffective  at  increasing  uniformity.  In  fact,  perfusion  barriers 
decrease uniformity through the creation of dead zones and high velocity zones. 
However, perfusion barriers play a key structural role maintaining separation 
between the two flexible layers of the PDMS chip. 
 
Secondly,  bending  analysis  of  the  prototype  device  implied  the  bending  of 
frames is responsible for a high frequency of leaking, a highly variable burst 
pressure, and a high sensitivity to screw torque. A new device design, including 
a  holder to house  up  to  three  devices,  minimises  bending.  The  decrease  in 
bending  increases  the  burst  pressure  from  59  ±  18  kPa  to  370  ±  120  kPa 
though the variation remains high. The new design no longer encounters leaks 
at typical operating pressures and is not sensitive to the screw torque used for 
clamping. 
 
The elimination of the sensitivity to screw torque also makes the new design 
easier to use. Ease of use is also increased by reducing the number of parts per 
device (by eliminating the bottom plate) and the number of clamping screws 
(from 30 to 12 for three devices). The reusable parts of the new system have 
been  made  more  robust.  This  is achieved  through  use  of  aluminium for the 
holder and interconnects, and thicker polycarbonate for the top frame which is 
also subject to less bending stress. 
 
A newly designed gas permeable lid system allows oxygen to be supplied to 
cells without the perfusion of medium. The rate of oxygen supply can therefore 
be  controlled  independent  from  shear  stress  and  the  concentration  of  other 
soluble factors (albeit not fully decoupled). Higher pericellular dissolved oxygen 144 
 
concentrations can be achieved than with the previous impermeable lid system. 
The pericellular dissolved oxygen is also more uniform, even when oxygen is 
not supplied through the lid, due to the high permeability of PDMS. While the 
new lid system improves control, careful manipulation of the partial pressure of 
oxygen  is  required  to  deliver  the  most  uniform  and  consistent  pericellular 
dissolved oxygen possible. 
 
The  new  designs  of  culture  device  and  control  and  automation  platform 
increase the extent of data that can be obtained by phase contrast microscopy. 
Up  to  two  sets  of  three  parallel  culture  devices  can  be  positioned  on  a 
motorised microscope stage. This allows time lapse imaging of the entirety of all 
six  culture  areas.  Use  of  a  fully  motorised  microscope  facilitates  the  use  of 
different  magnifications  and  lighting  conditions.  A  fully  motorised  inverted 
microscope  is  a  powerful  and  useful  tool  for  analysis  of  culture  in 
microfabricated culture devices but is not suitable for wide-scale use. 
 
The new platform now incorporates commercially available medium reservoirs 
to make user customisation easier. The fluidics have also been expanded to 
allow  selection  from  up  to  two  gas  supplies  and  four  medium  reservoirs  to 
supply  1-2  sets  of  3  parallel  culture  devices.  An  automated  purge  valve 
attached to the bubble trap allows regular removal of trapped gas and more 
rapid  switching  of  medium  supply.  High  resistance  tubing  is  employed  to 
increase  the  uniformity  of  flow  through  parallel  devices.  Finally,  a  waste 
collection system has been designed that delivers a constant back pressure to 
reduce bubble formation. 
 
The control and automation platform still consists of two units but the number of 
components on the stage-top unit has been reduced to minimise weight. The 
number  of  power  supplies  required  has  been  reduced  to  one.  Similarly,  the 
number of connections between the two units and the data acquisition card has 
been reduced to three. These changes make the platform simpler to operate 
and reduce space requirements. The control software is also simpler to operate 
than it was in the previous platform, and all redundant code has been removed. 145 
 
 
The new designs retain the strengths of the prototype designs while improving 
control, monitoring, robustness, and ease of use. While none of the changes 
would  be  expected  to  make  the  system  less  suitable  for  cell  culture,  the 
capacity  for  cell  culture  must  be  revalidated.  It  would  also  be  beneficial  to 
investigate  any  significant  differences  in  culture  outcome  due  to  the  design 
changes to the PDMS chip and the lid system. Finally, a new heating system for 
device culture chambers is still needed that allows continued use of TC-PS as a 
culture surface.   146 
 
4.  Evaluation of the Improved Microfabricated Culture 
System 
4.1  Review of the Prototype and Improved Culture Systems 
A prototype microfabricated adherent culture device was introduced in chapter 
2. The device facilitates low-shear perfusion of medium through a short, wide 
culture chamber, providing good control over soluble factor concentrations. A 
resealable  lid  allows  static  seeding  of  cells  directly  onto  the  culture  surface, 
which  can  be  tissue  culture  polystyrene  or  any  other  smooth  flat  material. 
Mouse embryonic stem cells appear to attach at similar rates in the prototype 
culture  device  and  a  T-25  culture  flask.  Mouse  embryonic  stem  cells  also 
appear  to  expand  at  a  similar  rate  under  static  culture  conditions,  with  the 
resealable  lid  not  included.  Furthermore,  the  prototype  culture  device  was 
shown  suitable  for  the  perfusion  culture  of  human  embryonic  stem  cells  co-
cultured on inactivated mouse embryonic fibroblasts. Colonies expand over two 
days of perfusion culture and continue to stain positive for pluripotency markers. 
 
Chapter  2  also  introduced  a  control  and  automation  platform  to  house  the 
device. Medium can be perfused form one of two chilled reservoirs, through a 
preheat unit, to up to three prototype culture devices. The devices themselves 
can also be heated though this requires use of a glass culture substrate. The 
platform is designed to be used with an inverted microscope, which can be used 
to monitor cultured cells using phase contrast microscopy. 
 
The designs of both the culture device and the control and automation platform 
were improved upon in chapter 3. The structure of the channels in the PDMS 
chip  (through  which  the  medium  is  perfused)  was  changed  to  improve  the 
uniformity  of  the  fluid  velocity  field  when  the  chip  is  uncompressed. 
Consequently,  uniformity  of  shear  stress  and  soluble  factor  concentrations 
should  also  improve.  Uniformity  of  pericellular  dissolved  oxygen  was  further 
improved by introducing a gas permeable lid design. Design changes made to 
the packaging of the culture device improve robustness by reducing the bending 
of rigid components. The design changes significantly increase burst pressure, 147 
 
and  the  reduced  bending  should  increase  the  uniformity  of  fluid  flow. 
Furthermore, the new device design, which includes an aluminium holder, is 
easier  to  assemble;  sealing  devices  in  a  biological  safety  cabinet  setting 
requires the tightening of fewer screws, and to less specific screw torques. 
 
The aluminium holder fits in the stage of a motorised microscope, expanding 
monitoring capabilities to include time-lapse imaging of whole culture chambers 
and the use of multiple objectives. Up to two sets of three culture devices can 
be imaged in this way. These devices can be controlled and monitored by the 
improved control and automation platform. The improved platform is designed 
to use two pressurised gas mixtures to perfuse medium from a choice of four 
medium reservoirs. The fluidics of the improved platform achieve more equal 
flow through parallel devices and maintain a back pressure to reduce bubble 
formation. The whole platform, including the control software, has been made 
simpler to assemble and operate. 
4.1.1  Next Steps 
Following  the  implementation  of  these  design  changes,  the  next  step  is  to 
demonstrate  that  the  microfabricated  culture  system  remains  able  to  culture 
embryonic stem cells. The changes made are not expected to make the device 
unsuitable for stem cell culture, but validation of this assumption is required. 
Furthermore,  it  would  be  useful  to  investigate  whether  the  design  changes 
significantly affect culture outcomes. In particular, the changes to the PDMS 
chip and the introduction of the gas permeable lid may result in more uniform 
culture outcomes across the chip, corresponding to the increased uniformity of 
culture  conditions.  The  higher  pericellular  DO,  resulting  from  the  additional 
oxygen  supplied  through  the  gas  permeable  lid,  may  also  affect  culture 
outcomes. 
 
Once  a  culture  system  design  is  finalised,  equivalence  will  need  to  be 
established with traditional adherent culture systems. This will validate results 
generated with the system and support the translation of protocols to and from 
the  microfabricated  system.  The  first  step  of  this  process  is  establishing 
identical  starting  points  in  both  the  microfabricated  and  traditional  culture 148 
 
systems. The rate of seeding in the prototype culture device was investigated in 
chapter 2 by counting the cells that remained unattached. By this method the 
rate of attachment appears to be the same as the rate in a T-25 culture flask. 
With techniques to automatically measure confluency now available (Jaccard et 
al., 2014a), this work needs to be extended to show that the confluency after 
seeding is equal in both systems. 
 
Finally,  a  new  solution  is  needed  to  heat  the  culture  chambers  of  the 
microfabricated culture devices. The prototype control and automation platform 
achieved  this  using  Indium-Tin-Oxide  coated  glass  slides.  This  solution  was 
rejected for the improved platform as it removes the substrate flexibility that is a 
key advantage of the microfabricated culture device. As an interim solution, the 
improved  platform  can  be  housed  within  a  cage  incubator  to  maintain  the 
culture  chamber  temperature.  However,  a  more  compact,  direct  and  cost 
efficient  heating  solution  would  be  preferred  if  the  microfabricated  culture 
system is to become widely used. 
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4.2  Materials and Methods 
E14Tg2a mouse embryonic stem cells were maintained as previously (section 
2.2.6).  Likewise,  culture  system  parts  were  manufactured  as  previously 
(sections 2.2.1 and 3.2.1). 
 
4.2.1  Seeding of Mouse Embryonic Stem Cells 
Prior  to  each  experiment,  the  aluminium  holder  and  parts  for  three 
microfabricated culture devices (top frames, PDMS chips, and gaskets) were 
cleaned with reverse osmosis water, autoclaved at 121°C for 20 minutes, and 
placed  in  a  drying  oven  over  night.  The  microfabricated  devices  were 
assembled  with  sterile  Nunclon®  TC-PS  microscope  slides  (16004,  Fisher 
Scientific, UK) inside a biological safety cabinet and inserted into the aluminium 
holder. The 12 screws of the aluminium holder were then tightened to seal the 
three  devices.  The  culture  chambers  of  the  devices  were  filled  with  0.1% 
gelatine solution (156 μl), as were three T-25 Nunclon® cell culture flasks (2 ml) 
(156367, Fisher Scientific, UK). The gelatine solution was left for 15 minutes 
and removed before seeding. 
 
Cells  were  harvested  from  a  T-25  flask  as  per  a  normal  passage.  The 
resuspended cells  were analysed twice  with a haemocytometer and  used to 
prepare a cell suspension of the desired concentration and volume. The cell 
suspensions were analysed again with a haemocytometer. The cell suspension 
was  then  used  to  seed  the  three  culture  devices  (156 μl)  and  three  flasks 
(7.5 ml). A 200 μl pipette tip was used to seed the microfabricated device and a 
10 ml sterological pipette was used to seed the flasks. In both cases the pipette 
tip  was  placed  in  a  specific  corner  of  the  culture  surface  (top  left  in  the 
microfabricated devices and bottom left in the flasks). Flat pieces of sterilised 
polycarbonate  were  placed  loosely  on  top  of  the  culture  chambers  of  the 
microfabricated culture devices to protect them from contamination. 
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Experiments 1-7 
For  the  first  seven  experiments,  the  microfabricated  culture  devices  and  T-
flasks were immediately transported to an incubator. The culture vessels were 
incubated for 6 hours at 37°C and 5% CO2. Following incubation the vessels 
were  transported  back  to  the  biological  safety  cabinet  and  the  medium  was 
exchanged. During the exchange, the pipette tip was placed in the same corner 
of  the  culture  surface  as  for  seeding.  An  excess  of  medium  (200  μl)  was 
replaced in the microfabricated culture devices and the sterile polycarbonate 
cover was replaced to eliminate meniscus effect for imaging. The vessels were 
then transported to an inverted microscope (Ti-E, camera Fi-1, Nikon, UK) and 
20  random  phase  contrast  images  were  taken  of  each  vessel  using  a  10× 
objective. 
 
Experiment 8 
For the eighth experiment, all culture vessels were imaged prior to incubation. 
As the flasks were placed into the incubator, they were held with one corner 
down and swirled gently to mix the cell suspension then immediately laid flat on 
the incubator shelf. Following the 6 hour incubation the vessels were imaged 
again prior to the medium exchange and then for a third time after the medium 
exchange. At all imaging time points, 20 random phase contrast images were 
taken of each vessel using a 10× objective. 
 
Experiments 9-14 
For the last six experiments, the culture vessels were only imaged after the 
medium exchange, as was done in the first seven experiments. However, the 
flasks were mixed immediately before laying them flat in the incubator, as was 
done in the eighth experiment. 
 
Seeding Experiment Image Analysis 
Images from the seeding experiments were analysed with PHANTAST software 
(Jaccard et al., 2014a) to calculate the confluency of stem cells in each image. 151 
 
The previously optimised settings (section 2.2.10) of ˃=3.54, ʵ=0.0876, and a 
maximum halo removal ratio of 0.281 were used. The remaining settings were; 
for  halo  processing,  a  minimum  fill  area  of  25  pixels  and  removal  of  small 
objects setting of 400, and for additional processing, removal of small objects 
bellow 100 pixels. 
 
4.2.2  Perfusion Culture of Mouse Embryonic Stem Cells 
These culture experiments used different combinations of open and closed PC 
lid components, and prototype and improved PDMS chips. Special top frames 
were manufactured to accommodate the prototype PDMS chip in the aluminium 
holder of the improved culture system. These top frames had the inlet and outlet 
holes, and interconnect attachment points, 4 mm closer together to match the 
prototype  chip.  The  special  top  frames  were  otherwise  the  same  as  the 
standard top frames (see appendix 2 for full dimensions). 
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Figure 4.1 - Chamber cover for seeding period. 
Bottom [a] and side [b] views of the polycarbonate cover used to protect against contamination 
during  seeding.  The  outer  dimensions  fit  inside  the  recess  around  the  lid  hole  [c]  while  the 
dimensions of the cavity are slightly larger than the dimensions of the lid gasket. 
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Prior  to  each  experiment,  the  aluminium  holder  and  parts  for  three 
microfabricated culture devices (top frames, PDMS chips, gaskets, interconnect 
bars, and PDMS and PC lid components) were cleaned with reverse osmosis 
water, autoclaved at 121°C for 20 minutes, and placed in a drying oven over 
night.  Also  cleaned  and  autoclaved,  were  covers  to  protect  the  culture 
chambers  from  contamination  during  seeding  (Figure  4.1)  and  the  medium 
bottle, waste bottle and tubing of the improved control and automation platform 
(section 3.3.7). The valving and temperature control systems of the improved 
platform were not used.  
 
The  microfabricated  culture  devices  were  assembled  in  open  configuration, 
using sterile Nunclon® TC-PS microscope slides (16004, Fisher Scientific, UK), 
inside  a  biological  safety  cabinet.  The  devices  were  then  inserted  into  the 
aluminium holder and the 12 screws of the aluminium holder were tightened to 
seal the three devices. The culture chambers of the devices were filled with 
0.1% gelatine solution (156 μl). The gelatine solution was left for 15 minutes 
and removed before seeding. 
 
Cells  were  harvested  from  a  T-25  flask  as  per  a  normal  passage.  The 
resuspended cells  were analysed twice  with a haemocytometer and used to 
prepare  a  cell  suspension  of  approximately  2.5×10
5  cells.ml
-1.  The  cell 
suspensions were analysed again with a haemocytometer. The cell suspension 
was then used to seed the three culture devices (156 μl) using a 200 μl pipette 
tip. The pipette tip was placed in the top left corner of the culture surfaces. After 
seeding,  sterilised  polycarbonate  covers  were  placed  loosely  on  top  of  the 
culture chambers of the microfabricated culture devices to protect them from 
contamination. The holder was then transferred to an incubator and incubated 
statically for 6 hours at 37°C and 5% gaseous CO2. 
 
The  perfusion  system  was  prepared  during  the  static  incubation.  A  sterile 
0.22 μm syringe filter was attached to the gas inlet of the medium bottle. The 
medium  bottle  was  filled  with  100-120  ml  of  mESC  culture  medium  and 
transferred to the cage incubator surrounding the motorised microscope. The 154 
 
Sensirion flow meter (SLG64-0075, Sensirion AG, Staefa, Switzerland), used in 
all but the first experiment, was sterilised by flushing with 80% ethanol, leaving 
filled  with  ethanol for 30 minutes, and  then flushing  with  autoclaved  reverse 
osmosis water. Finally, the inlet and outlet tubing were assembled and flushed 
with mESC culture medium. The flow meter was positioned in the inlet tubing 
upstream from where the combined inlet split into three streams. 
 
 
Figure 4.2 - Schematic of lid insertion process. 
A schematic showing the insertion of the PDMS component of the gas permeable lid system. First 
one edge of the lid is partially inserted with the lid at an angle [1]. Then the angle is slowly reduced 
to inset the other edge without entrapping any air [2]. Finally, the whole lid is slowly pressed down 
until the top layer is flush with the top of the gasket [3]. 
 
Following 6 hours of static incubation, the aluminium holder was returned to the 
biological safety cabinet and the polycarbonate covers removed. The medium 
was gently aspirated from the culture chambers and new medium was inserted 
through both the inlet and outlet ports in order to prime the channels. The final 
volume  of  medium  in  the  culture  chambers  was  sufficient  that  the  surface 
protruded above the top of the gasket. The PDMS lid components were inserted 
using sterile tweezers (Figure 4.2): First, one side of the lid was inserted slightly 
[1],  before  slowly  bringing  down  the  other  side  to  avoid  entrapping  any  air 
bubbles [2]. Once the whole lid was partially inserted it was gently pressed the 
rest  of  the  way  [3].  Medium  forced  from  the  chamber  was  aspirated  with  a 
pipette. Finally, the PC lid components were screwed down on top of the PDMS 
components. 
 
Following lid insertion, the inlet and outlet tubing was connected to the culture 
devices. This was done after lid insertion in order to provide low resistance flow 155 
 
paths by which medium could be forced from the chamber during lid insertion. 
The holder, complete with tubing, was then transported to the microscope and 
connected to the medium bottle. In all but the first experiment, the flow meter 
was  connected  to  the  computer  and  the  logging  and  control  software  was 
initiated. Pressure was manually increased until the flow rate was near the set 
point, before setting this pressure as the pressure bias and initiating the PI flow 
controller. For the first experiment the pressure was left manually controlled to a 
pressure expected to give the target flow rate (2.24 V from previous resistance 
measurements; section 3.3.5 and 3.3.7). 
 
With  medium  perfusion  and  the  control  software  initiated,  the  holder  was 
screwed in place on the microscope stage and the image positions entered. 
Image positions were added in a grid pattern with a fixed step between images 
that ensured overlap. The cells were then cultured with continuously perfused 
medium for up to 92 hours. Phase contrast images were taken every 2 hours 
using a 10× objective. At the end of this period perfusion was stopped, inlet and 
outlet tubing disconnected, and the holder transported back to the biological 
safety cabinet for immunostaining of the cells. 
 
Culture Experiment Image Analysis 
Phase contrast microscopy images were analysed with software developed by 
Nicolas  Jaccard  (Jaccard  et  al.,  2014b,  Reichen  et  al.,  2012):  At  each  time 
point,  all  the  image  positions  of  a  culture  chamber  were  stitched  into  single 
images  showing  the  whole  culture  chamber.  Each  stitched  image  was  then 
analysed to detect cells and determine confluency. The image analysis software 
uses a random forest machine learning algorithm (Breiman, 2001) to classify 
pixels  as  either  cell  or  background.  The  classifications  are  based  on  local 
histograms  of  Basic  Image  Features  (BIFs)  computed  at  different  scales. 
Computation of BIFs consists of classifying each pixel of an image according to 
local symmetries and structures, for example radially symmetric blobs or lines 
(Griffin et al., 2009). The machine learning software had been trained on a set 
of phase contrast microscopy images of E14 mESCs achieving a mean F-score 
(i.e. overlap between the algorithm output and manual annotations by human 156 
 
experts)  of  0.92.  The  software  also  splits  each  image  into  a  36×10  grid  of 
smaller images (350×350 μm) and outputs the confluency of each grid square 
to allow the determination of spatial variation in confluency and growth rate. 
 
The  output  of  the  image  processing  software  was  used  to  generate  growth 
curves showing confluency over time. Confluency is not perfectly proportional to 
cell  number,  as  cell  area  can  change  through  an  experiment.  However, 
confluency  provides  a  reasonable  estimate  of  cell  number  throughout 
monolayer growth (Jaccard et al., 2014a). Instantaneous specific growth rates 
were generated from the confluency curves using an average of the forward, 
backward and central differences (equation 4.1); 
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Where SGRn is the specific growth rate, tn is the time, and Cn the confluency at 
point n. Relative specific growth rates were also calculated for each device in 
each experiment. This was done by taking the mean specific growth rate of all 
the devices in an experiment away from the individual specific growth rates for 
each device.  
 
The average growth rate of each grid element was calculated over two periods; 
12-26 and 26-40 hours after the start of perfusion. These calculations used the 
following equation; 
 
1 2
1 2
2 1 t t
C C ln
GrowthRate

    (4.2) 
Where C1 and t1 are the concentration and time at the start of the period, and C2 
and t2 are the concentration and time at the end of the period. 
Relative growth rates for each grid element were then calculated by subtracting 
from the growth rate of each grid element, the mean growth rate across the 
entirety of all three culture chambers in that experiment. 
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4.2.3  Cell Staining 
Cells  from  the  triplicate  perfusion  culture  experiments  were  stained  for 
pluripotency markers. After halting perfusion culture, the aluminium holder was 
returned  to  a  biological  safety  cabinet  for  immunostaining.  With  all  tubing 
disconnected,  the  PC  lid  components  were  unscrewed  and  removed.  The 
PDMS lid components were then carefully removed using tweezers. mESC cells 
were fixed with 4% (v/v) paraformaldehyde (PFA) in DPBS for 20 minutes then 
washed three times. All washing was with DPBS supplemented with 10% (v/v) 
FBS to block non-specific binding. Fixed cells were permeabilised by incubating 
with 0.2% Triton X-100 for 15 min at room temperature before washing a further 
3 times.  
 
Permeabilised cells were incubated with primary monoclonal antibodies Oct-4 
(ab19857), Nanog (ab80892), or Sox-2 (ab97959, Abcam, UK) at a dilution of 
1:200  in  10%  FBS,  for  one  hour  at  room  temperature.  The  cells  were  then 
washed three times and incubated with a corresponding secondary antibody, 
which had a excitation wavelengths of 488 nm (A-11008, Invitrogen, USA), at a 
dilution of 1:200 in 10% FBS, for one hour at room temperature. 
 
Cells in the second and third experiment were then washed three times and co-
stained  for  SSEA-1.  Co-staining  involved  repeating  the  primary/secondary 
staining procedure above, with an SSEA-1 primary antibody (ab16285, Abcam, 
UK) and a secondary that had an excitation wavelength of 555 nm (A-21422, 
Invitrogen, USA). For the second experiment both the primary and secondary 
antibody were diluted 1:200 in 10% FBS. For the third experiment the primary 
antibody was diluted 1:10 following information from supplier.  
 
Finally, the cells in all three experiments were washed with DPBS and stained 
with  4',6-diamidino-2-phenylindole  (DAPI)  (D1306,  Invitrogen,  Carlsbad,  CA, 
USA). DAPI at a dilution of 1:200 was incubated with cells at room temperature 
for  10  minutes.  Stained  cells  were  imaged  with  an  inverted  fluorescent 
microscope  (Ti-E,  camera  Fi-1,  Nikon,  UK)  using  an  LED  excitation  system 
(CoolLED pE-2, CoolLED, UK). For the second and third experiments devices 158 
 
were  removed  from  the  aluminium  holder for fluorescent  imaging.  Care  was 
taken not to move the PDMS chips relative to the TC-PS slides, as this would 
disrupt the culture surface. 
 
 
4.3  Results and Discussion 
Mouse  embryonic  stem  cells  were  used  for  the  engineering  studies  in  this 
chapter as they are more easily cultured reproducibly than human embryonic 
stem cells and can be seeded as a suspension of single cells without a layer of 
feeder cells. As the purpose of these studies is engineering characterisation of 
the  device,  the  relative  ease  of  reproducible  culture  is  worth  the  lesser 
relevance of the mouse cell line. Mouse embryonic stem cells are from a similar 
in vivo environment to human embryonic stem cells and are therefore expected 
to  be  sufficiently  representative  of  human embryonic stem  cell behaviour  for 
engineering characterisation and preliminary studies. 
 
4.3.1  Seeding of Mouse Embryonic Stem Cells 
The rate at which seeded cells attach in the prototype microfabricated culture 
device was compared to the rate in T-25 culture flasks, in section 2.3.5. The 
number  of  adherent  cells  proved  difficult  to  measure,  particularly  in  the 
microfabricated culture device, due to inefficient detachment of cells. However, 
the decrease in unattached cells proved easier to measure and is the same in 
the both culture systems. Following improvements to the culture device, and the 
development of software to accurately and consistently measure the confluency 
of attached cells (Jaccard et al., 2014a), this work is now extended to compare 
the confluency of attached cells after seeding. Previous work indicated that over 
90% of seeded cells attach within 6 hours of seeding (Figure 2.10). This was 
the incubation time chosen to allow cell attachment in future experiments.  
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Figure 4.3 - The results of initial experiments to  investigate post-seeding confluency as a 
function of seeding cell density. 
The average confluency of culture flasks and improved culture devices after 6 hours of incubation 
and a medium exchange. The confluency was investigated for different densities of seeded cells, 
with the same cell suspension used to seed 3 flasks and 3 culture devices. Error bars show the 
standard deviation of all images of the same vessel type seeded from the same suspension (n=60). 
Displayed on the figure are linear trend lines through the origin and their respective R2 values. 
 
Seeding was investigated at a range of seeded cell densities. This was done in 
order to search for a relationship between the two systems that is independent 
of the seeding density. Following the six hour incubation, culture medium was 
exchanged to remove unattached cells. Images of the culture vessels were then 
taken and analysed to determine confluency. Initial experiments indicated that 
the post-seeding confluency is lower in microfabricated culture devices than in 
T-25 flasks (Figure 4.3). However, the expected linear trend between seeded 
cells and flask confluency is not apparent in this data (R
2 = 0.667).  
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Figure 4.4 - Illustration of mean and standard deviation calculations made following seeding 
experiments. 
This figure illustrates the calculations made following the seeding experiments. 20 images are taken 
of  each  vessel  (flask  or  microfabricated  culture  device)  in  each  experiment.  The  images  are 
processed with PHANTAST software to get confluence figures. Means [ma,b] and standard deviations 
[sta,b] are calculated for each set of 20 images. The mean of these standard deviations, across all 
flasks or devices, and in all experiments, is the mean of the standard deviations between images of 
the same vessels. This indicates the average uniformity of cell distribution. The standard deviations 
between  the  mean  confluencies  of  the  three  similar  vessels  in  each  experiment  are  also  taken 
[stmc].  The mean of these values across all experiments is the mean of the standard deviations 
between images of the same vessel type, seeded from the same suspension. This value indicates 
how repeatably a culture system can be seeded from the same suspension and, consequently, the 
variation in average starting confluence between vessels in a culture experiment. 
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Moreover, there is significant variation both between the mean confluency of 
vessels  seeded  from  the  same  cell  suspension,  and  between  the  individual 
confluency measurements made at different locations within these vessels. The 
mean of the standard deviations between images of a specific culture vessel is 
65%, for culture flasks, and 51%, for microfabricated devices (Figure 4.4). The 
mean of the standard deviations, between the confluencies of vessels of the 
same type, seeded from the same cell suspension, are lower at 12%, for culture 
flasks, and 18%, for microfabricated devices (Figure 4.4). A higher variation is 
expected between microfabricated culture devices as their small volumes make 
them more susceptible to non-uniform cell suspensions. 
 
There are a number of possible reasons why the confluency might be lower in 
microfabricated culture devices than in flasks. A greater percentage of cells may 
be lost during pipetting due to the different surface area to volume ratios of 
different sized pipettes. Alternatively, cells may be forced into the channels of 
the microfabricated device. These three possibilities would result in fewer cells 
being  in  suspension  above  the  culture  surface  at  the  start  of  the  6  hour 
incubation. Reduced confluency may also be caused by increased cell death 
over the 6 hour incubation or by wash-out of cells during the medium exchange 
due to shear near the pipette tip. 
 
 
Figure 4.5 - Variability between images of the same culture vessel during seeding 
experiment 8. 
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The figure shows the standard deviation in image confluency (n=20), for individual culture vessels, 
as a fraction of the mean confluency for those culture vessels. The mean of three vessels’ standard 
deviations is shown, with error bars showing the standard deviation between vessels. Variation is 
shown immediately after seeding, 6 hours later immediately before medium exchange (following 
redistribution of cells in flasks), and immediately after medium exchange. 
 
 
Figure 4.6 - Changes in mean confluency due to post-seeding medium exchange in seeding 
experiment 8. 
The figure shows the mean confluency of vessels before and after the medium exchange that takes 
place 6 hours after seeding. Error bars show standard deviation between vessels (n=3). 
 
To narrow this range of possibilities, an experiment was carried out where the 
culture  vessels  were  imaged  immediately  after  seeding  as  well  as  prior  to 
medium exchange. When imaging the cells immediately after seeding, it was 
noted that cells were concentrated in the middle of the flasks. The mean of the 
standard deviations between images of the same flask was 74% of the mean 
confluencies for those flasks (Figures 4.4 and 4.5). The cells were redistributed 
immediately prior to incubation by holding the flask with one corner down (to 
achieve a high volume to surface area ratio) and gently swirling (to achieve a 
uniform  suspension),  then  immediately  laying  the  flask  flat  on  the  incubator 
shelf.  
 
Cells  in  microfabricated  devices  appeared  to  be  present  in  slightly  higher 
density  near  the  edges  of  the  culture  chamber.  The  mean  of  the  standard 
deviations between images of a culture device is 37% (Figures 4.4 and 4.5). 
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This is possibly due to fluid flow during the filling of the culture chamber; fluid 
flows rapidly away from the pipette tip towards the chamber edges and forms a 
meniscus.  The  image  processing  software  appeared  to  struggle  when 
classifying  cells  immediately  after  seeding.  This  is  due  to  the  significantly 
different  morphology  of  unattached  cells,  and  the  fact  that  not  all  cells  had 
settled into the focal plane. However, while the mean values are not accurate, 
the image to image variation remains indicative of variation in cell density. 
 
Immediately  prior  to  medium  exchange  the  cells  in  the  flask  were  more 
uniformly distributed (Figure 4.5) (the mean of the standard deviations between 
images  of  a  specific  culture  flask  is 12%),  showing  the  effectiveness  of  the 
redistribution method. As expected, the mean of the standard deviations in the 
microfabricated  devices  remained  similar  (34%)  (Figure  4.5).  Following  the 
medium exchange, the mean confluencies in the microfabricated devices and in 
the flasks were 7% and 10% respectively (Figure 4.6). These results were much 
closer than previously recorded, and suggest that the very low uniformity of cell 
distribution in the flasks was having a significant effect on the calculated means.  
 
The final mean confluency of the flasks is 75% of the mean confluency before 
the medium exchange, and the mean standard deviation remains similar (the 
mean of the standard deviations between images of a specific culture flask is 
13%) (Figures 4.5 and 4.6). The final mean confluency of the culture devices is 
79%  of  the  confluency  before  the  medium  exchange,  and  the  mean  of  the 
standard deviations is higher at 40% (Figures 4.5 and 4.6). This suggests that 
the medium exchange removes a lower fraction of cells in the microfabricated 
culture device but that cells are removed less uniformly. The reduced fraction of 
cells removed may be due to the steep fluid velocity gradients caused by the 
close proximity of the chamber walls. The low velocity areas near the chamber 
walls  may  protect  more  loosely  adhering  cells.  Similarly,  more  cells  are 
removed in the high velocity area immediately adjacent to the pipette tip. As 
these high and low velocity areas are also significant fractions of the culture 
area, this would also explain the decrease in uniformity. The larger culture area 
of the flasks results in shallower velocity gradients, and the low velocity areas 164 
 
near the walls and high velocity area near the tip are much smaller fractions of 
the culture area. 
 
 
Figure 4.7 - The results of experiments, using an improved methodology, to investigate post-
seeding confluency as a function of seeding cell density. 
The average confluencies of culture flasks and improved culture devices after 6 hours of incubation 
and a medium exchange. The confluencies were investigated for different densities of seeded cells, 
with the same cell suspension used to seed 3 flasks and 3 culture devices. Error bars show the 
standard deviation of all images of the same vessel type seeded from the same suspension (n=60 
images). Displayed on the figure are linear trend lines through the origin and their respective R2 
values. 
 
The  same  range  of  seeding  densities  was  investigated  again,  using  the 
technique outlined above to distribute cells more uniformly in the flasks. Figure 
4.7  shows  the  results  of  these  experiments  as  well  as  the  microfabricated 
device  results  from  the  previous  experiments.  Results  with  the  improved 
method  show  that  a  specific  density  of  seeded  cells  will  result  in  a  similar 
confluency  of  attached  cells,  in  both  culture  systems,  following  the  6  hour 
incubation period. Furthermore, there is a more linear relationship (R
2 = 0.939 
compared  to  previous  value  of  0.667)  visible  between  the  density  of  cells 
seeded and the confluency of attached cells in the flask (Figure 4.7). The mean 
of the standard deviations in confluency between images of the same flask is 
reduced to 14% (Figure 4.4), and the mean of the standard deviations, between 
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the  mean  confluencies  of  flasks  seeded  from  the  same  cell  suspension,  is 
reduced to 6% (Figure 4.4). The additional experiments with the microfabricated 
culture device have minimal effect on their standard deviations, which are 47% 
and 17% respectively. 
 
The results show that seeding the same density of mouse embryonic stem cells, 
in a microfabricated culture device and in a T-25 culture flask, will result in a 
similar confluency of attached cells after a 6 hour incubation period. Therefore, 
this parameter can be maintained when translating processes between the two 
systems. This result also implies that significant quantities of cells are not forced 
into the channels of the microfabricated culture device and that the device does 
not have a significant impact on the attachment process or cell viability over this 
period. This supports the microfabricated culture devices suitability for adherent 
cell culture. Figure 4.7 also shows that the mean confluency achieved with a 
particular density of seeded cells is repeatable. It is therefore possible for repeat 
experiments  to  start  at  the  same  mean  confluency  making  them  more 
comparable. 
 
The significant difference in results, resulting from the change in methodology to 
better  distribute  cells,  highlights  the  high  levels  of  variability  that  can  be 
introduced  in  manually  operated  culture  systems.  Care  must  be  taken  to 
minimise  such  variations,  as  they  may  lead  to  similar  variations  in  culture 
outcome throughout the culture vessel.  It is not obvious how the uniformity of 
seeding  can  be  increased  in  the  microfabricated  culture  devices.  The  low 
volume of the chamber makes mixing in the chamber ineffective, as the near 
proximity of the chamber walls creates high velocity  gradients. If the lack of 
uniformity  persists  beyond  the  early  stages  of  culture,  then  a  new  seeding 
technique may need to be developed to minimise variation within the device. 
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4.3.2  Perfusion Culture of Mouse Embryonic Stem Cells 
Initial Experiment 
To demonstrate a continued capacity of the improved microfabricated devices 
to  culture  ESCs,  they  were  used  to  expand  mouse  ESCs  with  continuously 
perfused  medium.  Furthermore,  to  investigate  the  effects  of  specific  design 
changes,  three  different  device  configurations  were  used;  with  either  the 
prototype or improved PDMS chip (Figure 3.3[a,d]) used in combination with 
either the open or closed PC component of the new gas permeable lid system 
(Figure 3.11[b,d]). For the first experiment, the three combinations were; the 
improved  chip  with  the  open  PC  lid  component,  the  improved  chip  with  the 
closed  PC  lid  component,  and  the  prototype  chip  with  the  closed  PC  lid 
component. The experiment utilised the monitoring, gas driven perfusion, and 
outlet  fluidics  (capillaries  and  back  pressure  regulating  waste  bottle)  of  the 
improved control and automation platform, but not the valves and temperature 
control systems, which were still under construction. As previously, the target 
flow rate in each reactor was 300 μl.h
-1, to check for cell retention and survival 
at extreme flow rates (a factor of 50 higher than a typical medium exchange rate 
in flask culture). 
 
The improved culture devices with the aluminium holder are much simpler to 
assemble in a sterile manner than the prototype culture devices (testimony of 
multiple users within the department). Assembly can also be achieved with a 
simple hex screwdriver or hex key, rather than a precision torque screwdriver. 
Time savings are estimated at approximately 60%, or 40 minutes, relative to 
assembling  3  prototype  devices.  The  assembly  of  the  fluidics  remains  more 
challenging, due to the number of connectors that must be tightened and the 
relatively low flexibility of PEEK tubing. This is an area that would benefit from 
further improvement. As  expected from  previous  experiments  (sections 2.3.5 
and 4.3.1), the majority of cells attach to the culture surface after 6 hours of 
static  incubation,  allowing  medium  to  be  exchanged  and  perfusion  to  be 
initiated. 
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In  the  initial  experiment,  it  was  observed  that  too  much  medium  had 
accumulated  in  the  waste  bottle  after  16  hours  of  perfusion  culture.  This 
indicated  the  required  pressure  was  significantly  lower  than  expected  from 
pressure measurements using water and a syringe pump. The voltage to the 
gas pressure regulator was lowered from 2.24 V to 1 V in an effort to achieve a 
closer flow rate to the target. After a further 24 hours of culture the medium 
volume in the waste bottle had not risen significantly and the regulator voltage 
was increased to 1.5 V. In spite of the variable flow rate, cells were retained, 
and survived and proliferated. Devices two and three surpass 90% confluence 
after  less  than  48  hours  of  perfusion  culture  (Figure  4.8).  The  uneven 
illumination caused by the open PC lid component of device one over expose 
some  images  affecting  image  processing.  Auto-exposure  was  used  for 
subsequent experiments to avoid this issue. Culture with perfused medium was 
continued for 92 hours but the cells were not stained due to the variable and 
unmeasured flow rate. 
 
Figure 4.8 – Confluence curves for each device in the initial perfusion culture experiment. 
Following 6 hours of static culture to allow seeded cells to settle and adhere, medium was perfused 
through the three culture devices for 92 hours with a target combined flow rate of 900 μl.h-1. The 
confluence  of all  three  device  configurations  is  shown  over  the  duration  of  medium  perfusion. 
Device  1  used  the  improved  PDMS  chip  with  the  open  PC  lid  component.  Device  2  used  the 
improved PDMS chip with the closed PC lid component. Device 3 used the prototype PDMS chip 
with the closed PC lid component. 
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Figure 4.9 - Flow rate at the combined inlet of three culture devices with a constant pressure 
regulator voltage. 
Graphs  showing  the  flow rate  measured  at  the  combined  inlet  of three  culture  devices,  with  a 
constant pressure regulator voltage of 1.2 V. Graph [a] shows a 12 hour period of culture, with 
points every 6.4 seconds, while pane [b] shows the first 180 seconds of that same period with 
points every 0.64 seconds. 
 
A repeat experiment, with a flow sensor included at the inlet, indicated that the 
flow  resistance  of  the  culture  system  is  highly  variable  during  a  culture 
0 
200 
400 
600 
800 
1000 
1200 
0  2  4  6  8  10  12 
F
l
o
w
 
R
a
t
e
 
(

l
.
h
-
1
)
 
Time (h) 
a) 
750 
800 
850 
900 
950 
1000 
0  30  60  90  120  150  180 
F
l
o
w
 
R
a
t
e
 
(

l
.
h
-
1
)
 
Time (s) 
b) 169 
 
experiment. Figure 4.9 shows the variation in flow rate, while applying the same 
driving gas pressure, over different time scales. The reason for the variation in 
flow rate is unclear. The precision of the pressure regulator is the most likely 
source of the small variations seen in the flow measurements (Figure 4.9[b]). 
More uniform flow may be achievable with a higher quality regulator.  
 
Spikes in flow rate (Figure 4.9[a,b]) are most likely due to either small bubbles 
passing  through  the  flow  sensor  or  temporary  flow  obstructions,  such  as 
detached cells in the capillaries or bubbles anywhere in the flow path. Detached 
cells in the capillaries could be avoided if the capillaries were moved upstream 
of the culture chamber. However, the back pressure at the outlet would need to 
be  increased  to  force  out  bubbles  formed  as  pressure  drops  along  the 
capillaries. Bubble formation appears minimal in the current configuration, and 
may  be  reduced  further  with  the  introduction  of  the  combined  preheat  and 
bubble trap unit (section 3.3.7).  
 
The gradual increase in flow resistance, over the long term (Figure 4.9[a]), may 
be  caused  by  fouling  of  the  capillaries  by  medium  components.  Fouling  is 
difficult to avoid but, if the length of the capillaries could be reduced, the effects 
of fouling may be minimised. Reducing the length of the capillaries would be 
possible if the flow resistance of different culture devices was more consistent. 
This consistency could potentially be achievable by using a single device design 
mass produced by a technique such as injection moulding or hot embossing (as 
discussed in chapter 5). 
 
Integration of Flow Control 
To  compensate  for  the  changing  flow  resistance  of  the  system, 
proportional-integral flow rate control was added to the LabVIEW VI that had 
been  developed  as  part  of  the  improved  control  and  automation  platform. 
Derivative control was not used as it is not appropriate for systems with noise. 
The  VI  allows  regulator  pressure  to  be  adjusted  by  the  proportional-integral 
routine, in order to maintain the combined flow rate of the three devices at a 
setpoint. A ‘bias’ setting is included to set the initial regulator pressure, while a 170 
 
‘deadband’  setting  prevents  excessive  controller  action.  The  frequency  of 
measurements and the number of measurements averaged per control action 
can be adjusted to reduce measurement noise. The proportional and integral 
control  terms  can  also  be  easily  adjusted  through  the  user  interface.  The 
proportional integral routine used the following algorithm; 





     
t
0
dt
Ti
error
error Kp Bias Voltage Regulator    (4.3) 
Where Kp is the proportional term, Ti is the integral term, and error is equal to 
the  current  flow  rate  subtracted  from  the  flow  rate  setpoint.  If  the  controller 
output exceeds the upper or lower limit of the regulator (0-5 V), the integrated 
error  term  is  adjusted  to  compensate.  When  the  flow  rate  falls  within  the 
deadband,  the  bias  is  adjusted  to  the  current  regulator  voltage  and  the 
integrated error term is set to zero. No further control action takes place until the 
flow rate moves outside the deadband. 
 
Figure 4.10 - Measured flow rate, at the combined inlet for three culture devices, over the 
duration of three perfusion culture experiments. 
This  figure  shows  measurements  of  the  medium  flow  rate,  taken  every  0.2  seconds,  over  the 
duration of three perfusion experiments. The flow rate is measured at the combined inlet of three 
parallel culture devices. The flow rate is shown for three perfusion culture experiments all of which 
had a flow rate setpoint of 900 μl.h-1. The dashed lines show the upper and lower limits of the dead 
band. 
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The  proportional-integral  flow  rate  control  routine  was  used  for  three 
subsequent culture experiments. The set point for all three experiments was 
900 μl.h
-1, with a dead band of ± 45 μl.h
-1, a sampling rate of 5 Hz, and 20 
points averaged per controller action. The values of Kp and Ti were changed 
between experiments in an attempt to optimise flow rate stability. They were 
0.35 mV.h.μl
-1 and 30 s in experiment 1, 0.25 mV.h.μl
-1 and 200 s in experiment 
2,  and  0.35  mV.h.μl
-1  and  200  s  in  experiment  3.  Figure  4.10  shows  the 
recorded flow rates for the three experiments. The second experiment had the 
most consistent flow rate but this may be due to the initial flow rate rather than 
the values of Kp and Ti. 
 
It  is  challenging  to  implement  an  effective  flow  routine  due  to  the  differing 
response times of positive and negative control actions. Increases in regulator 
voltage have a relatively rapid effect, as the driving pressure can be increased 
in a matter of seconds. Conversely, decreases in regulator voltage have a very 
slow effect, as pressure is relieved by the gradual flow of medium. This disparity 
is seen in the rapid rises and slow decays of flow rate in experiments one and 
three  (Figure  4.10):  As  the  initial  flow  rates  (1090  μl.h
-1  and  1060  μl.h
-1  60 
minutes after the start of perfusion for experiments one and three respectively) 
are higher than the upper limit of the deadband, and the response to reducing 
regulator voltage is slow, the regulator voltage reduces too far before the flow 
rate  drops  into  the  deadband.  Therefore,  when  the  flow  rate  enters  the 
deadband  the  controller  bias  is  set  to  the  now  very  low  controller  output. 
Consequently,  the  pressure  continues  to  drop  below  the  setpoint  and  the 
system then over reacts causing the flow rate to spike above set point again. 
This did not occur in the second experiment, where the initial flow rate was very 
close to the set point (947 μl.h
-1 60 minutes after the start of perfusion). 
 
Logically, the Kp value could be decreased, to reduce the magnitude  of the 
initial controller response, and the Ti value could be significantly increased, to 
reduce the rate at which the integrated error increases the magnitude of the 
control action. This would reduce oscillation at the cost of slower recovery from 
disturbances. Alternatively, different Kp and Ti values could be used for positive 
and negative error values to allow for the non-symmetrical control action. These 172 
 
options were considered and are listed here for completeness. However, the 
challenge of this non-symmetrical control action will be overcome by the valve 
system of the improved control and automation platform. The improved platform 
includes a normally closed valve, attached to the bubble  trap, which can be 
opened to rapidly relieve pressure. Accordingly, none of the listed changes may 
be necessary.   
 
Triplicate Culture Experiments 
The three experiments with flow control used different combinations of parts to 
the initial experiment. The three combinations were; the prototype chip with the 
open PC lid, the prototype chip with the closed PC lid, and the improved chip 
with the closed PC lid component. This allowed separate investigation of the 
open  PC  lid  component  and  the  improved  PDMS  chip,  both  of  which  were 
expected to improve uniformity relative to a closed PC lid and prototype PDMS 
chip. As previously, the seeded cells were allowed to attach over a 6 hour static 
incubation  before  changing  the  medium  and  beginning  perfusion.  The  cells 
were cultured for a further 65 hours with phase contrast images taken every two 
hours. At the end of this period the phase contrast images were analysed using 
image  processing  software  developed  by  Nicolas  Jaccard  (Jaccard  et  al., 
2014b, Reichen et al., 2012). The cells were fixed and stained for pluripotency 
markers. 
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Figure 4.11 - Representative phase contrast microscope images of cells in culture device 1 
throughout the course of the first culture experiment. 
Representative phase contrast microscope images are shown for device 1 in the first of three repeat 
perfusion  culture  experiments.  Device  1  included  a  gas  permeable  lid system  with  an  open  PC 
element and the prototype PDMS chip.  Images are shown at 12 hour intervals after the start of 
perfusion as well as the first set of images taken at the 2 h mark. Images were taken with a 10× 
objective and the scale bars are 200 μm. 
 
 
Figure 4.12 - Representative phase contrast microscope images of cells in culture device 2 
throughout the course of the first culture experiment. 
Representative phase contrast microscope images are shown for device 2 in the first of three repeat 
perfusion  culture  experiments.  Device  2  included  a  gas  permeable  lid system  with  a  closed  PC 
element and the prototype PDMS chip. Images are shown at 12 hour intervals after the start of 
perfusion as well as the first set of images taken at the 2 h mark. Images were taken with a 10× 
objective and the scale bars are 200 μm. 174 
 
 
Figure 4.13 - Representative phase contrast microscope images of cells in culture device 3 
throughout the course of the first culture experiment. 
Representative phase contrast microscope images are shown for device 3 in the first of three repeat 
perfusion  culture  experiments.  Device  3  included  a  gas  permeable  lid system  with  a  closed  PC 
element and the improved PDMS chip. Images are shown at 12 hour intervals after the start of 
perfusion as well as the first set of images taken at the 2 h mark. Images were taken with a 10× 
objective and the scale bars are 200 μm. 
 
 
Figure 4.14 - Stitched images of the whole culture chamber of culture device 1 throughout 
the course of the first culture experiment. 
Images of the whole culture chamber of culture device 1 stitched together from individual phase 
contrast microscope images are shown for the first of three repeat perfusion culture experiments. 
Device 1 included a gas permeable lid system with an open PC element and the prototype PDMS 
chip. Images are shown at 12 hour intervals after the start of perfusion as well as the first set of 
images taken at the 2 h mark. Individual images were taken with a 10× objective. The direction of 
flow is left to right. 
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Figure 4.15 - Stitched images of the whole culture chamber of culture device 2 throughout 
the course of the first culture experiment. 
Images of the whole culture chamber of culture device 2 stitched together from individual phase 
contrast microscope images are shown for the first of three repeat perfusion culture experiments. 
Device 2 included a gas permeable lid system with a closed PC element and the prototype PDMS 
chip. Images are shown at 12 hour intervals after the start of perfusion as well as the first set of 
images taken at the 2 h mark. Individual images were taken with a 10× objective. The direction of 
flow is left to right. 
 
 
Figure 4.16 - Stitched images of the whole culture chamber of culture device 3 throughout 
the course of the first culture experiment. 
Images of the whole culture chamber of culture device 3 stitched together from individual phase 
contrast microscope images are shown for the first of three repeat perfusion culture experiments. 
Device 3 included a gas permeable lid system with a closed PC element and the improved PDMS 
chip. Images are shown at 12 hour intervals after the start of perfusion as well as the first set of 
images taken at the 2 h mark. Individual images were taken with a 10× objective. The direction of 
flow is left to right. 
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Figure 4.17 - Examples of pixel classification by image processing software. 
Raw images side-by-side with images showing (in red) the border between pixels classified as cells 
and pixels classified as background. The first four images [a-d] show single elements (350×350 μm) 
of the 36×10 grid at 2 [a], 12 [b], 22 [c], and 32 [d] hours after the start of medium perfusion. The 
final  pair  of  images  [e]  shows  the  entire  culture  chamber  12  hours  after  the  start  of  medium 
perfusion. All images are from the first device (open PC lid component and prototype PDMS chip) in 
the third experiment. 
 
Figures  4.11  -  4.13  show  representative  phase  contrast  microscope  images 
from  the  three  culture  devices,  in  the  first  experiment,  at  12  hour  intervals. 
Images were taken using a 10× objective. For each culture device, one chosen 
image position is shown at each time point. Likewise, Figures 4.14 – 4.16 show 
the entire culture chamber of each device at 12 hour intervals. These images 177 
 
have been stitched together from multiple microscope images taken  using a 
10× objective. A few gaps were present in images of the second experiment. 
Due  to  overly  rapid  entry  of  the  imaging  positions,  the  same  position  was 
imaged twice and the next position was skipped.  Finally, Figure  4.17 shows 
examples of image processing outputs. 
 
Figures  4.11  -  4.16  show  the expansion  of  mESCs  over the  duration of the 
culture experiment, through full confluency, into multilayer culture. mESC are 
typically cultured statically in T-flasks for 72 hours between passages. However, 
the culture devices reach full confluency well before the completion of culture (6 
hours  static  and  65  hours  perfused).  This  shows  that  the  constant 
replenishment  of  nutrients  and  removal  of  secreted  molecules  achieved  in 
perfusion  culture  significantly  increases  the  growth  rate  of  mESCs.  This 
increased  average  growth  rate  with  more  frequent  (continuous)  medium 
exchange is consistent with static culture experiments in 6-well plates (Jaccard 
et al., 2014a). Finally, Figure 4.17 shows that the image processing software 
accurately classifies the majority of pixels as cell or background. The generated 
confluency measurements can therefore be used to further analyse cell growth. 
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Figure 4.18 - Mean culture surface confluency of each culture device through the first of 
three perfusion experiments. 
The mean confluency of the entire culture surface is plotted against time for each device in the first 
of three repeat perfusion culture experiments. Device 1 included a gas permeable lid system with 
an open PC element while the other two devices included closed PC components. Device 3 included 
the improved PDMS chip while the other two devices included the prototype PDMS chip. 
 
 
Figure 4.19 - Mean culture surface confluency of each culture device through the second of 
three perfusion experiments. 
The mean confluency of the entire culture surface is plotted against time for each device in the 
second of three repeat perfusion culture experiments. Device 1 included a gas permeable lid system 
with an open PC element while the other two devices included closed PC components. Device 3 
included the improved PDMS chip while the other two devices included the prototype PDMS chip. 
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Figure 4.20 - Mean culture surface confluency of each culture device through the third of 
three perfusion experiments. 
The mean confluency of the entire culture surface is plotted against time for each device in the third 
of three repeat perfusion culture experiments. Device 1 included a gas permeable lid system with 
an open PC element while the other two devices included closed PC components. Device 3 included 
the improved PDMS chip while the other two devices included the prototype PDMS chip. 
 
 
Figure 4.21 - Mean culture surface confluency of culture device 1 through all three perfusion 
experiments. 
The mean confluency of the entire culture surface is plotted against time for device 1 in each of 
three repeat perfusion culture experiments. Device 1 included a gas permeable lid system with an 
open PC element and the prototype PDMS chip. 
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Figure 4.22 - Mean culture surface confluency of culture device 2 through all three perfusion 
experiments. 
The mean confluency of the entire culture surface is plotted against time for device 2 in each of 
three repeat perfusion culture experiments. Device 2 included a gas permeable lid system with a 
closed PC element and the prototype PDMS chip. 
 
 
Figure 4.23 - Mean culture surface confluency of culture device 3 through all three perfusion 
experiments. 
The mean confluency of the entire culture surface is plotted against time for device 3 in each of 
three repeat perfusion culture experiments. Device 3 included a gas permeable lid system with a 
closed PC element and the improved PDMS chip. 
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Repeatability 
Figures  4.18,  4.19,  and  4.20  show  the  confluency  curves,  for  all  three 
combinations of components, for each experiment respectively. Figures 4.21, 
4.22, and 4.23 show the confluency curves, for all three experiments, for each 
combination of components respectively. Three measurements were calculated 
from this data as indicators of reproducibility; the confluency at 2 hours (C2), the 
time taken to reach a confluency of 0.5 (T0.5), and the time taken to reach a 
confluency of 0.8 (T0.8). Confluency at 2 hours indicates the reproducibility of 
the  seeding,  lid  insertion  and  initialisation  of  perfusion.  Time  to  0.8  is  an 
indicator  of  reproducibility  in  average  monolayer  growth  rate.  A  confluency 
value of 0.8 is used rather than 1, as cells in some areas may begin multilayer 
growth  prior  to  other  areas  reaching  full  confluency.  Time  to  0.5  indicates 
reproducibility in how specific growth rate varies between early and late phase 
monolayer growth. 
 
The mean C2 values across all three devices in an experiment are 0.28 ± 0.06, 
0.30 ± 0.04, and 0.32 ± 0.09 for the three experiments respectively (Standard 
deviation, n=3 devices). The standard deviation between the three experiments 
is 0.02 or 8% of the mean value (n=3 experiments). The mean of the standard 
deviations  between  the  three  devices  in  each  experiment  is  higher  at  21%, 
close to the variation seen in the seeding experiments in section 4.3.1 (17%).  
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Figure 4.24 – The effect of bubbles on image analysis of early time points. 
Stitched phase contrast images, of the three devices in the first experiment, next to grids showing 
the spatial distribution of confluency based on image analysis. Images were taken 2 h after the start 
of medium perfusion. Dark low confluency areas on the grids correspond to the bubbles in the 
culture chamber. 
 
The  C2  values  indicate  a  reasonably  repeatable  process  of  seeding,  lid 
insertion, and initialisation of perfusion. However, the C2 results are affected by 
bubbles  that  are  present  in  the  chamber  at  this  early  stage  of  perfusion. 
Bubbles can be trapped during the connection and insertion of parts or originate 
from  incompletely  primed  channels  in  the  PDMS  chip.  These  bubbles  are 
detected by the image processing software as areas of lower confluency, as 
seen in Figure 4.24. It takes up to 12 h for bubbles to be completely forced from 
the culture chamber in some devices. Therefore, confluency data prior to the 12 
h point will not be as accurate as data after the 12 h point. 
 
The  mean  T0.8  values  are  31  ±  1  h,  37  ±  2  h,  and  35  ±  9  h  for  the  three 
experiments  respectively  (averaged  across  the  three  devices  in  each 
experiment). The standard deviation between the three experiments is 3 h. This 
indicates a variation in average monolayer growth rate, between experiments, 
of just 9%. The mean of the standard deviations between devices in the same 
experiment is slightly higher at 12%. The mean T0.5 values are 17 ± 1 h, 17 ± 4 183 
 
h, and 15 ± 9 h for the three experiments respectively (averaged across the 
three devices in each experiment). The standard deviation between the three 
experiments is 1 h or 7%. This low variation indicates that a greater fraction of 
the variation in T0.8 comes from late stage monolayer growth than comes from 
early  stage  monolayer  growth.  The  mean  of  the  standard  deviations  in  T0.5 
between devices in the same experiment is 31%. 
 
 
Figure 4.25 - Specific growth rate of each culture device through the first of three perfusion 
experiments. 
The specific growth rate is plotted against time for each device in the first of three repeat perfusion 
culture experiments. Device 1 included a gas permeable lid system with an open PC element while 
the other two devices included closed PC components. Device 3 included the improved PDMS chip 
while the other two devices included the prototype PDMS chip. 
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Figure 4.26 - Specific growth rate of each culture device through the second of three 
perfusion experiments. 
The  specific  growth  rate  is  plotted  against  time  for  each  device  in  the  second  of  three  repeat 
perfusion  culture  experiments.  Device  1  included  a  gas  permeable  lid system  with  an  open  PC 
element  while  the  other  two  devices  included  closed  PC  components.  Device  3  included  the 
improved PDMS chip while the other two devices included the prototype PDMS chip. 
 
 
Figure 4.27 - Specific growth rate of each culture device through the third of three perfusion 
experiments. 
The  specific  growth  rate  is  plotted  against  time  for  each  device  in  the  third  of  three  repeat 
perfusion  culture  experiments.  Device  1  included  a  gas  permeable  lid system  with  an  open  PC 
element  while  the  other  two  devices  included  closed  PC  components.  Device  3  included  the 
improved PDMS chip while the other two devices included the prototype PDMS chip. 
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Figure 4.28 - The mean specific growth rate for the first of three perfusion culture 
experiments plotted alongside the recorded total flow rate. 
Plotted on the left axis is the mean specific growth rate of all three devices in the first of three 
repeat  perfusion  culture  experiments.  Plotted  on  the  right  axis  is  the  total  medium  flow  rate 
measured at the combined inlet of the three devices. The flow rate was measured every 0.2 s and 
then every 40 points were averaged. 
 
 
Figure 4.29 - The mean specific growth rate for the second of three perfusion culture 
experiments plotted alongside the recorded total flow rate. 
Plotted on the left axis is the mean specific growth rate of all three devices in the second of three 
repeat  perfusion  culture  experiments.  Plotted  on  the  right  axis  is  the  total  medium  flow  rate 
measured at the combined inlet of the three devices. The flow rate was measured every 0.2 s and 
then every 40 points were averaged. 
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Figure 4.30 - The mean specific growth rate for the third of three perfusion culture 
experiments plotted alongside the recorded total flow rate. 
Plotted on the left axis is the mean specific growth rate of all three devices in the third of three 
repeat  perfusion  culture  experiments.  Plotted  on  the  right  axis  is  the  total  medium  flow  rate 
measured at the combined inlet of the three devices. The flow rate was measured every 0.2 s and 
then every 40 points were averaged. 
 
 
 
It is clear, from Figures 4.18 – 4.23, that variations between experiments have 
more  effect  on  the  shape  of  the  confluency  curves  than  variations  in  the 
components used in the devices (PDMS chip design and PC lid component). 
This  is  clearer  still  when  considering  the  specific  growth  rate  (Figures  4.25-
4.27). Peaks and troughs in the specific growth rate occur at the same time for 
all three devices in each experiment.  However, these peaks and troughs do not 
occur at consistent times or confluency points across experiments. It is also 
clear, from Figures 4.28 - 4.30, that the variations are not correlated with the 
changes  in  total  medium  flow  rate.  The  reasons  behind  these  peaks  and 
troughs in the specific growth rate remain unclear.    
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Figure 4.31 – Mean specific growth rates of each culture device across all three perfusion 
experiments. 
The  mean  specific  growth  rate  is  plotted  against  time,  for  each  device,  across  all  three  repeat 
perfusion  culture  experiments.  Device  1  included  a  gas  permeable  lid system  with  an  open  PC 
element  while  the  other  two  devices  included  closed  PC  components.  Device  3  included  the 
improved PDMS chip while the other two devices included the prototype PDMS chip. 
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Figure 4.32 - Mean relative specific growth rates of each culture device, across all three 
perfusion experiments, plotted against culture time. 
For each device, in each experiment, the mean specific growth rate of all devices in that experiment, 
was subtracted from the individual device’s specific growth rate to give a relative specific growth 
rate. For each device, a mean was taken of these relative specific growth rates across the three 
repeat experiments. The error bars show the maximum and minimum relative specific growth rates 
for each device at each time point. Device 1 included a gas permeable lid system with an open PC 
element  while  the  other  two  devices  included  closed  PC  components.  Device  3  included  the 
improved PDMS chip while the other two devices included the prototype PDMS chip. 
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Figure 4.33 - Mean relative specific growth rates of each culture device, across all three 
perfusion experiments, plotted against mean device confluency. 
For each device, in each experiment, the mean specific growth rate of all devices in that experiment, 
was subtracted from the individual device’s specific growth rate to give a relative specific growth 
rate. For each device, across the three repeat experiments, these relative specific growth rates were 
plotted against the mean confluency of the culture surface. Device 1 included a gas permeable lid 
system  with  an  open  PC  element  while  the  other  two  devices  included  closed  PC  components. 
Device 3 included the improved PDMS chip while the other two devices included the prototype 
PDMS chip. 
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Effect of Different Components 
While significant variation exists between experiments, the specific growth rate 
is also affected by the different components used in the three devices. This is 
indicated by the mean standard deviations in T0.5 (31%) and T0.8 (12%) between 
different devices in the same experiment. Variation is also somewhat evident in 
Figure 4.31 where the mean specific growth rate across all three experiments is 
plotted for each device. While the major trends are similar for all three devices 
there  are  also  variations  about  these  trends.  These  variations  can  be  made 
clearer by removing the features specific to experiments. Figure 4.32 shows the 
mean  relative  specific  growth  rates  of  each  device  (the  mean  difference 
between, the specific growth rate of a device, and the mean specific growth rate 
of devices in that experiment). Relative specific growth rates are also plotted 
against  mean  device  confluency  in  Figure  4.33.  As  any  temporal  variations 
consistent across all devices in an experiment have been removed, remaining 
trends are most likely caused by the changing cell density. 
 
The  results  (Figures  4.32  and  4.33)  suggest  that  the  third  device  (improved 
PDMS chip and closed PC lid component) promotes growth in the early stages 
of culture (the first 16 hours, or up to a confluency of ~0.45). The first device 
(prototype PDMS chip and open PC lid component) shows the second highest 
early growth and the highest specific growth rate from 16 hours, or confluency 
of ~0.45, to 56 hours, or confluency of ~0.95. The specific growth rate of the 
second device (prototype PDMS chip and closed PC lid component) is lower 
than the first device for the first 18 hours, or up to a confluency of ~0.5, after 
which the relative specific growth rates of the two devices are comparable. After 
56 hours (confluency of ~0.95), the specific growth rates of all three devices 
converge and no observable differences remain. 
 
Increased growth using the gas permeable lid system, with an open, rather than 
closed, PC component (Device 1), is consistent with expectations. A previous 
investigation by Powers et al (2008) found that gaseous oxygen concentrations 
of less than 20% reduced the specific growth rate of mESCs grown statically in 
T-25 culture flasks. The open PC lid component has an increasing effect on the 191 
 
pericellular DO concentration as confluency increases (section 3.3.6) This effect 
appears to outweigh the early advantage of the improved PDMS chip partway 
through monolayer culture (16 hours, confluency ~0.35). The key advantage of 
the  improved  PDMS  chip  over  the  prototype  PDMS  chip,  is  the  increased 
uniformity of flow (section 3.3.1). This may improve specific growth rate in early 
culture through increased provision of nutrients/removal of waste to/from the 
central areas of the culture chamber and/or reduced shear at the edges of the 
chamber. 192 
 
 
Figure 4.34 - Spatial distribution of confluency, in each culture device, during monolayer growth. 
36×10 grids showing the spatial distribution of confluency, in each culture device, during monolayer culture. For each device, the confluency distribution is shown 2, 12, 
26, and 40 hours after the start of medium perfusion. Medium flows left to right. 193 
 
 
Figure 4.35 - Mean spatial distribution of growth rate for different device configurations. 
36×10 grids showing the mean spatial distribution of growth rate for each device configuration. 
The growth rates are shown for the periods from 12 to 26 h and 26 to 40 h after the start of 
medium perfusion. Medium flows from left to right. Device 1 included a gas permeable lid system 
with an open PC element while the other two devices included closed PC components. Device 3 
included the improved PDMS chip while the other two devices included the prototype PDMS chip. 
 194 
 
 
Figure  4.36  -  Mean  spatial  distribution  of  relative  growth  rate  for  different  device 
configurations. 
36×10  grids  showing  the  mean  spatial  distribution  of  growth  rate,  relative  to  the  mean 
experimental growth rate, for each device configuration. The relative growth rate of a single grid 
element is calculated by subtracting from the growth rate of that element the mean growth rate 
(over the same period) for all devices in that experiment. A mean is then taken of the relative 
growth rates of that grid position, in that device configuration, across the three repeat experiments. 
The relative growth rates are shown for the periods from 12 to 26 h and 26 to 40 h after the start of 
medium perfusion. Medium flows left to right. Device 1 included a gas permeable lid system with an 
open PC element while the other two devices included closed PC components. Device 3 included the 
improved PDMS chip while the other two devices included the prototype PDMS chip. 
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Figure 4.34 shows the spatial distribution of confluency in the three different 
device configurations, in all three experiments, at four different time points. As 
with the mean confluency curves, there are no clear differences in the spatial 
distribution of confluency between different device configurations. However, the 
mean spatial distributions of growth rate for each device show some evidence 
of configuration based differences (Figure 4.35). These differences are clearer 
when  looking  at  whether  growth  rates  are  above  or  below  the  mean 
experimental growth rate (Figure 4.36). To visualise this, the mean experimental 
growth  rate  (over  the  same  period)  is  subtracted  from  each  growth  rate 
distribution, and the range represented by the intensity gradient is reduced so 
that  growth  rates  significantly  above  the  mean  are  white,  growth  rates 
significantly below the mean are black, and growth rates near the mean are 
shades of grey. The growth rates were investigated between 12 h and 40 h to 
avoid the effects of both bubbles (<12 h), and space limitations at confluencies 
near 1 (>40 h). This range was split in half to allow comparison of mid and late 
monolayer culture. 
 
The  observed  patterns  in  growth  rate  (Figure  4.36)  for  the  different 
configurations  are  consistent  with  the  expectations  for  oxygen  controlled 
growth. The first device configuration achieves higher downstream growth than 
the  second  and  third  configurations.  Its  open  PC  lid  component  replenishes 
more of the oxygen consumed form the medium by upstream cells. The third 
device configuration achieves lower growth in the downstream corners of the 
culture  chamber.  Its  improved  PDMS  chip  delivers  reduced  flow  rate  at  the 
chamber edges as part of the overall increase in flow uniformity. Both patterns 
are more exaggerated during the later stages of monolayer culture when higher 
cell densities result in lower pericellular dissolved oxygen. 
 
The mean standard deviations in the spatial distribution of growth rate are 35%, 
38%, and 44%, between 12 and 26 hours, and 57%, 63%, and 80%,  between 
26 and 40 hours, for the three different configurations respectively  (standard 
deviation n=370, mean n=3). As expected for a system with oxygen controlled 
growth, the first device configuration, with the open PC lid component and the 
prototype PDMS chip, achieves the most uniform growth rate over both periods. 196 
 
This is due to the open PC lid element and permeable membrane supplying a 
more  uniform  DO  across  the  top  surface  of  the  culture  chamber,  which 
translates to a more uniform pericellular DO.  
 
However,  contrary  to  expectations,  the  third  device  configuration,  with  the 
closed  PC  lid  component  and  the  improved  PDMS  chip,  achieves  the  least 
uniform growth rate over both periods investigated. This implies that the slightly 
below average velocities at the chamber edges (caused by wall shear) have a 
more  negative  effect  on  growth  rate  uniformity  than  the  significantly  above 
average velocities present with the prototype chip. This supports the theory that, 
under  these  experimental  conditions,  a  rapidly  consumed  or  secreted  factor 
(most likely DO) has more effect on growth rate than hydrodynamic shear. 
 
The  mean  and  spatially  distributed  confluency  data  provides  evidence  that 
mESC  growth  is  significantly  affected  by  pericellular  DO  when  medium  is 
perfused through a culture device at 300 μl.h
-1. Consequently, use of the gas 
permeable lid system with an open PC component increases the uniformity of 
growth  in  mid  to  late  monolayer  culture.  Furthermore,  use  of  this  lid 
configuration with a normoxic atmosphere increases the growth rate during mid 
to late monolayer culture. Under these conditions, the hydrodynamic shear rate 
does  not  appear  to  significantly  affect  growth  rate  in  mid  to  late  monolayer 
culture. As a result the improved PDMS chip has a negative effect on growth 
rate  uniformity.  At  lower  medium  flow  rates  these  effects,  of  both  the  gas 
permeable lid system and the PDMS chip design, are expected to become more 
exaggerated. Thus, experiments at lower flow rates could be employed to more 
conclusively confirm these design based effects. 
 
Bubbles  in  the  culture  chamber  prevent  a  similar  understanding  of  early 
monolayer  culture.  Improvements  in  design,  or  assembly  and  priming 
techniques, may overcome this limitation. It is also not clear from this data, what 
effect  parameters  such  as  DO,  shear  rate,  and  the  concentration  of  soluble 
factors have  on  cell fate.  A  quantitative  assessment  of  pluripotency  markers 
(e.g.  qPCR)  would  allow  the  investigation  of  overall  affects  on  cell  fate. 197 
 
Investigation of effects on spatial distribution would require the use of a spatially 
resolved assessment of marker expression, such as laser scanning cytometry. 
These are all areas for future investigation. 
 
 
 
Figure 4.37 – Mouse embryonic stem cells cultured in the improved microfabricated culture 
devices and stained for the pluripotency marker Oct-4. 
Microscope  images  of  mESCs  cultured  in  the  three  different  microfabricated  culture  devices;  a 
device with an open PC lid component and a prototype PDMS chip, a device with a closed PC lid 
component  and  a  prototype  PDMS  chip,  and  a  device  with  a  closed  PC  lid  component  and  an 
improved PDMS chip. Phase contrast references are compared with fluorescent microscopy images 
after the cells were stained for the nuclear pluripotency marker Oct-4. Images were taken with a 
10× objective and the scale bars represent 200 μm. 
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Figure 4.38 - Mouse embryonic stem cells cultured in the improved microfabricated culture 
devices and stained for the pluripotency marker Nanog. 
Microscope  images  of  mESCs  cultured  in  the  three  different  microfabricated  culture  devices;  a 
device with an open PC lid component and a prototype PDMS chip, a device with a closed PC lid 
component  and  a  prototype  PDMS  chip,  and  a  device  with  a  closed  PC  lid  component  and  an 
improved PDMS chip. Phase contrast references are compared with fluorescent microscopy images 
after  the  cells  were  stained  for  the  nuclear  marker  DAPI  and  the  nuclear  pluripotency  marker 
Nanog. Images were taken with a 20× objective and the scale bars represent 200 μm. 
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Figure 4.39 - Mouse embryonic stem cells cultured in the improved microfabricated culture devices and stained for the 
pluripotency markers Sox-2 and SSEA-1. 
Microscope images of mESCs cultured in the three different microfabricated culture devices; a device with an open PC lid component and a 
prototype PDMS chip, a device with a closed PC lid component and a prototype PDMS chip, and a device with a closed PC lid component and 
an improved PDMS chip. Phase contrast references are compared with fluorescent microscopy images after the cells were stained for the 
nuclear marker DAPI, the nuclear pluripotency marker Sox-2, and the surface expressed pluripotency marker SSEA-1. Images were taken 
with a 20× objective and the scale bars represent 200 μm. 200 
 
Pluripotency Markers 
For each culture experiment, all three culture devices were stained in the same 
way. The first experiment was stained for Oct-4 as well as staining with the 
nuclear stain DAPI. The second experiment was stained for Nanog and SSEA-1 
as  well  as  staining  with  the  nuclear  stain  DAPI.  The  third  experiment  was 
stained for Sox-2 and SSEA-1 as well as staining with the nuclear stain DAPI. 
No  DAPI  signal  could  be  obtained  for  the  first  experiment.  It  was  later 
established that the PC component filling the viewing window of the aluminium 
holder (Figure  3.12) blocks  the  excitation  wavelength  of the  DAPI  stain.  For 
experiments  2  and  3  the  culture  devices  were  removed  from  the  aluminium 
holder for  staining.  In  the  future,  the  material  of  the  window  filler  should  be 
changed to one that transmits this wavelength e.g. polystyrene or glass. The 
SSEA-1  signal  for  the  second  experiment  was  very  weak  due  to  use  of 
insufficient primary antibody. This was corrected for the third experiment. 
 
Figures 4.37, 4.38, and 4.39 show the staining results for the 9 different culture 
devices. Oct-4, Nanog, and Sox-2 are nuclear markers and match the nuclear 
stain DAPI, while SSEA-1 is a surface marker. The majority of cells in every 
culture device stain positive for the four pluripotency markers. This evidence 
supports  the  maintenance  of  pluripotency  (section  1.1.2).  In  turn,  the 
maintenance of pluripotency during expansion supports the continued suitability 
of the culture device for stem cell culture. 
 
4.3.3  Culture Chamber Heating Solution 
Following  the  improvements  made to  the  control  and  automation  platform  in 
chapter  3,  control  of  the  temperature  in  the  culture  chamber  remained  an 
outstanding issue. In the prototype platform, the culture chamber was heated by 
applying a voltage across an ITO coating on the bottom of a glass microscope 
slide (section 2.3.8). However, this solution limited the culture surface to glass, 
negating the design efforts to allow the use of TC-PS and other flat materials. 
Furthermore,  any  heating  solution  integrated  into  the  disposable  device 
components  (i.e.  the  microscope  slide  or  PDMS  chip)  will  complicate  and 201 
 
increase  the  expense  of  producing  those  components.  This  is  a  significant 
disadvantage for single use components. 
 
Following the improvements to the platform in chapter 3 (section 3.3.7), heat 
was  provided  to  the  culture  chambers  via  a  cage  incubator.  This  was  the 
method used for the culture experiments in this chapter. The cage incubator has 
the advantage of being entirely separate from the culture system. Therefore, it 
complicates  neither  the  production  of  parts  nor  the  assembly  of  the  culture 
system. Furthermore, as the incoming medium and all external surfaces of the 
culture  system  are  heated  to  37°C  by  the  incubator  environment,  no 
temperature gradients exist within the culture devices. Not only does this result 
in a completely uniform temperature in the culture chamber, it eliminates the 
need for an integrated temperature sensor to control the heating input.  
 
Unfortunately, in order to enclose the culture system and imaging system, the 
cage incubator must be much larger than the holder and three culture devices, 
making  it  space  inefficient.  The  cage  incubator  is  also  inconvenient  as  it 
interferes  with  installation  of  the  culture  system  on  the  microscope. 
Furthermore,  it  would  be  useful  if  the  heating  could  be  operated  throughout 
manual  handling  exercises,  such  as  cell  seeding.  This  would  avoid  the 
temperature shifts that occur when moving between an incubator and biological 
safety cabinet (Veraitch et al., 2008, Jaccard et al., 2014a). 
 
An  alternative  to  the  two  heating  solutions  discussed  above,  is  to  integrate 
heating  with  the  reusable  components  of  the  culture  system.  As  these 
components are used for multiple culture experiments, the additional expense 
and complexity of integrating heating is less of a disadvantage. This solution will 
also  avoid  limitations  on  the  culture  substrate  material,  allowing  the  use  of 
TC-PS as intended. However, unlike the cage incubator solution, this solution 
requires an integrated temperature sensor to control heat input. It will also result 
in temperature gradients between the heat sources and external surfaces of the 
culture  system.  These  gradients  must  be  accounted  for  when  relating  the 
measured temperature to the temperature at the culture surface. 202 
 
 
 
Figure  4.40  -  Positioning  of  flexible  heating  circuits  for  culture  chamber  temperature 
control. 
A photograph [a] showing six flexible polyamide heating circuits in place on the bottom plate of the 
aluminium holder. The circuits are affixed with thermally conductive adhesive.  A schematic front 
view of a single device [b] shows how the heating circuits fit in an existing gap between the bottom 
plate of the holder and the top frame of the device.  
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To  implement  this  heating  solution,  heaters  were  placed  either  side  of  the 
TC-PS slides in order to provide heat symmetrically, and as near as possible to 
the culture chamber without interfering with the light path for imaging. Flexible, 
polyamide heating circuits (6× HK5571R40.0L12B, Minco, France) were used 
so  as  to  fit  in  the  existing  space  between  the  bottom  plate  and  top  frame 
(Figure 4.40).  The heating circuits were fixed to the bottom plate with thermally 
conductive adhesive, and the negative and positive lead wires were bundled 
into  single  pin  connectors.  This  design  has  minimal  impact  on  the  space 
requirements, ease of assembly, and ease of operation of the culture system. 
 
 
 
Figure 4.41 - Cross-section view showing thermistor position. 
A thermistor is required to provide feedback to the controller, which adjusts the heater output to 
control the temperature of the culture chamber. The thermistor is held against the top surface of 
the microscope slide by a plastic screw. It is offset from the culture chamber to an area beyond the 
limits of the PDMS chip. 
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As with the prototype platform (section 2.3.8), the temperature of the culture 
chamber can be controlled by using pulse width modulation, which varies the 
fraction of time the heaters are active over a short cycle time. The pulse width 
modulation can be adjusted in response to temperature measurements from a 
thermistor that is in contact with the top surface of the microscope slide but 
offset from the culture chamber (Figure 4.41). The heating solution was tested 
using a manually switched 12 V laboratory power supply (IPS-2303, RS, UK) 
and a thermistor connected to a multimeter (Fluke 179 True RMS DMM with 
80BK Temperature Probe, Fluke, UK). Heating was applied to the aluminium 
holder  assembled  with  3  improved  culture  devices,  but  without  fluidics 
connected to the devices, as the low flow rate of preheated medium will not 
significantly impact chamber heating. 
 
 
Figure 4.42 - Measured and predicted temperature change during heating and cooling. 
The temperature measured by the thermistor is shown over periods of heating (100% power) and 
cooling (0% power). Also shown are the temperatures predicted by equation 4.5, with the terms of 
the equation optimised to fit the experimental data. 
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Upon application of 12 V across the heating circuits, the temperature measured 
by the thermistor immediately began to rise. Temperature rose, at a decreasing 
rate,  for  27  minutes  before  the  power  supply  was  switched  off  allowing  the 
system to cool down (Figure 4.42). Assuming uniform temperature throughout 
the aluminium holder and the culture devices, the temperature rise and fall can 
be modelled by the following energy balance (equation 4.4); 
   
P
R
P C m
T t T hA
C m
P
dt
dT




    (4.4) 
Where T is the temperature, P is the applied heater power, m is the mass, Cp is 
the  average  heat  capacity,  hA  is  the  sum  of  the  products  of  heat  loss 
coefficients area for the external surfaces, and TR is room temperature. This 
first order differential equation can be integrated to give equation 4.5; 
   


 




  
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
P
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C m
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Microsoft  Excel’s  solver  add-in  was  used  to  minimise  the  sum  of  squares 
difference between the equation and experimental results by adjusting the three 
terms 
hA
hA T P R 
,  1 C , and 
P C m
hA

  (Figure 4.42).  
 
From  the  optimised  values  and  the  known  power  input  (21.6  W),  room 
temperature  (22.1°C),  and  weight  (0.344  kg),  the  calculated  Cp  is  1.02 
kJ.kg
-1K
-1.  This  value  falls  between  the  values  for  the  constituent  materials 
(Aluminium  0.91  kJ.kg
-1K
-1,  Polycarbonate  1.2-1.3  kJ.kg
-1K
-1,  PDMS  1.5 
kJ.kg
-1K
-1). The calculated value of hA is 0.54 J.K
-1s
-1. Based on these values 
the maximum temperature achievable in a 20°C room is 60°C. 
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Figure 4.43 - Stability of measured temperature with constant average power output. 
The figure shows temperature measurements made by the thermistor every 15 second over a 10 
minute period. During this period the heaters were switched between 0% and 100% power ever 30 
seconds i.e. a heater duty of 50% and a cycle time of 60 seconds. 
 
The  temperature  of  the  culture  chamber  will  be  less  than  the  measured 
temperature due to gradients between the heat sources and external surfaces 
of  the  system.  To  investigate  this,  the  temperature  was  held  constant  by 
alternating  the  voltage  on  and  off  for  30  second  periods  (average  power  of 
10.8 W). Figure 4.43 shows the temperature measured by the thermistor, under 
these conditions, over a 10 minute period. The average temperature is 42.3°C, 
which is in agreement with the temperature predicted by equation 4.4 (setting 
dT/dt to 0). The variation in temperature is minimal, and will be reduced further 
by increasing the frequency of the voltage switching.  
 
After 20 minutes of alternating voltage on and off, the thermistor was moved to 
the culture chamber and pressed against the centre of the culture surface. The 
chamber  was  open  to  allow  this  but  full  of  water.  The  temperature  was 
measured  twice,  5  minutes  apart,  reading  33.0°C  on  both  occasions.  The 
thermistor  was  then  returned  to  its  original  position  and  showed  that  the 
temperature remained ~42.3°C. At room temperature (22.1°C) the temperature 
at  the  two  points  would  be  the  same.  Extrapolating  linearly  from  these  two 
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points, the set point for temperature control should be 49.7°C to give a chamber 
temperature  of  37°C.  This  will  require  pulse  width  modulation  with  power 
applied 74% of the cycle length. The heating solution described can reach this 
temperature from room temperature in less than 15 minutes. 
 
 
4.4  Conclusions 
In  chapter  3  improvements  were  made  to  the  design  of  the  microfabricated 
culture  system.  In  this  chapter  the  effects  of  those  improvements  were 
evaluated by investigating the seeding and perfusion culture of mESCs. Initial 
experiments  showed  large  variations  in  the  post-seeding  confluence  when  a 
uniform cell suspension was not achieved immediately prior to incubation. It is 
relatively easy to achieve this uniform cell suspension in tissue culture flasks 
but not in microfabricated culture chambers due to the low volume. The low 
volume  also  contributes  to  greater  variation  between  devices.  Despite  these 
issues,  the  average  post-seeding  confluency  is  the  same  for  tissue  culture 
flasks and the microfabricated culture devices. Therefore, experiments in these 
two  systems  can  be  conducted  with  the  same  starting  point  for  the  sake  of 
comparability.  
 
Initial culture experiments showed that the improved culture system is easier to 
assemble.  However,  the  flow  resistance  of  the  system  is  variable  over  the 
course  of  multi-day  perfusion  culture  experiments.  Feedback  control  over 
medium flow rate was implemented but the control parameters used were not 
optimal for the system used. The planned inclusion of a purge valve to regularly 
relieve pressure should make optimisation of these parameters easier.  
 
With flow control in place, a culture experiment was repeated three times, with 
three different device configurations in each experiment. Confluency monitoring 
by phase contrast microscopy shows 7% variation, between experiments, in the 
time taken to reach a confluency of 0.5, and 9% confluency in the time taken to 
reach  a  confluency  of  0.8.  While  this  indicates  reasonable  repeatability, 208 
 
confluency  curves  also  show  clear  variations  between  experiments.  The 
reasons for these experiment to experiment variations are unclear and require 
further investigation. All the cultures reach full confluency well before 72 h of 
total culture time; the typical passage period of statically cultured cells. This 
suggests that culture in the microfabricated devices, with medium perfused at 
300 μl.h
-1, increases the average growth rate relative to typical static culture. 
 
Differences between the configurations of microfabricated device can be seen 
in  both  the  overall  growth  rates,  and  the  spatial  distribution of  growth  rates. 
There is weak evidence that the introduction of a gas permeable lid (with an 
open polycarbonate element) increases the magnitude and uniformity of growth 
rate, particularly late in monolayer culture. Likewise there is weak evidence that 
the improved PDMS chip decreases the magnitude and uniformity of growth 
rate. These observations are consistent with pericellular dissolved oxygen being 
the most limiting factor in the expansion of the cells. However, the evidence of 
these  design  induced  differences  is  weak  due  to  the  extent  experiment  to 
experiment variability. Furthermore, it was not possible to draw conclusions on 
the first 12 hours of culture due to the presence of bubbles in some culture 
devices. 
 
Finally,  a  new  method  of  temperature  control  for  the  culture  chambers  was 
investigated. A heating system was developed that is independent of disposable 
parts,  allowing  the  use  varied  culture  substrates  including  TC-PS.  Flexible 
heating circuits were affixed to the bottom plate of the aluminium holder near 
the TC-PS microscope slide. These heaters can heat the culture chamber well 
above the standard set point of 37C. Temperature control can be achieved by 
pulse width modulation in response to measurements from a thermistor near the 
culture  chamber.  The  system  does  not  overly  complicate  the  assembly  or 
operation  of  the  culture  devices,  and  could  be  operated  while  conducting 
manual operations such as cell seeding. The chief limitations of the new heating 
system  are,  that  thermal  gradients  exist  in  the  culture  system,  and  that, 
consequently, monitoring of a site offset from the culture chamber, and relation 
of that position to the culture chamber, is required. 209 
 
 
In its current state the microfabricated adherent culture system has improved 
reliability,  ease  of  use,  comparability  with  traditional  culture  systems,  and 
control over process parameters that should make it a useful tool for process 
development. 
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5.  Potential Commercial Adaptations of the 
Microfabricated Culture system 
Thus far, the microfabricated culture system has been developed as a prototype 
process development system. This chapter discusses how it might be adapted 
into a commercial system; firstly for process development and then for small 
scale production. 
 
5.1  A Commercial Process Development System 
As a prototype, the microfabricated culture system has been designed around 
the use of commercially available parts wherever possible. Custom parts have 
only been used where they directly impact the intended function of the device 
e.g. the PDMS chip, the aluminium holder, and the lid system. For a commercial 
system greater use of custom parts becomes a viable option. This is particularly 
true  of  disposable  parts  as  mass  production  lends  itself  to  different 
manufacturing  techniques.  The  requirements  of  a  commercial  system  and 
opportunities presented by the use of custom parts can be considered for the 
different  system  components;  the  online  monitoring,  the  culture  device,  the 
fluidics, and environmental control. 
 
Monitoring 
First, consider the monitoring. As discussed in section 3.3.7, the cost of the fully 
motorised inverted fluorescent microscope (>£60,000) is very high relative to 
the 6 microfabricated culture devices it can continually monitor. Similarly, the 
space  requirements  are  very  large  relative  to  those  of  the  culture  devices. 
Ideally,  a  commercial  system  would  make  use  of  a  smaller  and  cheaper 
monitoring  solution.  However,  phase  contrast  microscope  images  remain  a 
preferred option due to their non-invasive nature and the wealth of information 
they provide (Matsuoka et al., 2014, Jaccard et al., 2014a). Other non-invasive 
methods,  such  as  electrical  cell-substrate  impedance  sensing,  quartz  crystal 
microscopy,  and  optical  waveguide  lightmode  spectroscopy,  require  the 
integration of sensors or electrodes (Hug, 2003, Arndt et al., 2004, Hong et al., 211 
 
2011), which alter the cell culture surface and make them less appropriate for 
use with disposable parts. 
 
 
Figure 5.1 - Optical train for phase contrast microscopy. 
A schematic of the optical train required for phase contrast microscopy including; the source of 
collimated  light,  the  condenser  annulus,  the  condenser  lens,  a  specimen  to  be  imaged,  a  phase 
contrast objective containing an objective lens and phase ring, and a detector such as a CCD camera. 
 
Monitoring  with  phase  contrast  microscope  images  does  not  require  all  the 
functionalities of an inverted fluorescent microscope, and removing redundant 
components will reduce the cost. Neither the fluorescent light source nor the 
filter turret is required. Similarly, the nosepiece turret may not be required as, to 
date, only the 10× objective has been utilised. Finally, it is not necessary to 
have  eyepieces  in  addition  to  the  microscope  camera.  Phase  contrast 
monitoring does require a camera and a single phase contrast objective as well 
as the collimated light source, condenser lens and condenser annulus (Figure 
5.1).  
 
Monitoring also requires the ability to move the culture chambers relative to the 
optics while keeping the cells in focus. When using the improved control and 
automation  platform,  this  was  achieved  by  manually  setting  the  x,  y  and  z 
positions,  for  each  individual  image,  at  the  start  of  the  experiments.  The 
temperature control of the cage incubator was relied on to prevent thermal drift 
over  the  duration  of  the  experiment.  This  method  was  effective  but  time 
consuming and would not be practical for larger numbers of culture chambers or 
experiments done without the cage incubator. 212 
 
 
There are a number of different options to automatically adjust focus between 
images.  Different  microscope  manufacturers  offer  solutions  to  automatically 
adjust  for  physical  and  temporal  focal  drift  (Nikon’s  Perfect  Focus  System, 
Leica’s  Adaptive  Focus  Control,  Olympus’  IX3-ZDC  module,  and  Carl  Zeiss’ 
Definite Focus). These systems rely on the interaction of infrared light at the 
interface  between  a  culture  vessel  and  the  liquid  it  contains,  to  track  those 
interfaces and automatically adjust for changes in height. Alternatively, software 
approaches  can  adjust  focus  based  on  analysis  of  images  at  different  focal 
positions. However, such systems are computationally expensive and inherently 
less reliable, as they rely on a computer’s interpretation of which image is most 
in focus. 
 
Finally, while it is necessary to move the culture devices relative to the optics, 
either  the  optics  or  the  culture  device  can  be  moved  to  achieve  this.  If  a 
commercial system integrates custom optics these could be motorised to move 
rather than moving the culture devices on a stage. This may allow the imaging 
of culture chambers across a larger area making, the imaging system more cost 
and space effective.  
 
A  promising  alternative  microscopy  method  to  scan  large  areas  is  digital 
holographic  microscopy  (Kim,  2010,  Mann  et  al.,  2005).  Digital  holographic 
microscopy uses interference patterns to image a specimen through its entire 
depth  without  moving  it  in  the  vertical  direction  (Colomb  et  al.,  2010).  This 
allows  the  generation  of  both  phase  contrast  equivalent  images  and  3D 
topographies. The additional information provided by 3D topographies can be 
used to detect morphological differences (Rappaz et al., 2014, Pavillon et al., 
2012) increasing the power of microscopy as a monitoring tool. Amongst other 
methods, digital holographic microscopy can be achieved with as little as one 
lens,  a  laser  light  source  (both  stationary),  and  a  commercial  scanner  as  a 
detector (Shimobaba et al., 2013). However, the reconstruction of images from 
interference patterns and selection of the correct focal plane is computationally 
expensive. 213 
 
 
Culture Device 
Regardless of the chosen microscopy method and its limitations, fitting more 
culture chambers in the area that can be imaged will increase the cost and 
space  effectiveness  of  the  system.  The  areas  of  the  microfabricated  culture 
devices presented in the previous chapters are more than 50 times the area of 
the culture chamber. This size was dictated by both the size of the microscope 
slide used to provide a culture surface, and the area occupied by the fluidic 
connections and the channels used to expand and contract the fluid flow. For a 
commercialised system, custom parts can be used to overcome both of these 
limitations. 
 
The  prototype  and  improved  microfabricated  culture  devices  utilise  the 
microscope  slide  format  as  a  commercially  available  source  of  flat,  sterile 
TC-PS. For a commercialised system, custom disposable TC-PS components 
could  be  mass  produced  by  hot  embossing  or  injection  moulding.  Doing  so 
would have multiple advantages: Firstly, the size of a culture device would no 
longer  be  limited  to  larger  than  a  microscope  slide.  Similarly,  the  culture 
chamber  would  no  longer  be  limited  to  smaller  than  a  microscope  slide. 
Furthermore,  the  TC-PS  component  could  have  complex  3D  geometries 
including  the  recessed  culture  chamber  and  the  inlet  and  outlet  channels 
currently included in the PDMS chip. This would eliminate the need for some 
parts  and,  consequently,  reduce  the  number  of  reversible  seals  required. 
Finally,  mass  production  methods  should  significantly  increase  the 
reproducibility  of  dimensions  and  therefore  flow  resistances  and  burst 
pressures. 214 
 
 
Figure 5.2 - Commercial connector concept. 
Orthographic [O] and section views [S1,S2] of a concept for a commercial connector. Section 1 [S1] shows the connector in-situ on a TC-PS component. Flow is distributed 
in the connector rather than the TC-PS component. A line of short capillaries, as seen in section 2 [S2], will both distribute flow and provide a significant resistance. The 
connector is anchored at one end by a hinge and at the other by a clip, both of which attach to the structure under the TC-PS component. 215 
 
 
Figure 5.3 - Concept for a mass produced TC-PS component. 
A concept for a mass produced TC-PS component to be used in a commercial system. 3D [a], plan 
[b], and side [c] views show a single culture chamber that has a significantly reduced footprint, as it 
relies on the connectors to distribute flow. The component is comprised of two elements: a lower 
element with recessed inlet and outlets, a deeper recessed culture chamber, and supports for the 
thin top element. The top element has rectangular holes corresponding to the inlet, outlet and 
culture chamber. These two elements could be bonded prior to surface treatment and sterilisation. 
The final image [d] shows how a 9×5 array of these culture chambers can fit in the area that can be 
imaged on the motorised microscope. 
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Another area where mass production could alter the culture device is the fluidic 
connections and the distribution of flow. The prototype and improved culture 
devices were designed to utilise simple and widely available connectors. Fluid 
flow was then expanded and contracted within the culture device by channels in 
the PDMS chip. A commercial system could make use of custom connectors to 
connect external fluidics to the culture device. These custom connectors could 
be the width of the culture chamber and include the flow distribution function in 
a vertical orientation (Figure 5.2). Such connections would eliminate the space 
requirements of the flow channels in the PDMS chip. Combined with the mass 
production of structured TC-PS components, this could reduce the area of a 
single culture device to 12×15 mm (Figure 5.3) allowing 45 culture chambers 
within the travel (110×75 mm) of the motorised microscope stage (rather than 
the current 6). 
 
Fluidics 
With the decreased variability in resistance offered by  mass produced parts, 
less additional fluidic resistance will be required to ensure equal flow distribution 
between parallel devices. A significant back pressure would still be desirable to 
prevent the build up of gas in the culture chamber. However, if this could be 
largely achieved by pressurising the waste bottle, then the pressure resistance 
of the downstream fluidics could still be reduced. Eliminating the long capillaries 
of the improved culture system would reduce the impact of fouling and small 
flow obstructions resulting in more consistent conditions. 
 
Simple  sterilisation  of  custom fluidics  would  be  a  challenge  in  a  commercial 
system. It is unlikely that the entire fluidic path could be autoclaved or sterilised 
by  steam  in  place.  The  improved  control  and  automation  platform  required 
chemical sterilisation of the flow meter, and this method may be required for all 
non-disposable  parts  in  a  commercial  system.  If  chemical  sterilisation  (e.g. 
NaOH and Ethanol) is the preferred method, care must be taken in the selection 
of construction materials to ensure compatibility. 
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For  a  commercial  process  development  tool,  the  ability  to  vary  process 
parameters between individual culture chambers remains important. Therefore, 
the  availability  of  multiple  switchable  medium  reservoirs  per  set  of  parallel 
chambers should be retained (as seen in section 3.3.7). To this end, Schott 
bottles remain a useful standard that is reusable and available in a variety of 
sizes.  To  maximise  versatility  and  economy  of  space  it  would  be  useful  if 
inactive  bottles  could  be  switched  for  new  ones  during  an  experiment.  This 
would  require  sterile  connection  changes,  which  are  becoming  common  in 
disposable biotech systems. It should also be possible to pump medium form 
different reservoirs at different rates. This would require an electronic pressure 
regulator and flow meter for each set of parallel chambers (Figure 5.4). 
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Figure 5.4 - Schematic of gas flow in a conceptual commercial system. 
A schematic of gas flow and control in a conceptual commercial system. Cycling three on/off valves 
with different timings allows control over the concentration of each gas in the mixing chamber 
(mixed by diffusion). Gas concentrations can be adjusted based on feedback from sensors at the 
chamber outlets. A needle valve reduces the pressure after the mixing chamber. After the needle 
valve, gas is split to both the medium bottles and to the lids. The gas flowing through the lids is also 
used  to  pressurise  the  waste  bottle.  The  pressure  of  the  stream  to  the  lids  is  reduced  by  an 
electronic  regulator  allowing  control  over  the  medium  flow  rate.  A  final  needle  valve  prevents 
excessive gas flow through the vent on the waste bottle. 
 
Environmental Control 
Gas is used not only to drive the perfused medium, but also to control dissolved 
oxygen  and  pH  in  the  culture  chamber.  Therefore,  it  should  be  possible  to 219 
 
control the gas composition separately for each set of parallel culture chambers. 
This can be achieved by having a single manually regulated supply of each gas 
component connected to small gas mixing chambers (one for each parallel set 
of culture chambers) by electrically actuated on/off valves (Figure 5.4). Cycling 
the valves for each gas open for different amounts of time would control the 
composition in the mixing chamber. The mixing chamber could feed both the 
medium  reservoirs,  and  the  head  spaces  of  gas  permeable  lids.  The  head 
space gas could also be used to pressurise the waste bottles, as discussed 
earlier. The lid head space and waste bottle would need a lower pressure than 
the pressure in the culture chamber. Achieving this with an electronic pressure 
regulator would also allow control over medium flow rate.  
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Figure 5.5 - Lid concept for a commercial system. 
Orthographic [O] and section views [S1,S2] of a concept for a commercial resalable lid. Section 2 
[S2] shows the connector in situ on a TC-PS component. The lid is anchored at one end by a hinge 
and at the other by a clip, both of which attach to the structure under the TC-PS component. Gas 
flows along one side of the lid from the inlet then back along the other side to the outlet. A thin gas 
permeable membrane is positioned flush with the top of the TC-PC component. The membrane is 
supported by a perforated layer of rigid plastic. 
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Continuing with environmental control, gas compositions could be controlled by 
feedback from dissolved oxygen and pH measurements. Flow through sensors 
situated downstream from the culture chambers could provide information on 
bulk  DO  and  pH  values.  The  gas  composition  could  then  be  adjusted 
accordingly.  This  information  would  also  provide  valuable  insight  into  cell 
metabolism.  Oxygen  control  could  also  be  improved  by  the  use  of  thinner 
PDMS  membranes  (currently  4.12  mm  thick).  A  shallow  chamber  in  open 
configuration would allow for such membranes, as well as easier lid ‘insertion’ 
(Figure 5.5). However, thinner membranes will require more structural support 
to prevent deformation or breakage under the pressure differential of perfusion 
culture.  Finally,  the  temperature  control  method  introduced  in  the  previous 
chapter could be extended to a commercial system; simply heating the surface 
the TC-PS sits on,, in the areas around the culture chambers. 
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Concept 
 
Figure 5.6 - Concept of a commercial system for process development. 
An  orthographic  view  of  a  concept  for  a  commercial  process  development  system.  A  TC-PS 
component (too thin to see at this scale), containing the culture chambers, sits on a heated glass 
surface with fluidic connectors and lids clipped on top. The TC-PS component has 27 rows, with 
each  row  containing  either  one  wide  culture  chamber,  or  multiple  narrower  culture  chambers 
operated in parallel. The system incorporates monitoring by microscopy with, x and y drives to 
move the light source and detection optics. A large space is allocated for storage of the medium and 
waste bottles. The surrounding space would contain the valves, regulators, sensors, circuits, and 
other control hardware. 223 
 
 
Figure 5.7 - Front and side views of conceptual commercial process development system. 
Front [a] and side [b] views of the concept for a commercial process development system pictured 
above. A TC-PS component (too thin to see at this scale), containing the culture chambers, sits on a 
heated glass surface with fluidic connectors and lids clipped on top. The TC-PS component has 27 
rows, with each row containing either one wide culture chamber, or multiple narrower culture 
chambers operated in parallel. The system incorporates monitoring by microscopy with, x and y 
drives to move the light source and detection optics. A large space is set aside for storage of the 
medium and waste bottles. The surrounding space would contain the valves, regulators, sensors, 
circuits, and other control hardware. 
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Figures  5.2-5.7  show  a  conceptual  design  based  on  the  considerations 
discussed  above.  The  complete  concept  system  shown  in  Figures  5.6-5.7 
consists of 27 rows, with each row containing one wide culture chamber, or 
multiple  narrower  culture  chambers  operated  in  parallel.  The  approximate 
dimensions  of  the  concept  system  are  0.5×0.5×0.5  m.  The  concept  system 
incorporates  online  monitoring  by  microscopy  (phase  contrast  or  digital 
holographic) and versatile control over process parameters. 
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5.2  A Small Scale Production System 
The above design could be extended to a small scale production system by 
scaling up and out. The extent to which the length of a culture chamber can be 
increased will be limited by the sensitivity of the desired process to differences 
in concentrations of consumed and secreted molecules. However, there is no 
such limitation on the width dimension of the culture chamber. Sheets of wide, 
short, parallel culture chambers could be used to produce similar numbers of 
cells to static multilayer systems with the high level of control offered by the 
microfabricated system.  
 
For example, working with a 15 mm length dimension of the chamber footprint 
(a 4 mm chamber plus connections) and increasing the chamber width to 400 
mm, a single 400×400 mm sheet would have a culture area of 416 cm
2. Twenty 
such sheets, stacked vertically, would have 8320 cm
2 of culture area, enough to 
produce 4×10
9 mESCs (high confluence cell density of 5×10
5 cells.cm
-2, other 
cell lines will vary). This is more than enough for a dose of a patient specific 
treatment  or  for  multiple  doses  of  some  allogeneic  treatments  (dose  size 
8×10
4 - 1×10
9 cells; (Mason and Dunnill, 2009)). Therefore, such a scaled up 
and  out  system  may  prove  appropriate  for the  production  of  patient  specific 
treatments or low dose allogeneic treatments for rare conditions. 
 
Assuming similar culture progress in identical culture chambers, a production 
system  would  not  require  the  same  independent  control  as  a  process 
development system i.e. all culture chambers could be controlled together. A 
production  system  could  therefore  use  a  single  gas  mixing  chamber  and 
electronic regulator, and a single set of large interchangeable medium bottles. 
This  reduced  complexity  of  the  control  system  contrasts  the  increased 
complexity of monitoring with microscope images. A separate imaging system 
for each sheet of chambers would be neither cost nor space effective. Instead 
the  system  would  need  the  capacity  to  image  multiple  sheets  with  a  single 
imaging system. 
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Concept 
The figure below (Figure 5.8) outlines a conceptual design of a production scale 
system. Multiple stacked sheets of culture chambers (4×400 mm) are operated 
in  parallel  form  a  single  set  of  medium  bottles.  An  elevating  platform  can 
withdraw any sheet from the stack and transfer it to an imaging station, allowing 
monitoring  by  microscopy.  A  liquid  handling  robot  may  allow  automation  of 
seeding and harvesting. For environmental control the whole system is housed 
in a sterile chamber heated to 37°C. 
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Figure 5.8 - Concept for a production scale system. 
A conceptual production scale culture system based on the prototype process development system presented above. Multiple stacked sheets of culture chambers (4×400 
mm) are operated in parallel form a single set of medium bottles. An elevating platform can withdraw any sheet from the stack and transfer it to an imaging station, 
allowing monitoring by microscopy. A liquid handling robot may allow automation of seeding and harvesting. The whole system is housed in a sterile chamber heated to 
37°C. 228 
 
6.  Concluding Remarks 
6.1  Summary of Results 
This  research  project  aimed  to  build  on  existing  technologies  to  develop  a 
microfabricated adherent cell culture system for stem cell process development. 
The  multipotency  and  self  renewal  of  stem  cells  make  them  a  potentially 
limitless source of human cells, suitable for both screening and regenerative 
medicine applications. However, processing stem cells is challenging due to; 
the complexity of whole cell products, the breadth of process parameters, and 
the  typical  use  of  adherent  culture.  It  is hypothesised  that  a microfabricated 
adherent culture system could facilitate process development with minimal use 
of  resources,  including  scarcely  available  cell  lines  and  expensive  growth 
factors.  Furthermore,  microfluidic  systems  offer  advantages  in  spatial  and 
temporal  control  of  the  microenvironment  that  may  benefit  process 
development. Through this project, an existing microfabricated culture system 
has  been  further  developed.  The  improved  reliability,  comparability  with 
standard  culture  systems,  and  control  over  process  parameters  of  the  new 
system should make it a useful tool for process development.  
 
The existing prototype system was critically evaluated; considering the design 
and opportunities for improvement, modelling fluid velocity, shear stress, and 
dissolved  oxygen,  and  demonstrating  the  seeding  and  perfusion  culture  of 
embryonic  stem  cells.  The  system  showed  considerable  promise  for  the 
perfusion  culture  of  adherent  embryonic  stem  cells.  The  use  of  reversible 
compression seals facilitates both traditional culture methods (static seeding) 
and materials (TC-PS). Furthermore, the prototype culture device facilitates the 
seeding  and  expansion  of  human  embryonic  stem  cells,  co-cultured  on 
inactivated mouse embryonic fibroblasts, for one day of static and two days of 
perfusion culture. However, the culture system had multiple areas of potential 
improvement,  including  both  reliability  and  control  over  medium  velocity 
distribution and pericellular dissolved oxygen. 
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The  prototype  system  was  then  improved,  based  on  this  evaluation. 
Improvements increased the reliability, ease of use, monitoring capabilities, and 
control over key process parameters. Modelling supported frame bending as the 
most  likely  cause  of  leaking  and  burst  pressure  variation  in  the  prototype 
system.  Therefore  a  new  device  holder  was  fabricated  out  of  aluminium  to 
reduce bending to acceptable levels. The opportunity was also taken to make 
culture devices easier to assemble, by reducing the number of screws and the 
sensitivity to screw torque. Improvements to the design of the PDMS chip and 
resealable lid were made to improve control over medium velocity distribution 
and  pericellular  dissolved  oxygen  respectively.  These  improvements  were 
based on modelling of the process parameters. 
 
The design of the new device holder was also influenced by a redesign of the 
surrounding process and control platform; the holder was designed such that 
two holders could position six culture chambers in the area that can be imaged 
by a motorised inverted fluorescent microscope. This microscope was used to 
enhance the monitoring capabilities of the culture system allowing automated 
time lapse imaging of multiple positions within the culture chambers. In addition 
to monitoring improvements, the external fluidics and the control hardware and 
software were redesigned to improve the ease and flexibility of operation. 
 
The effects of the system improvements were evaluated by re-investigating the 
seeding and perfusion culture of mouse embryonic stem cells. On average, the 
improved  culture  system  shows  similar  seeding  behaviour  to  the  commonly 
used T-25 tissue culture flask.  Therefore, experiments in these two systems 
can  be  conducted  with  the  same  average  starting  point  for  the  sake  of 
comparability. However, the small volume of the microfabricated devices results 
in more variability in the starting cell confluency.  
 
Initial culture experiments showed that, while the improved culture system is 
easier  to  use,  its  flow  resistance  is  variable  over  the  course  of  multi-day 
perfusion  culture  experiments.  It  was  therefore  necessary  to  implement 
feedback  control  over  the  medium  flow  rate.  With  flow  control  in  place, 230 
 
confluency monitoring showed 7% variation between experiments in the time 
taken to reach a confluency of 0.5 and 9% confluency in the time taken to reach 
a confluency of 0.8. While this indicates reasonable repeatability, confluency 
curves  also  showed  clear  variations  between  experiments.  The  reasons  for 
these  experiment  to  experiment  variations  are  unclear  and  require  further 
investigation. 
 
The overall growth rates, and the distributions of growth rate, show evidence 
that  the  introduction  of  a  gas  permeable  lid  (with  an  open  polycarbonate 
element)  increases  both  the  magnitude  and  uniformity  of  growth  rate, 
particularly  in  late  stage  culture.  Likewise  there  is  some  evidence  that  the 
improved PDMS chip decreases the magnitude and uniformity of growth rate. 
These observations are consistent with pericellular dissolved oxygen being the 
most  limiting  factor  in  the  expansion  of  the  cells.  However,  the  evidence  of 
these  design  induced  differences  is  weak  due  to  the  high  experiment  to 
experiment variability. Furthermore, it was not possible to draw conclusions on 
the first 12 hours of culture due to the presence of bubbles in some culture 
devices. 
 
The last design challenge to be overcome was a method of temperature control 
for the culture chambers. A heating system was developed that is independent 
of disposable parts, does not overly complicate the assembly or operation of the 
culture  devices,  and  could  be  operated  while  conducting  manual  operations 
such  as  cell  seeding.  The  chief  limitation  of  the  new  heating  system  is  that 
thermal gradients exist in the culture system, requiring the monitoring of a site 
offset  from  the  culture  chamber  and  relation  of  that  position  to  the  culture 
chamber. 
 
Finally,  consideration  was  given  to  the  requirements,  and  opportunities  for 
design improvement, that arise if the system is to be commercialised; firstly as a 
process  development  system  and  then  as  a  production  system.  Design 
concepts  based  on  these  considerations  are  included  this  report  in  order  to 
guide future work with the culture system. In its current state the microfabricated 231 
 
adherent culture system has improved reliability, ease of use, comparability with 
traditional culture systems, and control over process parameters, which should 
make it a useful tool for process development. Many of these features have 
been demonstrated in the investigation of design changes on the growth rate of 
mouse embryonic stem cells. 
 
6.2  Future Work 
Future work invited by this research can be broken down into; extension of the 
investigations made into the microfabricated culture system, expansion of those 
investigations,  application  of  the  system  to  process  development,  and 
commercialisation of the system. Firstly, extending the investigations presented 
here, the perfusion culture experiments of chapter four should be repeated in 
increased  numbers.  A  higher  number  of  repeats  may  make  the  evidence  of 
design induced differences in growth rate more conclusive. Repeat experiments 
may also shed light on the cause of the experiment to experiment variability 
observed. Efforts should also be made, through inclusion of the preheat and 
bubble trap unit and improvements to the method of priming, to minimise the 
inclusion of bubbles at the start of perfusion. This would allow analysis to be 
extended into early monolayer culture. 
 
At the same time the investigation could be expanded to include effects on the 
average  expression  and  spatial  distribution  of  pluripotency  markers.  The 
maintenance of pluripotency is a more important factor than growth rate in the 
expansion of embryonic stem cells. Cell fate may also prove to be more or less 
sensitive  to  factors  such  as  pericellular  dissolved  oxygen  and  shear  stress. 
Cells  could  also  be  expanded  in  the  microfabricated  culture  system  through 
multiple passages to investigate the occurrence of karyotipic changes. Another 
area  where  investigation  of  the  culture  system  could  be  expanded,  is  cell 
seeding. While it was established that mouse embryonic stem cells seed in a 
similar time and to a similar average confluency to a tissue culture flask, the 
variability  in  the  post  seeding  confluency  is  high.  Techniques  to  reduce  this 
variability could be investigated. 
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The potential applications of the culture system to process development are 
broad,  in  terms  of  both  process  parameters  and  stem  cell  processes.  The 
design is especially well suited to looking at the effects of soluble factors by 
controlling them within very narrow ranges. It would be particularly interesting to 
integrate dissolved oxygen sensors either at the outlet or on the culture surface 
to allow precise control over pericellular dissolved oxygen. Processes known to 
be affected by gas phase oxygen concentration could then be re-investigated to 
find optimal pericellular values.  
 
Finally, if it is to be widely adopted for process development applications, the 
system needs to be commercialised. Concepts of a commercial design are laid 
out in chapter 5. Implementation of the design changes, and development of the 
commercial  system  would  be  best  carried  out  by,  or  in  conjunction  with, 
industrial partners with experience of mass producing parts, and assembling 
and marketing commercial cell culture systems. If subsequent research with the 
process development system shows its control advantages are necessary for 
some developed processes, then a production system could also be developed 
(a concept is shown in chapter 5). 
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7.  Appendix 1 – Technical Drawings from Chapter 2 
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Figure 7.1 - Technical drawing of prototype bottom frame. 235 
 
 
Figure 7.2 - Technical drawing of prototype top frame. 236 
 
 
Figure 7.3 - Technical drawing of prototype PDMS chip mould. 237 
 
 
Figure 7.4 - Technical drawings of prototype lid & connector bar. 238 
 
 
Figure 7.5 - Technical drawing of prototype gasket mould.   239 
 
 
8.  Appendix 2 – Technical Drawings from Chapter 3 
 240 
 
 
Figure 8.1 - Technical drawings of the four PDMS chip designs modelled. 241 
 
 
Figure 8.2 - Technical drawing of aluminium version of prototype bottom frame. 242 
 
 
Figure 8.3 - Technical drawing of aluminium clamp. 243 
 
 
Figure 8.4 - Technical drawing of aluminium holder bottom plate. 244 
 
 
Figure 8.5 - Technical drawing of aluminium holder top plate. 245 
 
 
Figure 8.6 - Technical drawing of aluminium holder bracket. 246 
 
 
Figure 8.7 - Technical drawing of improved design top frame. 247 
 
 
Figure 8.8 - Technical drawings of aluminium connector bar & polycarbonate window filler. 248 
 
 
Figure 8.9 - Technical drawing of mould for tree-like PDMS chip. 249 
 
 
Figure 8.10 - Technical drawing of gasket mould for improved culture device. 250 
 
 
Figure 8.11 - Technical drawing of mould for PDMS lid component. 251 
 
 
Figure 8.12 - Technical drawing  of polycarbonate  lid component with options for closed, 
open, or gas connection. 252 
 
 
Figure 8.13 - Technical drawing of layer 1 (bottom) of the preheat and bubble trap unit. 253 
 
 
Figure 8.14 - Technical drawing of mould for layer 2 of the preheat and bubble trap unit. 254 
 
 
Figure 8.15 - Technical drawing of mould for layer 4 of the preheat and bubble trap element 
(plasma bonded to layer 3, a 0.12 mm spin-coated layer of PDMS). 255 
 
 
Figure 8.16 - Technical drawing of layer 5 (top) of the preheat and bubble trap unit.   256 
 
9.  Appendix 3 – Cross-sections and Second Moments 
of Inertia for Bending Calculations 
 
Multiple cross-sections are used across the width of the components modelled 
in bending calculations. Second moments of inertia were calculated for each 
rectangular feature and then adjusted for the features distance from the centre 
axis  to  give  second  moments  of  inertia  about  the  same  axis.  The  adjusted 
second moments of inertia were multiplied by the appropriate elastic modulus 
and the product added or subtracted from the previous total as appropriate. 
 
Figure 9.1 – Cross-sections of the prototype top frame used for bending calculations. 
Three cross-sections were used across the width of the top frame; a solid rectangle, a rectangle less 
the gasket and chip recesses, and a rectangle less the opening to access the culture chamber and the 
gasket and chip recesses.  257 
 
 
Figure  9.2  -  Cross-sections  of  the  prototype  bottom  frame  and  slide  used  for  bending 
calculations. 
Four cross-sections were used across the width of the bottom frame and slide; a solid rectangle, a 
rectangle less the slide recess, a rectangle less the slide recess plus the slide, and a rectangle less the 
viewing window and slide recess plus the slide. 258 
 
 
Figure 9.3 - Cross-sections of the upper components of the improved design used for bending 
calculations (part 1). 
Six cross-sections were used across the width of the upper components which included both the 
top plate of the aluminium holder and the polycarbonate top frame. 259 
 
 
9.4  -  Cross-sections  of  the  upper  components  of  the  improved  design  used  for  bending 
calculations (part 2). 
Six cross-sections were used across the width of the upper components which included both the 
top plate of the aluminium holder and the polycarbonate top frame. 260 
 
 
Figure 9.5 - Cross-sections of the lower components of the improved design used for bending 
calculations (part1). 
Four cross-sections were used across the width of the lower components which included both the 
bottom plate of the aluminium holder and the TC-PS slide. 
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Figure 9.6 - Cross-sections of the lower components of the improved design used for bending 
calculations (part1). 
Four cross-sections were used across the width of the lower components which included both the 
bottom plate of the aluminium holder and the TC-PS slide. 
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10.  Appendix 4 – Circuit Diagrams for Improved 
Culture System 
 
 
Figure 10.1 - Circuit diagram for valves controlling gas supply in improved platform. 
A 5V digital signal from the DAQ (National Instruments, UK) is used to switch the position of valves 
controlling the gas supply (Pneu-store, UK). The first two valves are to be 2-position 3-way valves 
(S070B-6CC-M3) controlling which of two gas supplies feeds the gas permeable lids of two parallel 
device sets. These valves were not installed in the initial build as only one gas supply was used. 
Valves 3-8 are normal closed on/off valves (LVM10R3Y-6A1-1-Q) to control which gas supplies are 
connected to which medium bottles. For the initial build with two medium bottles only tow valves 
were installed. The  Darlington Array and  resistors  were obtained  from Farnell,  UK. The digital 
ground of the DAQ is connected to the ground of the 12 V DC power source. 
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Figure 10.2 - Circuit diagram of electronic regulator. 
The electronic regulator (ITV0011-2BL, Pneu-Store, UK) is controlled by a 0-5V analogue output 
from the DAQ (National Instruments, UK) and powered by the 12 V power supply. 
 
 
Figure 10.3 - Circuit diagram for heating circuit control. 
The flexible heating circuits discussed in chapter 4 are controlled by a digital square wave output 
from the DAQ (National Instruments, UK) which operates a solid state relay (Farnell, UK) to connect 
the the 12 V power supply. 
 
 
 
 264 
 
 
Figure 10.4 - Circuit diagram for control of medium handling valves. 
 265 
 
 
 
 
 
 
 
 
 
 
As with the gas handling valves, switching is achieved by sending a 5 V digital output from the DAQ to a Darlington Array. The Darlington Array outputs activate 12V:24V 
DC:DC converters (JAH0212S34, Farnell, UK)  that, in-turn, power the Lee Company (Lee Company, UK) valves via Lee Company drivers (DRVA0000020A). The circuits 
around the drivers and DC:DC converters are based on specifications supplied by the manufacturer. Valves 1-3 and 5-7 are 2-position 3-way valves (LFRA1230110H) to 
select the medium bottle used to supply each of two parallel device sets. Valves 4 and 8 are normally closed ON/OFF (LFVA1230113H) valves used to purge the preheat 
and bubble trap units. 
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Figure 10.5 - Circuit diagram for thermistor measurements. 
The 10 kΩ NTC thermistors (B57863S103F40) provide analogue inputs to the DAQ via this circuit, which is taken from Marcel Reichen’s prototype platform (Reichen, 
2012). The circuit has been modified to use the single 12 V power supply via a 12V:5V DC:DC converter (IE1205D). All components were obtained from Farnell. UK. 267 
 
11.  Appendix 5 – Publications 
A number of publications by the author are related to the work presented in this 
thesis. 
The evaluation of the prototype culture device (chapter 2) is included in: 
  REICHEN, M. & MACOWN, R. J., JACCARD, N., SUPER, A., RUBAN, 
L., GRIFFIN, L. D., VERAITCH, F. S. & SZITA, N. 2012. Microfabricated 
Modular  Scale-Down  Device  for  Regenerative  Medicine  Process 
Development. Plos One, 7, e52246. 
The  improved  culture  device,  including  the  aluminium  holder  and  the 
improvement process (chapter 3), is the topic of: 
  MACOWN,  R.  J.,  VERAITCH,  F.  S.  &  SZITA,  N.  2014.  Robust, 
microfabricated  culture  devices  with  improved  control  over the  soluble 
microenvironment for the culture of embryonic stem cells. Biotechnology 
Journal, 9, 805-813. 
The  different  versions  of  image  processing  software  and  the  automation  of 
monitoring by phase contrast monitoring are covered further in: 
  JACCARD, N., GRIFFIN, L. D., KESER, A., MACOWN, R. J., SUPER, 
A., VERAITCH, F. S. & SZITA, N. 2014. Automated method for the rapid 
and precise estimation of adherent cell culture characteristics from phase 
contrast  microscopy  images.  Biotechnology  and  Bioengineering,  111, 
504-517. 
  JACCARD,  N.,  MACOWN,  R.  J.,  SUPER,  A.,  GRIFFIN,  L.  D., 
VERAITCH,  F.  S.  &  SZITA,  N.  2014.  Automated  and  Online 
Characterization  of  Adherent  Cell  Culture  Growth  in  a  Microfabricated 
Bioreactor. J Lab Autom, 2211068214529288. 
Finally, the packaging of the prototype device is discussed in: 
  REICHEN,  M.,  SUPER,  A.,  DAVIES,  M.  J.,  MACOWN,  R.  J., 
O’SULLIVAN, B., KIRK, T. V., MARQUES, M. P. C., DIMOV, N. & SZITA, 
N.  2014.  Characterisation  of  an  Adhesive-free  Packaging  System  for 
Polymeric Microfluidic Biochemical Devices and Reactors.  Chemical & 
Biochemical Engineering Quarterly, 28, 189-202. 268 
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